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ABSTRACT
Oxidative stress plays a key role in metabolic syndrome which includes obesity and
cardiometabolic diseases. It is implicated that oxygen-derived free radicals generated during the
mitochondrial electron transport chain alter the function of specific biological components, thus
activating obesogenic pathways such as glucose and lipid signaling. Research on this topic is of
vital importance as obesity is a high-risk factor in the development and progression of severe,
debilitating, life-threatening maladies such as cardiometabolic diseases, chronic inflammatory
pathologies, and cancer. Furthermore, there is no universal effective therapy to combat the rising
rates of obesity with over 1.9 billion (39%) adults classified as obese worldwide. Catalase is an
antioxidant enzyme that helps to catabolize hydrogen peroxide and has been shown in vivo
and/or in vitro to decrease oxidative stress in vascular cells, skeletal muscle tissue, and adipose
tissue which results in mitigating free radical damage in the heart, aging-effects in muscle tissue,
insulin resistance as well as dysfunctional glucose signaling, and cancer progression. With redox
stress being one of the major hallmarks of obesity, we hypothesized that overexpression of
antioxidant catalase would suppress redox stress-mediated obesogenic pathways. In our studies,
we first generated and investigated the effect of excess endogenous antioxidant by using a novel
mouse model termed “Bob-Cat.” These mice are a cross between heterozygous, leptin-deficient
mice (Ob/+) and [Tg(CAT)±] mice that ubiquitously express human catalase in addition to mouse
catalase. We first showed sex specific changes in redox stress, phenotype, metabolic parameters,
and adipose tissue function. These findings indicated this ‘stress-less’ model (overexpressing
antioxidant) would be optimal to study in combination with frequently prescribed diet and
exercise intervention strategies to alter key biomarkers related to obesogenic pathways. In an 8
week feeding study, we showed ad libitum feeding of an enriched omega 3 diet, in contrast to a

xv

high saturated fatty acid/ polyunsaturated fatty acid diet, promoted maintenance of body weight
and fat mass, increased energy metabolism, normal circadian rhythm, and insulin sensitivity
within the novel mice. These findings were evidenced to be a result of up-regulation of GPR120Nrf2 cross-talk (>30 fold, p<0.05), which to our knowledge, had not been previously evidenced
in any other studies. We also showed the role of sexual dimorphism in response to OM3 rich
diet. In relation to exercise, we showed evidence that antioxidant overexpression in addition to
moderate treadmill exercise 30 min. a day, 5 days/week for 8 weeks resulted in maintenance or
lowered body weight and fat mass, balanced energy metabolism, a normal feeding circadian
rhythm, and improvement in the lipid profile. Most interestingly, we saw significant differences
in skeletal muscle Type 1 / Type 2 fiber ratio and mRNA expression of key myokines which may
have induced a change in adipose tissue-brain cross-talk. Additionally, this study provided
evidence of an exercise and redox-induced shift in the taxa and predicted function of the gut
microbiome which beneficially impacted energy metabolism in the mice overexpressing
antioxidant catalase. Taken together, our studies suggest antioxidant overexpression is an
efficient adjuvant to diet and exercise intervention to combat metabolic dysfunction. Therefore,
the newly generated Bob-Cat mouse is an effective model to investigate redox stress in the
context of energy metabolism, metabolic tissue dysfunction, and the gut microbiome to discover
new preventative treatments and therapies to reduce the rising levels of obesity, cardiometabolic
diseases, chronic inflammatory – related illnesses, and cancer.
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CHAPTER I: INTRODUCTION
1.1 OBESITY DEFINED AND PREVALENCE
Obesity, now considered a world-wide epidemic (Sharma, Lee, Youssef, Salifu, &
McFarlane, 2017), is a serious health concern as it increases the risk of morbidity of several
pathologies including insulin resistance (IR), hypertension, dyslipidemia, type 2 diabetes (T2D),
coronary heart disease, stroke, non-alcoholic fatty liver disease (NAFLD), osteoarthritis, sleep
apnea, and numerous cancers (Savini, Catani, Evangelista, Gasperi, & Avigliano, 2013). Since
1975, global obesity rates have tripled. As of 2016, more than 1.9 billion adults (39%) are
overweight and more than 650 million are considered obese (13%) (Organization, 2018). Of
even greater concern, childhood obesity is also on the rise with more than 41 million children
less than 5 years old and 340 million children and adolescents between the ages of 5-19 years old
categorized as overweight or obese (Organization, 2018). Specifically, at the conclusion of 2018
in the United States, adult obesity rates exceeded 35% in 7 states, 30% in 29 states, and 25% in
48 states. West Virginia currently has the highest obesity rate at 38.1%. Seven states have
increased the number of obese residents in the past year, and all other states have maintained or
increased the number of obese individuals (Foundation, 2018).
Obesity is the result of a number of genetic, behavioral, and environmental factors that
contribute to disequilibrium between energy intake and expenditure (Gonzalez-Muniesa et al.,
2017; Manna & Jain, 2015). This results in accumulation of visceral adipose tissue to the extent
that both physical and psychosocial health and well-being are impaired (James, 2004). In the
clinical setting, overweight is defined as a Body Mass Index (BMI: weight (kg) / height (m2)) of
25.0 to 29.9 kg/m2 and obesity as a BMI of ≥ 30.0 kg/m 2 (Manna & Jain, 2015; Paniagua, 2016).
BMI is a robust yet indirect measure of body fat that provides more reliable information than
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“ideal weight” or other ratios involving weight and/or height. Nonetheless, exceptions to the
accuracy of BMI include athletes (higher percentages of muscle mass), the elderly, and
individuals who are extremely tall or short because it does not distinguish between lean or fat
mass (James, 2004). Additionally, although BMI is easy to measure, it indicates an overall
measure of “fat,” and does not identify the distribution of adipose tissue which directly
correlates with metabolic health (C. H. Jung, Lee, & Song, 2017). Increased visceral (central) fat
contributes to higher levels of pro-oxidant and pro-inflammatory states in addition to alterations
in both glucose and lipid metabolism in comparison to subcutaneous fat (directly under the skin).
Numerous studies have shown increased visceral fat is a high risk factor in T2D, dyslipidemia,
and cardiovascular diseases (CVD) (Figueroa et al., 2016; James, 2004; Luna-Luna et al., 2015).
For this reason, some clinicians prefer to look at the waist to height ratio in addition to the BMI
to measure the distribution of body fat. In general, higher levels of visceral adipose tissue
(abdominal, omental, and mesenteric) is more prevalent in males than females (Karastergiou,
Smith, Greenberg, & Fried, 2012). Females have higher levels of subcutaneous fat, and thus are
at lower risk for cardiometabolic diseases (Karastergiou et al., 2012). Mechanisms have not been
fully elucidated; however, higher levels of fat mass, especially within the visceral compartment,
contribute to adipose tissue dysfunction- defined as impaired adipose tissue expandability,
adipocyte hypertrophy, altered lipid metabolism, local inflammation, and dysregulation of
adipokine production and secretion (Fietta & Delsante, 2013; Goossens, 2017).
1.2 ADIPOSE TISSUE FUNCTION
Adipose tissue is currently characterized as an important endocrine organ having
autocrine, paracrine, and endocrine effects. Increases in adipose tissue deposition alter the
production and secretion of a number of cytokines- bioactive signaling molecules known as
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adipokines (Fietta & Delsante, 2013; Scherer, 2006). These alterations regulate signaling
mechanisms that control food intake, energy expenditure, inflammation, and fat storage
(Kershaw & Flier, 2004). (Figure 1) For example, leptin, a 42 kD protein, has been shown to
have a direct influence on food intake through regulating hypothalamic appetite regulating genes
(Ex. proopiomelanocortin - POMC and neuropeptide Y - NPY) (Frago & Chowen, 2015; Wilson
& Enriori, 2015).

Figure 1. Increased deposition of adipose tissue. Increases in fat mass cause
alterations in adipocytokine levels secreted by adipocytes and macrophages within
adipose tissue. These changes can result in insulin resistance, adipose tissue
inflammation and redox stress.
Histology has allowed characterization of adipose tissue according to its morphology.
Adipose tissue is classified as a type of connective tissue with specific properties (M. T. Sheehan
& Jensen, 2000) and is composed of multiple types of cells including preadipocytes, adipocytes,
immune cells (e.g. macrophages), fibroblasts, endothelial cells, and stem cells (Rosen &
Spiegelman, 2014). Preadipocytes are committed, immature forms of adipocytes and when
activated by specific transcription factors, will form mature adipocytes. Adipocytes primarily
regulate the storage and release of lipids, but they also use specific lipids for intracellular
signaling and numerous proteins (i.e. adipokines such as leptin and adiponectin) for intracellular
3

signaling and communication with nearly every system of the organism (Scherer, 2006). Immune
cells play a key role in the inflammatory response and help maintain adipose tissue integrity.
Fibroblasts play a role in the integrity of the adipose tissue by secreting precursors of the
extracellular matrix. They have also been shown to modulate the behavior and function of
epithelial cells and stem cells, but mechanisms have yet to be elucidated (R. Zhang et al., 2018).
The endothelial cells play a major role in growth and function of adipose tissue by interaction
with leukocytes, nutrients, and oxygen between circulation and adipose tissue (Villaret et al.,
2010). Finally, stem cells are mesenchymal cells with the capability of self-renewal and
multipotentiality allowing them to become adipocytes, chondrocytes, myocytes, osteoblasts, or
neurocytes dependent upon environmental factors (i.e. transcription factors). (Miana &
González, 2018)
Classically, there are two main types of adipose tissue with different origins and
functions relating to energy homeostasis. These are known as white adipose tissue (WAT) and
brown adipose tissue (BAT) (Choe, Huh, Hwang, Kim, & Kim, 2016; A. Rodriguez, Ezquerro,
Mendez-Gimenez, Becerril, & Fruhbeck, 2015; Tsoli et al., 2012). WAT is found in various
regions of the body and is primarily responsible for storing excess energy inside of its cells as
triacylglycerol which can be used during a caloric deficit (Kajimura, Spiegelman, & Seale,
2015). As previously described, the location of WAT determines its influence on metabolic
homeostasis with increased fat in the visceral region correlating with metabolic dysfunction
(Kusminski, Bickel, & Scherer, 2016). On the other hand, BAT is found in very few depots
compared to WAT. In rodents, it is found in the interscapular, axillary, and cervical regions. In
humans, the largest depot is concentrated in the interscapular region (Cypess et al., 2009;
Kajimura et al., 2015; Sacks & Symonds, 2013). The cellular structure of BAT also differs from

4

WAT in that it is highly vascularized and has a high density of mitochondria promoting nonshivering thermogenesis through the induction of uncoupling protein 1 (UCP-1) (Kajimura et al.,
2015; A. Rodriguez et al., 2015; Sacks & Symonds, 2013). Additionally, research has shown
within WAT, increased cold exposure, exercise, and/or adrenergic signaling promotes a
browning effect resulting in the formation of beige (“brite”) adipose tissue (S. H. Kim & Plutzky,
2016; J. Wu, Cohen, & Spiegelman, 2013; L. Ye et al., 2013). Beige tissue has characteristics of
both WAT and BAT. However, in relevance to obesity, like BAT, beige fat cells display higher
levels of mitochondria and increased energy-dissipating capacity by promoting triacylglycerol
clearance, glucose disposal, and thermogenic properties (i.e. induction of UCP-1) that release
energy as heat (A. Rodriguez et al., 2015).
With differences in morphology and function, research has also discovered the type and
production of cytokines differ within the various types of adipose tissue (Balistreri, Caruso, &
Candore, 2010). Key adipokines and secreted factors that have been the concentration of
numerous studies are discussed in the proceeding paragraphs: (leptin, adiponectin, tumor
necrosis factor - alpha (TNF-α), interleukin – 6 (IL-6), resistin, monocyte chemotactic protein 1
(MCP-1/JE), and UCP-1 (Abella et al., 2017; Bluher & Mantzoros, 2015).
a)

Leptin

Leptin is an adipokine (hormone) that functions in a negative feedback loop to maintain
energy homeostasis through regulating adipose tissue storage (J. Friedman, 2016). When
functioning properly, it decreases appetite and simultaneously increases energy expenditure by
binding to the long form of the leptin receptor (LepR) located on the hypothalamic neurons of
the brain. LepR is located on both neuropeptide Y (NPY) and proopiomelanocortin (POMC)
neurons on the arcuate nucleus (ARC) of the hypothalamus. When leptin binds to its receptor,
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NPY is inhibited while POMC is activated thus creating a satiety effect and increasing energy
expenditure (Flak, 2017; Funahashi et al., 2003). Due to this function, leptin is referred to as the
“satiety” hormone (Chowen & Argente, 2011). Mutations in leptin and/or its receptor promotes
obesity in both rodent models and humans (Clement et al., 1998), but leptin administration can
effectively counteract obesity (Chong, Lupsa, Cochran, & Gorden, 2010). Leptin acts on
hypothalamic neurons (in addition to other locations), and mutations affecting this neuronal
circuit elicit “Mendelian” forms of obesity (J. Friedman, 2016). When leptin levels fall, many
physiological systems are affected causing a reduction in energy expenditure. This includes, but
is not limited to, reduction or termination of menstrual cycles in females, decrease in insulin
sensitivity, and compromised immune and neuroendocrine systems (Chong et al., 2010). These
effects are all common in patients with lipodystrophy. Lipodystrophy is a condition associated
with severe metabolic disease, but leptin administration is an approved treatment for the
generalized form of this condition (Bluher & Mantzoros, 2015). Many patients characterized as
obese have high endogenous levels of leptin, and some cases are related to mutations in the
normal signaling pathway by which leptin acts. However, in the majority of patients, improper
leptin signaling is characterized as a state of leptin resistance (Kuryszko, Slawuta, & Sapikowski,
2016). Nonetheless, more research will be necessary to understand the function of this adipokine
in the context of obesity and energy metabolism.
b)

Adiponectin

In addition to leptin, adiponectin is another fat-derived hormone that accounts for 0.01%
of total serum protein, making it the most abundant adipokine in circulation (Achari & Jain,
2017; Villarreal-Molina & Antuna-Puente, 2012). Adiponectin serves as a critical signaling
molecule in the cross-talk between adipose tissue and other metabolic organs including liver,
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heart, kidney, and skeletal muscle (Z. V. Wang & Scherer, 2016). Through binding to one of its
two targeted receptors, AdipoR1 or AdipoR2, it promotes insulin sensitization, and therefore,
improvement in whole body energy homeostasis (Balistreri et al., 2010; Fang & Judd, 2018). In
skeletal muscle, adiponectin enhances fatty acid oxidation and nutrient utilization (Fang & Judd,
2018; Yamauchi et al., 2001) and in liver, gluconeogenesis is significantly suppressed by the
inhibition of genes involved in glucose production (Combs & Marliss, 2014). Most importantly,
adiponectin serves as an anti-inflammatory factor by inhibiting pro-inflammatory cytokine
signaling pathways such as tumor necrosis factor - alpha (TNF-α) – induced endothelial adhesion
molecules, and macrophage-to-foam cell transformation (Villarreal-Molina & Antuna-Puente,
2012). In addition, adiponectin also has both anti-apoptotic and anti-oxidant effects (EbrahimiMamaeghani, Mohammadi, Arefhosseini, Fallah, & Bazi, 2015; Ren et al., 2017). It is now well
established that plasma levels of adiponectin are decreased in individuals characterized as obese,
having T2D, or with a history of coronary artery disease (Villarreal-Molina & Antuna-Puente,
2012). With these known roles, adiponectin serves as a means of preventing numerous
pathological events, including but not limited to, obesity, T2D, atherosclerosis, and
cardiometabolic diseases (Achari & Jain, 2017; Z. V. Wang & Scherer, 2016).
III. TNF-alpha
Contrary to the beneficial anti-inflammatory effects of the adipokine adiponectin, TNFalpha is a pro-inflammatory cytokine secreted by adipose tissue (Engin, 2017b). Within adipose
tissue, TNF-α is produced by macrophages, adipocytes and stromal cells and is responsible for
inducing IR by blocking receptors for adiponectin (J. Liu et al., 1998). Additionally, it also
inhibits the adipose tissue’s ability to esterify fatty acids, prevents glucose transport to liver cells,
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and blocks fatty acid oxidation (Kuryszko et al., 2016). TNF-alpha can also compromise insulin
production in pancreatic beta cells thus inhibiting insulin secretion (Kuryszko et al., 2016).
c)

IL-6

Interleukin-6 (IL-6) is an adipokine, but is also expressed in other metabolic tissues such
as skeletal muscle causing it to also be considered a myokine as well as an adipomyokine
(Raschke & Eckel, 2013). In adipose tissue, it is a pro-inflammatory hormone. Approximately
30% of circulating IL-6 is derived from adipose tissue with much higher concentrations secreted
from visceral vs. subcutaneous adipose tissue depots (Kuryszko et al., 2016). Like TNF-alpha,
excessive production of IL-6 causes IR. IL-6 decreases insulin receptor expression, adipogenesis,
secretion of adiponectin, and induces liver gluconeogenesis (Kern, Ranganathan, Li, Wood, &
Ranganathan, 2001).
d)

Resistin

Like TNF-alpha, Resistin, a 12 kD peptide produced by both macrophages and
adipocytes, also exerts opposite effects compared to adiponectin (Banerjee & Lazar, 2003).
Contrary to what is desired in promoting metabolic homeostasis in individuals characterized as
obese or having one of its co-morbidities, resistin’s primary role is to maintain fasting glycaemia
by forming an excess accumulation of WAT (Kuryszko et al., 2016). Resistin induces
gluconeogenesis, increases glycogenolysis, and promotes IR. Additionally, as a proinflammatory factor, it increases the production of TNF-α, Interleukin (IL) IL-1β, IL-6, and IL12 (Kuryszko et al., 2016).
e)

MCP-1

MCP-1, monocyte- chemotactic protein-1, has now been characterized as an adipokine
due to its high abundance in adipose tissue although it is primarily expressed and secreted by
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macrophages and endothelial cells (Kanda et al., 2006; Sartipy & Loskutoff, 2003). It functions
as a potent chemotactic factor for monocytes. Increased levels of MCP-1 contribute to chronic
low-grade inflammation in adipose tissue and IR by recruitment of macrophages that infiltrate
and exacerbate the inflammatory state (Kanda et al., 2006). Another result of increased MCP-1
and infiltration of macrophages is overproduction of reactive oxygen species (ROS) and other
inflammatory cytokines (Surmi & Hasty, 2010).
f)

UCP-1

Adipose-derived UCP-1 is expressed primarily in BAT, but also in the beige cells of
WAT (Leal, Lopes, & Batista, 2018). UCP-1 dissipates the proton gradient in the form of heat by
uncoupling cellular respiration from mitochondrial ATP synthesis thus playing a key role in nonshivering thermogenesis. (Kajimura et al., 2015). With the uncoupling protein’s ability to
increase energy expenditure (S. H. Kim & Plutzky, 2016), it has been investigated as a potential
candidate to treat obesity and its related co-morbidities.
Depending on the type and level of adipokine produced, chronic low-grade inflammation
may result thus impacting other metabolic tissues that contribute to overall energy homeostasis
(skeletal muscle, brain, liver, gut-microbiome). Although the precise mechanisms are still
unclear, dysregulated production or secretion of these adipokines caused by excess adipose tissue
and/or adipose tissue dysfunction can contribute to the development of obesity-related metabolic
diseases.
1.3 THE REDOX STATE
Redox stress is an imbalanced oxidative or reductive environment which leads to
detrimental effects such as increased production of oxidative free radicals and ROS (Rani, Deep,
Singh, Palle, & Yadav, 2016), alterations in metabolic signaling pathways, increased
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inflammation, and eventually cell death. ROS are a normal product of cellular metabolism and at
low or moderate concentrations, they function to control physiological cell processes (Birben,
Sahiner, Sackesen, Erzurum, & Kalayci, 2012). However, excessive ROS (high levels of
oxidants) can attack cellular proteins, lipids, and nucleic acids resulting in dysregulation of
energy metabolism, altered cell signaling and cell cycle control, gene mutations, dysfunctional
cellular transport, a hampered immune system, and increased inflammation (Rani et al., 2016).
This shift in redox balance is termed “oxidative stress.” Nonetheless, a balance is required
between oxidants and antioxidants. Therefore, not only are excessive levels of oxidants
detrimental, significantly lower oxidants compared to reducing factors result in disorder when
the body naturally attempts to compensate to resume redox homeostasis (Korge, Calmettes, &
Weiss, 2015; Lloret, Fuchsberger, Giraldo, & Vina, 2016; Mentor & Fisher, 2017; L. J. Yan,
2014). The excessive levels of reducing reagents/oxidants has been coined “reductive stress”
(Lipinski, 2002).
The major oxidants involved in normal cellular metabolism include the superoxide anion,
hydroxyl radical, and hydrogen peroxide (H2O2). Xanthine oxidase, nicotinamide adenine
dinucleotide phosphate (NADPH), and electron leakage in the electron transport chain all
stimulate the formation of the superoxide anion as well as hydrogen peroxide through specific
redox reactions. Additionally, when dismutated by superoxide dismutase (an endogenous
antioxidant), H2O2 is generated as one of the products (Birben et al., 2012). H2O2 can then be
broken down further into water and oxygen by endogenous antioxidants: catalase or glutathione
peroxidase.
In order to maintain redox homeostasis, such as when there are excessive levels of
oxidants (as occurs in oxidative stress), the antioxidant response system is activated. Numerous
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studies have investigated this system in the context of obesity, chronic pathologies, and
metabolic dysfunction (Brewer, Mustafi, Murray, Rajasekaran, & Benjamin, 2013; J. Chen,
Zhang, & Cai, 2014; Gao et al., 2007; Tarantini et al., 2018). The transcription factor, nuclear
factor erythroid 2-related factor 2 (Nrf2), plays a key role in the antioxidant response system. In
a quiescent environment, the transcription factor interacts with kelch like ECH associated protein
1 (Keap1) in the cytoplasm, thus maintaining a low expression of Nrf2 target genes.
Nevertheless, when stimulated by oxidative and electrophilic stress factors, Nrf2 disassociates
from Keap1, translocates to the nucleus and induces the expression of several antioxidant genes
(i.e. catalase) which are able to aid in regaining redox homeostasis (Kensler, Wakabayashi, &
Biswal, 2007).
Redox balance is commonly assessed by evaluating markers of antioxidant defense or
oxidative stress. The most widely used biomarkers of the antioxidant environment are tissue
levels or plasma concentrations of antioxidant enzymatic activity (Superoxide dismutase (SOD),
glutathione peroxidase (GPX), and catalase), non-enzymatic antioxidants (vitamin E, vitamin C,
glutathione, and retinol), and minerals (selenium, zinc, and manganese) (Savini et al., 2013).
Other studies have also used the total antioxidant capacity (TAC) to study the integrated action
of all plasma antioxidants (Pinchuk, Shoval, Dotan, & Lichtenberg, 2012). High levels of
oxidants can be measured either directly or indirectly. Electron spin resonance (ESR) and
immune spin trapping are two methods to directly measure oxidative stress (O.S.) (M. C. Lee,
2013). Indirect methods such as oxidized protein carbonyl groups, 3-nitrotyrosine, advanced
glycosylation end products, and advanced oxidation protein products, F2-isoprostanes,
malondialdeyde, oxidized low-density lipoproteins (LDLs), thiobarbituric acid reactive
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molecules, and 4-hydroxynonenal assays focus on measurement of the end-products of oxidative
damage (Savini et al., 2013).
1.4 ASSOCIATION OF THE REDOX STATE AND OBESITY
Excessive fat accumulation, resulting from higher energy intake vs. expenditure, can
occur due to a high calorie/low nutrient rich diet, low physical activity (sedentary lifestyle),
nutritional/early- life hormonal status, as well as genetic, cultural, and economic factors
(Gonzalez-Muniesa et al., 2017; Savini et al., 2013; Sies, Stahl, & Sevanian, 2005; Silventoinen
et al., 2016). Numerous epidemiological, clinical, and animal studies have provided evidence
that obesity is coupled with redox stress and increased risk for cardiometabolic diseases in both
sexes and is independent of age (Carrier, 2017; Codoner-Franch et al., 2012; Hermsdorff et al.,
2014; Karaouzene et al., 2011; Krzystek-Korpacka et al., 2008; Rani et al., 2016; Tran, Oliver,
Rosa, & Galassetti, 2012). Numerous studies conducted throughout the past decade have shown
juvenile aged individuals who were obese or overweight have high levels of oxidative stress
compared to lean individuals (Tran et al., 2012). Additionally, adult obese subjects show higher
levels of oxidized lipids including oxidatively modified low density lipoproteins (oxLDLs),
arachidonic acid oxidation products (AAOPs), and thiobarbituric acid reactive substances
(TBARS) in comparison to control subjects (D'Archivio et al., 2012). Additionally, other studies
have shown BMI, total body fat, and waist circumference were positively correlated with urinary
F2-isoprostane levels (Keaney et al., 2003). Oxidative stress levels have also been evaluated in
highly metabolic tissues and body systems. In DIO models, cerebrocortical O.S. was shown to be
increased (Freeman et al., 2013), a positive correlation was observed between O.S. and
mitochondrial dysfunction in both skeletal muscle and liver (Yuzefovych, Musiyenko, Wilson, &
Rachek, 2013), and in a third study there were increased levels of lipid and protein oxidation as
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well as markers indicative of apoptosis (S. Wang & Kaufman, 2012). Additionally, excess fat
mass can increase the inflammatory state. This is important with the accumulating evidence of an
association between oxidative stress and inflammatory markers, hyperlipidemia, and
hyperglycemia in overweight and obese subjects (Codoner-Franch et al., 2012; Pou et al., 2007).
Combined, these studies implicate the interaction between O.S. and obesity/fat mass in addition
to the negative consequences on tissue function and energy metabolism.
In contrast to assessing levels of oxidative stress by determining if there are increased
levels of oxidants, there is also evidence showing that circulating antioxidant levels are lower
and/or antioxidant defense mechanisms are compromised in obese individuals (Gutierrez-Lopez
et al., 2012; Nikolaidis, Kerksick, Lamprecht, & McAnulty, 2012). Specific relationships
between the BMI, body fat, and antioxidant defense signaling mechanisms are still being
investigated due to variability in results. Differing outcomes in past research is likely a result of
differences in availability of antioxidants and functionality of antioxidant defense systems in
each individual (Savini et al., 2013). It is well-documented that antioxidant expression and
enzymatic activity is progressively depleted as obesity worsens. Therefore, depending on the
characteristics of the obese individual analyzed including the progression of obesity,
inflammatory state, and dietary intake/ physical activity levels, antioxidant levels could
dramatically differ. Nonetheless, despite variability between individuals in the aforementioned
research, there are some consistencies in the data. In Attica, Greece an inverse relationship
between visceral fat and TAC was shown independent of sex, age, physical activity level, and
dietary habits. It was interesting that the correlation between the two variables was stronger for
waist circumference than BMI (Chrysohoou et al., 2007). Then, another study showed the TAC,
vitamin C, and vitamin E were lower while hydroperoxides and carbonylated proteins were
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higher in obese patients compared to their lean controls (Karaouzene et al., 2011). Endogenous
enzymatic antioxidants SOD, catalase, and GPx activity was also found to be inversely related to
BMI regardless of age (Amirkhizi, Siassi, Djalali, & Shahraki, 2014; Mittal & Kant, 2009;
Viroonudomphol et al., 2000). Additionally, specifically in obese women, serum GPx activity
levels were significantly increased after a reduction in body weight (Bougoulia, Triantos, &
Koliakos, 2006). Some studies have indicated a dietary effect on antioxidant content as well. In
mice, when fed a high fat diet, there were increases in antioxidant activity within heart tissue,
and specifically, a rapid induction of catalase. This is expected to have occurred to protect the
mitochondria from being damaged due to high oxidants being produced (Rindler, Plafker,
Szweda, & Kinter, 2013).
Individuals who are overweight or obese tend to have diets low in minerals and vitamins
that contribute to inadequate antioxidant defenses that aid in protection from oxidative stress
(Strauss, 1999; Via, 2012). In obese children, it was reported that there were lower levels of
selenium, especially when the individuals had higher levels of central adiposity (Ortega et al.,
2012). Furthermore, in morbidly obese patients, low levels of magnesium, selenium, iron, and
zinc were observed (Kaidar-Person, Person, Szomstein, & Rosenthal, 2008b). In addition to
metals, low levels of carotenoids have been inversely related to BMI and central fat distribution
in a number of different studies in obese patients (Andersen et al., 2006; Canoy et al., 2005;
Harnroongroj et al., 2002; Kaidar-Person et al., 2008b; Reitman, Friedrich, Ben-Amotz, & Levy,
2002; Schleicher, Carroll, Ford, & Lacher, 2009; Strauss, 1999).
1.5 CONDITIONS THAT GENERATE REDOX STRESS
Free radicals, including reactive oxygen species (ROS) and reactive nitrogen species
(RNS), are produced by several mechanisms in individuals with high levels of adiposity
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including dyslipidemia (Furukawa et al., 2004), hyperglycemia (Grattagliano, Palmieri,
Portincasa, Moschetta, & Palasciano, 2008), increased inflammation (Bondia-Pons, Ryan, &
Martinez, 2012), dysfunction of metabolic tissues (Serra, Mera, Malandrino, Mir, & Herrero,
2013), hyperleptinemia (Beltowski, 2012), and post ingestion of a high fat and/or high
carbohydrate meal (Sies et al., 2005). When adipose tissue depots become full and adipocytes
can no longer store triglycerides (TG), lipotoxicity occurs and ectopic fat accumulates in tissues
including the heart, skeletal muscle, liver, and pancreas. As fat accumulates, organ dysfunction
results and free radicals are formed. One mechanism by which this occurs is inhibition of the
adenosine nucleotide translocator which results in adenosine triphosphate (ATP) accumulation in
mitochondria, reducing the speed of oxidative phosphorylation, leading to mitochondrial
uncoupling and free radical production. This was shown to occur in the skeletal muscle and liver
of rodents provided a high fat diet (Serra et al., 2013; Yuzefovych et al., 2013). Ectopic fat
accumulation also blocks glucose and insulin signaling pathways (Coen & Goodpaster, 2012;
Olivares-Corichi, Viquez, Gutierrez-Lopez, Ceballos-Reyes, & Garcia-Sanchez, 2011), and
hyperglycemia enhances the glycolytic pathway/ tricarboxylic acid (TCA) cycle promoting
nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FADH)
overproduction (J. Wu, Jin, Zheng, & Yan, 2016). This leads to electron leakage and thus
superoxide (ROS/free radical) production. Superoxide is then able to inhibit glyceraldehyde-3phosphate dehydrogenase which redirects metabolites of the normal TCA cycle to alternative
pathways which induce further oxidative stress as well as nitrosative stress (J. Wu et al., 2016).
Free radical production then progresses even further since hyperglycemia/oxidative
stress/inflammation is an ongoing, vicious cycle. Many inflammatory mediators disrupt insulin
signaling and exacerbate both ROS and glucose levels (Bondia-Pons et al., 2012). Another
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mechanism by which free radicals are produced from increased adiposity is Endoplasmic
Reticulum (ER) stress. In a homeostatic environment, the ER favors disulfide bond formation
and proper protein folding. However, during ER stress, the unfolded protein response is
activated. If prolonged, chronic oxidative protein folding machinery promotes ROS production
in addition to release of free fatty acids and inflammatory mediators (S. Wang & Kaufman,
2012).
Metabolic tissue dysfunction increases oxidative stress as well as inflammation by
exacerbating insulin resistance, hyperglycemia, and hypertriglyceridemia. In adipose tissue an
increased expression of MCP-1, 2, and 4 recruits macrophages and leads to overproduction of
ROS and additional inflammatory cytokines (Surmi & Hasty, 2010). Additionally, adipose
dysfunction leads to deletion of redox sensitive, Nrf2, which weakens antioxidant defenses (Xue
et al., 2013).
As previously mentioned, leptin is an adipokine that regulates appetite and prevents
lipotoxicity in non-adipose tissue (Paz-Filho, Mastronardi, Wong, & Licinio, 2012).
Hyperlipidemia induces O.S. primarily by increased mitochondrial fatty acid oxidation (Ceci et
al., 2007). It also promotes inflammation by recruitment of macrophages and induction of TNFalpha and IL-6 (Tilg & Moschen, 2006).
Overweight and obese individuals generally consume diets higher in fat and
carbohydrates which is another contributor to O.S. in obesity. In fact, obese subjects show
evidence of having an exacerbated and prolonged oxidative and inflammatory response to a large
high fat/high carbohydrate meal than lean individuals (C. Patel et al., 2007). Therefore, chronic
intake of high fat and carbohydrate diet in obese individuals has an increased adverse effect in
comparison to a normal weight individual consuming the same diet.
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1.6 REDOX STRESS IS ASSOCIATED WITH OBESITY AND ITS COMORBIDITIES
Current research provides evidence that oxidative stress may be the mechanistic link
between obesity and its co-morbidities including metabolic syndrome, T2D, CVD, and cancer
(Manna & Jain, 2015; Rani et al., 2016; Savini et al., 2013). A flow chart of this process is
depicted in Figure 2.

Figure 2. Associations among obesity, oxidative stress, and other metabolic and chronic
diseases. Current research provides evidence that redox stress may be the mechanistic link
between obesity, its comorbidities, and other chronic diseases. Relationships linking the three
are shown in the flow chart above.
I. Metabolic Syndrome
Metabolic syndrome (MetS) is characterized as a cluster of cardiometabolic risk factors
associated with central adiposity and IR including hypertriglyceridemia, high levels of lowdensity lipoproteins (LDL), low levels of high-density lipoproteins (HDL), IR, hyperglycemia,
and hypertension (Bonomini, Rodella, & Rezzani, 2015). An individual with central adiposity
and two or more of these conditions is characterized as having the metabolic syndrome (Carrier,
2017; Savini et al., 2013). Location of adipose depots is a strong determinant in levels of O.S.
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and inflammation. Increased levels of visceral fat, having high levels of resident macrophages
and cytokines in comparison to subcutaneous adipose tissue (Harman-Boehm et al., 2007),
promotes higher levels of oxidative stress and inflammation, making it a high risk factor for
MetS (Bonomini et al., 2015). A study investigating the relationship between visceral fat mass
and MetS in patients with high central adiposity demonstrated visceral fat area was strongly
correlated with O.S. and MetS when high levels of oxidants were observed in the urine (Fujita,
Nishizawa, Funahashi, Shimomura, & Shimabukuro, 2006). Numerous additional studies have
used in vivo and ex vivo models that have also demonstrated the role of oxidative stress in the
development of MetS (Bryan, Baregzay, Spicer, Singal, & Khaper, 2013; Furukawa et al., 2004).
High ROS also contributes to IR, a common disease of MetS, through several mechanisms
involving activation of signaling kinases (Dokken, Saengsirisuwan, Kim, Teachey, & Henriksen,
2008), chronic inflammation by induction of pro-inflammatory cytokines such as TNF-alpha and
IL-6 (Styskal, Van Remmen, Richardson, & Salmon, 2012), as well as damage to insulinstimulated signals in its downstream signaling pathways (Bryan et al., 2013).
Increased levels of ROS also induce hypertension in obese subjects. One key mechanism
is through deregulation of insulin signaling by modifying the phosphatidylinositol 3-kinase
(PI3K)/ protein kinase B (Akt) pathway in endothelial cells. This decreases Nitric Oxide
(NO/NOX) synthesis and vasodilation while increasing blood pressure. Additionally, the reninangiotensin system is activated which further promotes hypertension (Whaley-Connell &
Sowers, 2012).
Liver dysfunction, promoted by redox stress and inflammation in obesity, contributes to
other aspects of MetS such as dyslipidemia, hypertriglyceridemia, high cholesterolemia, and low
HDL levels (Bryan et al., 2013). Additionally, low HDL levels can exacerbate O.S. by an
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inability to bind to transition metals used to eradicate oxidative species when there are already
high levels of oxidants (Bjelakovic, Nikolova, Gluud, Simonetti, & Gluud, 2012). This has the
propensity to perpetuate a negative continuous cycle of increasing O.S. and complications of the
MetS.
II. Type 2 Diabetes
T2D, non-insulin-dependent diabetes mellitus, develops as a result of hyperinsulinemia in
individuals with excess adiposity levels. When insulin-resistance develops, the pancreatic β-cells
undergo hyperplasia to compensate for low insulin sensitivity which can lead to exhaustion and
β-cell death (Cerf, 2013). Additionally, over time, hyperglycemia ensues due to lack of insulin
and β-cells which can promote ROS and RNS formation. At this point, β-cells begin to die due to
a low scavenging capacity when in an environment of chronic oxidative stress and adipokine
secretion (Chetboun et al., 2012; Dandona, Aljada, Chaudhuri, Mohanty, & Garg, 2005).
III. Cardiovascular Disease
In obesity, high levels of visceral fat, in addition to IR, oxidative stress, mitochondrial
dysfunction, endothelial dysfunction, and altered NO release are key factors in the development
of CVD (Figueroa et al., 2016; Luna-Luna et al., 2015; Parthasarathy & Santanam, 1994; Standl,
2012). One manner O.S. promotes the development of atherosclerosis and thrombosis is by
inhibiting the protective effects of NO in endothelial cells. Progression of vascular disease is
then exacerbated by obesity and hypertension which cause an induction of NOX-derived ROS
and release of cytokines which begins a continuous and vicious cycle (Carnevale et al., 2014;
Furukawa et al., 2004; Savini et al., 2013). ROS also triggers oxidation of LDL and macrophage
activation which promotes the formation of foam cells and atherosclerotic lesions (Ferretti,
Bacchetti, Masciangelo, & Bicchiega, 2010; Santanam, Auge, Zhou, Keshava, & Parthasarathy,
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1999; Shimasaki, Maeba, Tachibana, & Ueta, 1995; N. Wang et al., 1996). With regard to
adipose tissue, altered adipokine levels (leptin, resistin, chemerin, vaspin, visfatin, and omentin)
are correlated with cardiometabolic diseases (DeClercq, Enns, Yeganeh, Taylor, & Zahradka,
2013; Guzik, Mangalat, & Korbut, 2006). Elevated levels of leptin directly damage endothelial
and vascular smooth muscle cells which induce the secretion of lipoprotein lipase, retention of
lipoproteins, and formation of foam cells (Beltowski, 2012). Evidence has also been shown for
an age effect in obesity-associated vascular complications where elderly individuals are more
vulnerable to obesity-associated vascular diseases in comparison to the younger population. This
has been postulated to occur due to increased obesity-induced inflammation in perivascular
adipose tissue which elevates O.S. and inflammation (Bailey-Downs et al., 2013).
IV. Cancer
Cancer can also be stimulated as a result of redox imbalances in obesity. Evidence has
been provided from epidemiological studies that there is a positive correlation between BMI, fat
distribution, obesity, and cancer oncogenesis (Calle, Rodriguez, Walker-Thurmond, & Thun,
2003; Engin, 2017a; Martinez-Useros & Garcia-Foncillas, 2016). In fact, obesity was responsible
for approximately 14% and 20% of cancer deaths in men and women respectively in the past two
decades with obesity-associated mortality for primarily prostate and stomach cancer in men and
breast, endometrium, cervical, uterine, and ovarian cancer in women (Calle et al., 2003). Even
intermediate levels of O.S. cause DNA damage resulting in genomic instability and induction of
oncogenes/ inhibition of genes involved in suppressing tumor growth (Crujeiras, Diaz-Lagares,
Carreira, Amil, & Casanueva, 2013). For example, it was shown that oxidative metabolites of
estrogens in breast cancer stimulated ROS generation causing DNA oxidative damage and
promotion of cancer progression (Crujeiras et al., 2013). Evidence for O.S. with inflammation
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promoting oncogenesis was shown when IR patients were at higher risk for several types of
cancer through the activation of PI3K/Akt and rapamycin (mTOR) pathways (Vucenik & Stains,
2012).
1.7 THERAPIES TO COUNTERACT OBESITY AND ITS COMORBIDITIES BY
MODIFYING THE REDOX STATE
I.

Vitamins and Phytochemicals

With the significant amount of evidence showing O.S. plays a key role in metabolic
syndrome and its related pathologies, research has investigated the use of vitamins/dietary
supplements effective in counteracting free radicals. A plethora of studies have established there
is a strong correlation between redox balance/metabolic stability and diets rich in
phytochemicals/antioxidants (Crujeiras, Parra, Rodriguez, Martinez de Morentin, & Martinez,
2006; Gonzalez-Castejon & Rodriguez-Casado, 2011). Their mechanism of action primarily
stems from scavenging or neutralization of free radicals, induced antioxidant enzymatic activity,
and anti-inflammatory effects (Del Rio et al., 2011; O'Neil, Nicklas, Rampersaud, & Fulgoni,
2012). A beneficial role of citrus fruits in obesity and its co-morbidities has been shown in
numerous studies. The positive effects of citrus juices in relation to obesity have been shown in
neutralizing O.S. and inflammation in individuals consuming high fat/high carbohydrate meals
and obese children (Codoner-Franch et al., 2010; Ghanim et al., 2010). Additionally, broccoli
and carrots, known to have high concentrations of phytochemicals, improve oxidative stress
levels and increase serum antioxidant levels (Bahadoran et al., 2011; Potter, Foroudi, Stamatikos,
Patil, & Deyhim, 2011). Direct antioxidant supplementation by intake of Vitamin E and C has
been thought to be beneficial to obese individuals since there is a high rate of deficiency of these
vitamins in individuals with high levels of adiposity and/or IR (Aasheim & Bohmer, 2008;
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Kaidar-Person, Person, Szomstein, & Rosenthal, 2008a; Schleicher et al., 2009; Via, 2012).
Additionally, most observational studies have shown these vitamins are inversely associated with
cardiometabolic diseases and cancer. Nonetheless, results are controversial in supplementation
with Vitamin E. Some short-term studies show lowering of oxidative stress and improved lipid
profile while others show no effect, increased risk for CVD, or higher incidences of cancer
(Bjelakovic et al., 2012; Chae, Albert, Moorthy, Lee, & Buring, 2012; Garelnabi et al., 2012).
Vitamin C is non-toxic and has been shown to be beneficial in individuals with hypertension and
lowering the risk of CVD and cancer (Boekholdt et al., 2006; Juraschek, Guallar, Appel, &
Miller, 2012; Pfister, Sharp, Luben, Wareham, & Khaw, 2011). Therefore, it is recommended if
individuals are deficient since there are little side effects (Savini et al., 2013). Incorporating
polyphenols into the diet is another method of increasing antioxidant activity. Like Vitamin C
and E, it has been reported that obese individuals have lower serum levels of some polyphenols
(Suzuki et al., 2006). Therefore, dietary incorporation of foods high in polyphenols may prove to
be beneficial. Furthermore, some short-term clinical trials have studied the impact of
polyphenols on obesity and its comorbidities and observed a beneficial role in almost every study
evaluating oxidative stress/inflammatory markers, glucose homeostasis, and risk factors of
cardiometabolic diseases (Hokayem et al., 2013; Leiherer, Mundlein, & Drexel, 2013).
II.

Dietary Intervention

Dietary fatty acid composition has a profound effect on measures of oxidative stress and
energy homeostasis (Calder et al., 2011; Sies et al., 2005). Therefore, incorporating dietary
compounds evidenced to be effective in improving the redox state and energy metabolism may
be beneficial to obese individuals and those at high risk for its comorbidities. Diets rich in
saturated fatty acids (SFA) have been shown to increase fat deposition and body weight (Calder
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et al., 2011; Yuzefovych et al., 2013). Diet Induced Obesity (DIO) rodent models (i.e. C57Bl6
mice) are routinely used to investigate metabolic changes as a result of increased fat deposition
among the various fat pads. Generally, diets comprised of > 40% high-fat lard, milk, and butter
(primarily composed of SFA) fosters excess lipid storage in adipose tissue leading to adipocyte
hyperplasia and hypertrophy, abnormal adipokine secretion, hypoxia, elevated circulating free
fatty acids (FFA), endothelial dysfunction, and ectopic fat deposition in less than 8 weeks of
SFA diet intervention (Choe et al., 2016; Heydemann, 2016; Snel et al., 2012). Additionally,
adipose tissue inflammation is increased consequently to high levels of fat mass which induces a
pro-inflammatory state further inducing IR and inflammation in other metabolic tissues (liver,
skeletal muscle, and pancreas) (Z. Chen, Yu, Xiong, Du, & Zhu, 2017; Snel et al., 2012). The
fatty acid composition, length, and degree of saturation determine the severity of consequences
to a high-fat diet (HFD) (McArdle, Finucane, Connaughton, McMorrow, & Roche, 2013; Yeop
Han et al., 2010). Opposing the negative effects of diets high in saturated fat, diets primarily
comprised of unsaturated fatty acids have shown evidence toward being beneficial to metabolic
function (Albracht-Schulte et al., 2018; Luo et al., 2016; Saini & Keum, 2018; Shahidi &
Ambigaipalan, 2018). In humans, Mediterranean Diets (rich in fruits, vegetables, legumes, nuts,
oily fish, low-fat dairy products, and olive oil as the primary source of fat) exert preventive
effects in incidence or mortality from obesity, CVD, stroke, cancer, as well as neurodegenerative
diseases (Agnoli et al., 2013; Buckland et al., 2013; Demarin, Lisak, & Morovic, 2011;
Hadziabdic, Bozikov, Pavic, & Romic, 2012; Samieri, Okereke, E, & Grodstein, 2013; Sofi,
Abbate, Gensini, & Casini, 2010; Visioli, Grande, Bogani, & Galli, 2004). This effect was shown
in a study on abdominally overweight men and women where the Mediterranean Diet reduced
O.S. and inflammation after eight weeks of diet intervention (van Dijk et al., 2012). Omega 6
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polyunsaturated fatty acids (OM6 PUFA) include conjugated linoleic acids (CLA), which are
prevalent in meat and dairy products. These fatty acids have been investigated for their antiobesity and anti-diabetic effects in specific animal models showing results of decreased energy
intake, lipogenesis, increased energy expenditure, and increased lipid catabolism. Nonetheless,
numerous other studies have shown no effect on loss of fat mass (Dilzer & Park, 2012).
Additionally, no evidence has been provided on antioxidant defense systems after
supplementation of CLA in human trials (J. Kim, Paik, Shin, & Park, 2012). Monounsaturated
fatty acids (MUFA - major component of olive oil) and Omega 3 polyunsaturated fatty acids
(OM3 PUFA - major component in oily fish) have shown evidence of a protective role against
obesity, oxidative stress, and cardiometabolic diseases by in vitro and in vivo studies. In one
study, when SFA was replaced by MUFA for eight weeks, metabolic stress was reduced through
decreases in oxidative phosphorylation and apoB concentrations in men and women with high
levels of central adiposity (van Dijk et al., 2012). Specifically, diets with high concentrations of
fish oil (high OM3) have been mechanistically shown to lower systemic IR (Oliveira et al.,
2015), decrease fasting TG levels (Bargut, Silva-e-Silva, Souza-Mello, Mandarim-de-Lacerda, &
Aguila, 2016) and cholesterol levels (Ide & Koshizaka, 2018; Tani, Matsuo, & Matsumoto,
2018), and reduce inflammation (Oliveira et al., 2015). This directly opposes the effects that
have been evidenced in diets comprised of high levels of SFA (lard based HFD) (Bargut et al.,
2016; Yeop Han et al., 2010). Mechanisms behind the effects of OM3 supplementation were
better understood by Olefsky’s group when G-protein coupled receptor 120/Free fatty acid
receptor 4 (GPR120/FFAR4) was discovered (D. Y. Oh et al., 2010). GPR120 is a receptor for
long chain OM3 free fatty acids that is highly expressed in adipose tissue. Since its discovery,
researchers have shown its proposed mechanistic role in improving adipose tissue function and
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energy metabolism by its insulin sensitizing and anti-inflammatory effects (D. Y. Oh & Olefsky,
2012; D. Y. Oh et al., 2010; D. Y. Oh et al., 2014). OM3 fatty acids alter the balance of reductive
and oxidative species, and are additionally critical in glucose and lipid metabolism (McDonald,
O'Kane, McConville, Devine, & McVeigh, 2013; D. Y. Oh et al., 2010). Furthermore, alterations
in redox homeostasis through increased intake of OM3 fatty acids have been linked to activation
of the Nrf2 pathway (Cipollina, 2015; Kusunoki et al., 2013). Nrf2 is a transcription factor, key
in regulating redox homeostasis (Seo & Lee, 2013) by inducing the transcription of endogenous
antioxidants including catalase, glutathione transferase, heme oxygenase (HO-1), and NAD(P)H:
Quinone Oxidoreductase 1 (S. E. Lee et al., 2015; Yamamoto, Kensler, & Motohashi, 2018; Zhu
et al., 2008). Therefore, overall, these studies have pointed to plausible mechanisms by which
varying dietary fat composition (with particular emphasis on OM3 enriched diet) can influence
metabolic homeostasis by regulating the redox state.
III.

Exercise Intervention

Physical activity is a highly effective, non-pharmacological approach to preventing
dyslipidemia, hyperglycemia, hypertension, IR/T2D, atherosclerosis, CVD, osteoporosis, and
even some cancers (Golbidi & Laher, 2014; Leal et al., 2018; Nunan, Mahtani, Roberts, &
Heneghan, 2013; Savini et al., 2013). The mechanisms involved stem from an overall increase in
energy expenditure that results in a reduction of fat mass and body weight (Fiuza-Luces,
Garatachea, Berger, & Lucia, 2013; Golbidi, Mesdaghinia, & Laher, 2012; Leal et al., 2018).
Additionally, physical activity improves the lipoprotein profile through decreasing TG and LDL
and increasing HDL levels (Fiuza-Luces et al., 2013; Sanchis-Gomar, Fiuza-Luces, & Lucia,
2015; Warburton, Nicol, & Bredin, 2006). Exercise has also been shown to enhance glucose and
insulin signaling (Garelnabi et al., 2012; Tan, Du, Zhao, Pang, & Wang, 2018), lower systemic
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inflammation (Pedersen & Febbraio, 2012; Pil-Byung et al., 2011), improve cardiac function
(Barauna et al., 2005; Laterza et al., 2007; Phillips, Mahmoud, Brown, & Haus, 2015), boost
physical performance (Vina, Sanchis-Gomar, Martinez-Bello, & Gomez-Cabrera, 2012), and
augment neurological function (Radak, Marton, Nagy, Koltai, & Goto, 2013). Many of these
beneficial effects may be linked to the evidence that physical activity paradoxically increases
redox stress and in turn signals antioxidant production which aids in facilitation of redox
homeostasis (Done & Traustadottir, 2016; Mach & Fuster-Botella, 2017; Meilhac,
Ramachandran, Chiang, Santanam, & Parthasarathy, 2001; Savini et al., 2013; Vina et al., 2012).
The physical stress involved in physical activity modulates the structure and function of a
number of metabolic tissues including liver, adipose tissue, and skeletal muscle (Guo, Liong, So,
Fung, & Tipoe, 2015; Leal et al., 2018). During physical activity, skeletal muscle, the largest
human endocrine organ, generates the energy necessary for movement primarily by carbohydrate
and lipid oxidation, thus constituting it as a key player in energy metabolism (Iizuka, Machida, &
Hirafuji, 2014; Pedersen, 2013). Skeletal muscle is composed of numerous types of cells
including motor neurons, stem cells, fibroblasts, adipocytes, pericytes, connective tissue, and
muscle fibers (Ex. Type 1 and 2). Not only are genes upregulated to maintain energy
homeostasis by regulating glucose levels (i.e. glucose transporter 4 – GLUT 4) and producing
adequate levels of ATP (Fryer et al., 2002; Holmes, Kurth-Kraczek, & Winder, 1999) upon
increased skeletal muscle contraction in aerobic exercise, there are also shifts in the muscle fiber
type ratio toward higher levels of Type 1 / Type 2 muscle fibers (Fry et al., 2017; Y. X. Wang et
al., 2004). Additionally, there are alterations in the expression and secretion of bioactive
secretory factors termed myokines (e.g. GLUT 4, PGC1-alpha, FGF-21) (Iizuka et al., 2014).
Specifically, Fibroblast Growth Factors (FGFs) and Interleukins (Ex. IL-6 and IL-15) play an
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important metabolic or immunological role with autocrine and paracrine functions (S. M.
Sheehan, Tatsumi, Temm-Grove, & Allen, 2000). Research to date concentrating on the
autocrine, paracrine, and endocrine effects of myokines have contributed to our knowledge of the
beneficial effects of exercise on the nervous, endocrine, and immune systems in addition to
systemic energy homeostasis (Hoffmann & Weigert, 2017; Huh, 2018).
Adding to the beneficial effects of decreasing adipose tissue mass, physical activity also
plays a role in modulating adipose tissue function and contributing to systemic metabolic
homeostasis (Leal et al., 2018). Recent studies have shown evidence that one of the key
mechanisms is through the induction and secretion of “exercise-induced” myokines (Leal et al.,
2018; B. So, Kim, Kim, & Song, 2014). Furthermore, skeletal muscle cross-talk with adipose
tissue has been a current topic of interest. As previously discussed, adipose tissue is more than a
storage unit, it also is an important endocrine organ (Trayhurn, Bing, & Wood, 2006) allowing
for an adipokine effect on skeletal muscle function and vice versa. Key myokines postulated to
be involved in the “talk” between skeletal muscle and adipose tissues include, but are not limited
to, IL-6, FGF-21, and Irisin (Leal et al., 2018; Raschke & Eckel, 2013).
a)

IL-6

There are numerous isoforms of interleukins, but IL-6, in addition to being an adipokine
as previously mentioned, is an exercise induced myokine that plays a key role in inflammatory
signaling (Pratesi, Tarantini, & Di Bari, 2013). Higher levels of IL-6 have been reported after
exercise intervention (Leal et al., 2018). With their upregulation, they have also been shown to
directly contribute to increased expression of IL-1 receptor agonist and IL-10 thus constituting a
role in the anti-inflammatory effects of exercise. Plasma concentrations of IL-6 have been shown
to increase > 100 fold post-exercise. However, this effect does not occur in a linear pattern over
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time (MacDonald, Wojtaszewski, Pedersen, Kiens, & Richter, 2003). In addition to inducing
anti-inflammatory signaling pathways, it has also shown that IL-6 can inhibit inflammatory
cytokines such as TNF-alpha (Petersen & Pedersen, 2005). Furthermore, various studies have
shown a cross-talk between skeletal muscle interleukins and adipose tissue, which has shown to
increase adiponectin expression in exercised conditions (Macpherson, Huber, Frendo-Cumbo,
Simpson, & Wright, 2015; Quinn, Strait-Bodey, Anderson, Argiles, & Havel, 2005).
b)

FGF-21

Fibroblast growth factor 21 (FGF-21) is an exercised-induced myokine with pleotropic
effects (Cuevas-Ramos et al., 2012; K. H. Kim et al., 2013). Studies show it plays an important
role in energy metabolism by decreasing glucose levels and increasing lipolysis (Hojman et al.,
2009; Izumiya et al., 2008; Kharitonenkov et al., 2005; B. So et al., 2014; X. Zhang et al., 2008).
Not only is it expressed in skeletal muscle, it is also expressed in liver, adipose tissue, and
pancreas (Canto & Auwerx, 2012) where expression levels are dependent on factors such as
nutritional status, dietary fat intake, hormone levels, transcription factors, oxidative stress, and
physical activity (Gomez-Samano et al., 2017; Kharitonenkov et al., 2005). FGF-21 acts as an
endocrine factor. Evidence has shown that it cross-talks with adipose tissue and that it can
increase thermogenesis and WAT browning through induction of UCP-1 (Fisher et al., 2012).
Additionally, there is evidence of an interaction with adiponectin in adipose tissue. A recent
study showed that in adipocytes, both transcription and secretion of adiponectin are induced by
FGF-21 which has now been termed the “FGF-21-adiponectin axis.” Furthermore, in adiponectin
– null mice, the glucose-lowering, lipid clearance, and the anti-atherosclerotic benefits of FGF21 were diminished (Hui, Feng, Liu, Gao, & Xu, 2016). With these evidences, it is plausible that
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FGF-21 is another muscle-derived bioactive molecule involved in skeletal muscle – adipose
tissue cross-talk.
c)

PGC1-alpha/FNDC5/Irisin

Irisin has been considered one of the most promising myokines for metabolic
maintenance (Leal et al., 2018) and thus a potential therapeutic method in diseases relating to
metabolic dysfunction. When stimulated by exercise, peroxisome proliferator-activated receptorγ coactivator-1α (PGC1-alpha) stimulates the expression of fibronectin type III domaincontaining protein 5 (FNDC5) which encodes irisin, a type I membrane protein secreted into
circulation. Since its discovery, by Bostrom et al. in 2012 (Bostrom et al., 2012), further research
has shown irisin is secreted in an exercise-dependent manner by skeletal muscle and mediates
WAT metabolism (Aydin et al., 2014). Reports have discussed its ability to convert WAT to
BAT (browning of adipose tissue), resulting in increasing energy expenditure by inducing UCP1 expression (Bostrom et al., 2012; Mahgoub, D'Souza, Al Darmaki, Baniyas, & Adeghate,
2018). Additionally, a study conducted in obese humans on 8 weeks of aerobic exercise and
resistance exercise showed a positive correlation between irisin and changes of muscle mass, and
a negative correlation between the circulating irisin level and changes of fat mass and body fat
percentage (Huh et al., 2012). Mechanisms behind the effects of Irisin have been intensely
investigated in a number of studies (Aydin et al., 2014; Daskalopoulou et al., 2014; Hecksteden
et al., 2013; Huh, 2018; Huh et al., 2014; Huh et al., 2012; Huh, Siopi, Mougios, Park, &
Mantzoros, 2015; H. J. Kim, So, Choi, Kang, & Song, 2015; Pekkala et al., 2013; Roca-Rivada
et al., 2013; Tsuchiya et al., 2014). However, until a study was conducted by Huh et al., most
irisin investigations concentrated on plasma levels of its precursor, FNDC5, and the cleaved
protein -irisin (Leal et al., 2018). Huh et al. investigated the effect of physical activity
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specifically on skeletal muscle irisin levels and found that there was an age dependent effect with
higher serum levels in younger exercisers and that secretion rates were dependent on exercise
intensity. In addition, Huh et al. also showed increased irisin levels directly regulates muscle
metabolism through adenosine monophosphate-activated protein kinase (AMPK- activated
protein kinase) activation (Huh et al., 2014).
1.8 THE GUT MICROBIOME
I.

Composition and Development

The human gastrointestinal tract is occupied by more than 1013-1014 microorganisms,
termed the “gut microbiome.” Although only located within the intestinal tract, their genome
consists of a gene set approximately 150 times larger than the human genome (J. Chen, Guo,
Gui, & Xu, 2018; Gill et al., 2006; J. Qin et al., 2010). This microbiome is comprised of about
1,000–1,150 bacterial species, primarily consisting of two phyla: the Bacteroidetes and
Firmicutes (approximately 80-90%), followed by Actinobacteria and Proteobacteria (J. Chen et
al., 2018; Kallus & Brandt, 2012; Monda et al., 2017), and Verrucomicrobia, Fusobacteria, and
Euryarchaeota to a much lesser extent (Backhed et al., 2015). Among the phyla, Firmicutes
chiefly include the Ruminococcus, Clostridium, Lactobacillus, Eubacterium, Faecalibacterium,
and Roseburia. The Bacteroides phyla primarily consists of Prevotella and Xylanibacter (J. Chen
et al., 2018). The number, type, and function of microorganisms found within the gut varies from
the upper to lower ends of the intestine, but the majority are located in the large bowel where
nondigestible food is fermented providing the host with essential nutrients (Backhed, Ley,
Sonnenburg, Peterson, & Gordon, 2005; Conlon & Bird, 2014; Denou, Marcinko, Surette,
Steinberg, & Schertzer, 2016). The development of the microbiome begins during fetal
development when the intestine is sterile within the uterus of the mother (Mackie, Sghir, &
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Gaskins, 1999). Post conception, the gut is surrounded by the maternal microflora which begin to
colonize the intestine (Mackie et al., 1999; Mandar & Mikelsaar, 1996). However, numerous
factors influence the bacterial development in the infant stage promoting colonization of
different microorganisms. By the time the infant turns one year old, the microbiome presents an
“adult” signature with a dense population of microbes (C. Palmer, Bik, DiGiulio, Relman, &
Brown, 2007; Tannock, 2007). From this time point, numerous genetic, epigenetic, and
environmental factors shift the microbial population and its activity promoting high interindividual variability (Adlerberth & Wold, 2009; Ley, Peterson, & Gordon, 2006; Nicholson et
al., 2012). One key environmental factor is physical activity (type, duration, intensity, etc.),
which plays a key role in the diversity and function of the microbiome (C. C. Evans et al., 2014;
Matsumoto et al., 2008). Nonetheless, the gut microbiome continues to change throughout the
lifespan as the body ages. For example, the elderly show significant decreases in Bacteroidetes
and an increase in Firmicutes, but the cause has yet to be determined.
II.

Functions of the Gut Microbiome

The gut microbiota play many important roles including maturation of the host’s immune
system, regulation of intestinal barrier function, preventing colonization of pathogenic microbes
(Heiss & Olofsson, 2018), release of gut hormones, and regulation of oxidative stress and
inflammation (Savini et al., 2013). Microbiota also modulate host energy homeostasis through
harvesting energy from the diet as well as secreting various factors that affect its host’s
metabolic tissues responsible for energy metabolism (Monda et al., 2017). Thus, the role of the
commensal microbes is vital to the health status of the host due to their potential commensal or
symbiotic relationship.
III.

Association of Microbiome and Pathological Conditions
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With more studies concentrating on the gut microbiome, evidence is surmounting
showing the gut microbiota is essential to maintaining host gut and systemic homeostasis (G.
Clarke et al., 2014; Grenham, Clarke, Cryan, & Dinan, 2011). Several pathologies/diseases have
been associated with an altered composition of the gut microbiome, termed dysbiosis, which has
independently been shown to increase fat mass and elevate body weight (Monda et al., 2017).
Diseases associated with dysbiosis include (but are not limited to) obesity, cardiometabolic
diseases, IR/T2D, cancer, and inflammatory bowel disease (IBD) (J. Chen et al., 2018; Heiss &
Olofsson, 2018; Monda et al., 2017; Savini et al., 2013). Although all these pathologies have a
well-known multifactorial origin, part of which has previously been discussed (genetic,
epigenetic, diet, redox state, physical activity level, and environment), more recently, the
contribution of the microbiota has been considered a highly influential environmental factor
(Backhed et al., 2004; Bleau, Karelis, St-Pierre, & Lamontagne, 2015). This presents the gut
microbiome as a potential way to work as an intervention to counteract obesity, cardiometabolic
diseases, cancer, and other chronic inflammatory diseases (Small & Bloom, 2004). In 2005, Ley
et al. showed the leptin deficient, obese Ob/Ob mice exhibit a significant reduction of
Bacteroidetes and increase in Firmicutes (Ley et al., 2005; Savini et al., 2013) which was also
shown in obese humans when compared with lean controls (Turnbaugh et al., 2009; Turnbaugh
et al., 2006). Most interesting, this ratio has been shown to be reversed with an alteration in
dietary intake (Ley et al., 2006) or exercise intervention (S. F. Clarke et al., 2014). Additionally,
not only the composition, but the number of different bacterial taxa present (diversity) also
impacts host physiology. For example, decreased diversity has been shown in organisms
consuming HFD (Garcia-Mantrana, Selma-Royo, Alcantara, & Collado, 2018), those with
obesity-associated inflammatory characteristics (Ley et al., 2005), and/or sedentary individuals
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(Monda et al., 2017). Numerous studies have shown that a reduction in the phylogenetic
diversity is characteristic of obese vs. lean subjects and correlates with key metabolic parameters
including high serum insulin levels, Homeostasis Model Assessment for Insulin Resistance
(HOMA-IR), and plasma TG levels (Le Chatelier et al., 2013). Recovery from decreased
phylogenetic diversity has been observed in studies investigating the effect of exercise (Monda et
al., 2017) on microbial function as well as dietary intervention studies where a diet is lowered in
fat (lard) content (Garcia-Mantrana et al., 2018).
IV.

Microbial – Host Interaction

The gut microbiome plays a key role in the metabolic signaling of its host by regulating
tissue cross-talk with the brain, liver, adipose, and skeletal muscle (Grosicki, Fielding, &
Lustgarten, 2018; Mach & Fuster-Botella, 2017; Monda et al., 2017). The microbiome releases a
variety of factors dependent on the host diet as well as the permeability of the gut.
a)

Bile Acids

Primary bile acids are synthesized from cholesterol, secreted in bile, and bio-transformed
into secondary bile acids upon contact with the resident colonic microbiota. It is estimated that
approximately 50% of secondary bile acids are reabsorbed in the intestine and return to the liver
by the portal vein (Di Ciaula et al., 2017). Bile acids aid in the digestion and absorption of fat,
cholesterol, and fat-soluble vitamins in addition to acting as signaling molecules with antiinflammatory functions (Di Ciaula et al., 2017). It is expected that physical activity may improve
gastrointestinal motility and peristalsis, thus regulating the concentration of circulating bile acids
and their pleiotropic functions. Previous animal studies found that moderate physical activity
increased bile acid excretion (Bouchard et al., 1994; Watkins, Crawford, & Sanders, 1994;
Yiamouyiannis, Martin, & Watkins, 1993). Bile acids also interact with a variety of receptors in
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the adipose tissue, skeletal muscle, intestine, and liver (ie. G protein-coupled Bile Acid Receptor
1 (GPBAR‐1) and Farnesoid X Receptor (FXR)) (Brighton et al., 2015; Di Ciaula et al., 2017).
This results in the modification of metabolically relevant hormonal pathways (ie, release of
peptide YY (PYY) and glucagon‐like peptides) thus modulating appetite as well as glucose and
insulin metabolism (Molina-Molina et al., 2018).
b)

Short Chain Fatty Acids

One of the most significant contributions made by the gut microbiota to host function is
the supply of short chain fatty acids (SCFAs) (J. M. Evans, Morris, & Marchesi, 2013). Upon
fermentation (anaerobic) of a variety of carbon sources from the host diet, specific classes of the
microbiota produce SCFAs. The three most predominant are butyrate, acetate, and propionate
(Cummings & Macfarlane, 1997; J. M. Evans et al., 2013) which provide a significant source of
energy for the host (J. M. Evans et al., 2013). However, this is not the only function served by
SCFAs. It has also been shown that SCFAs act as signaling molecules and play a key role in
metabolic function by exerting effects on a variety of metabolic organs (Nicholson et al., 2012).
For example, within the gut, they bind to free fatty acid receptors and stimulate the release of
PYY and 5-hydroxytryptamine (5-HT) (Cherbut et al., 1998; Fukumoto et al., 2003) which
contributes to decreased intestinal transit rate as well as downstream signaling that controls
appetite regulation within the hypothalamic region of the brain (Heiss & Olofsson, 2018).
Another important function of which all the SCFAs play is the stimulation of leptin production in
adipose tissue (Xiong et al., 2004; Yonekura et al., 2003). This is of considerable relevance to
host metabolism with leptin being involved in a wide range of physiological processes including
appetite regulation, reproduction, and metabolic rate (J. M. Evans et al., 2013). The number of
SCFAs produced is determined by the host diet, microbial composition, and interaction between
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the microbes (Jumpertz et al., 2011). The production of acetate, propionate, and butyrate are all
upregulated by physical activity, but butyrate has become a particular interest in many exercise
studies. (J. Chen et al., 2018; J. M. Evans et al., 2013; Matsumoto et al., 2008; Monda et al.,
2017). The main microbes known to produce butyrate are Clostridia, Eubacteria, and Roseburia.
Butyrate regulates neutrophil function and migration, increases expression of tight junction
proteins (prevents “leaky gut”), lowers redox stress, and exhibits anti-inflammatory effects
(Nicholson et al., 2012). Its anti-inflammatory effects include increasing IL-10 and IL-8,
lowering IL-6, TNF-alpha, and IL-1B (S. F. Clarke et al., 2014; Molina-Molina et al., 2018), and
inhibiting Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) (Lai et al.,
2018). Propionate and acetate are substrates for gluconeogenesis and lipogenesis in the liver,
adipose tissue, and skeletal muscle (Samuel et al., 2008; Wong, de Souza, Kendall, Emam, &
Jenkins, 2006). Furthermore, specifically in skeletal muscle, SCFA activates the AMPK pathway
which controls cholesterol and glucose metabolism providing evidence of cross-talk between the
gut and skeletal muscle (Monda et al., 2017).
c)

Other Microbial Products

Along with bile acids and SCFAs, the gut microbiome impacts the host by producing
microbial products that play a significant role in metabolic processes such as the production of
lipopolysaccharides (LPS) /endotoxins, Caseinolytic Protease B (ClpB), and other endocrine
molecules. Obesity and its comorbidities are characterized by low-grade inflammation and
increased levels of circulating LPS (Cani et al., 2007). Chronically elevated LPS, as those
observed after consistent intake of a HFD (lard), can result in weight gain, insulin resistance,
higher expression of inflammatory mediators, and macrophage infiltration in WAT (Caesar,
Tremaroli, Kovatcheva-Datchary, Cani, & Backhed, 2015; Cani et al., 2007). Evidence suggests
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that the increased circulating LPS levels after HFD intervention could be the result of a more
permeable intestinal barrier (leaky gut). Contrary to a HFD, interventions such as an OM3 diet or
increased physical activity can cause a decrease in LPS production from the gut microbiome
(Heiss & Olofsson, 2018; Lai et al., 2018). In addition to the previously mentioned indirect
cross-talk between the microbiome and appetite regulation (Ex. through leptin), evidence has
been shown the microbiome also modulates the neuronal function of POMC by the bacterial
product ClpB (Breton et al., 2016). ClpB acts as a mimetic of α-melanocyte-stimulating
hormone, thus inducing satiety (Breton et al., 2016). Recent evidence has also confirmed that in
addition to the production of endocrine molecules produced by the host, there is a significant
level of dopamine and norepinephrine production in the human gut due to the expression of βglucuronidases by commensal gut bacteria (Asano et al., 2012; Eisenhofer et al., 1997). Gut
microbes can also produce non-noradrenergic, non-cholinergic transmitters such as NO, which
play a pivotal role in the regulation of gastric emptying (Orihata, Sarna, Orihata, & Sarna, 1994)
by the anaerobic reduction of nitrate to nitrogen (Cutruzzolà & Cutruzzolà, 2012; Sobko et al.,
2005) thus modulating the redox environment. This is evidence that specific microbes have the
potential to directly regulate host appetite, energy metabolism, the redox environment, and even
mood/behavior by directly signaling to the central nervous system (CNS).
d)

Bacterial Transfer

In an inflammatory or disease environment, the gut may increase permeability due to
modification of tight junctions (leaky gut). When this occurs, fragments of bacteria can leak from
the gut and activate immune responses in other tissues by activating receptors stimulated by
foreign particles (Burcelin, 2016). It is also of significant interest that whole bacteria from the
gut may be transferred from a leaky gut (inflammatory responses) and modulate what is now
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known as the “tissue microbiome.” This is of particular interest in the transfer of pathogenic
bacteria from the intestines that could cause havoc in other metabolic tissues by inducing tissue
dysfunction, inflammation, and possibly cell death (Burcelin, 2016).
With the metabolic function of the gut microbiome and its role as an endocrine organ
impacting key metabolic tissues through cross-talk, it has become evident that modifying the
species present and ensuring proper function could play a role in the incidence of obesity, its
comorbidities, and other chronic diseases (Brown, DeCoffe, Molcan, & Gibson, 2012; Small &
Bloom, 2004).
1.9 THE POTENTIAL OF ANTIOXIDANT CATALASE
As a natural response to alleviate oxidative stress, the body activates antioxidant defense
systems to upregulate endogenous antioxidant production and reduce the negative consequences
that result from oxidant insult. Antioxidants catabolize oxidative species and form products that
are less reactive/harmful to the cellular environment. Numerous investigations have been
undertaken to determine the impact of antioxidants inhibiting disease pathways facilitated by
increased levels of free radicals (Haidara et al., 2011; Spychalowicz, Wilk, Sliwa, Ludew, &
Guzik, 2012). A major antioxidant involved in detoxifying H2O2 (a ROS) to the neutral products
water and oxygen is catalase (X. Chen, Liang, Van Remmen, Vijg, & Richardson, 2004).
Catalase exists as a tetramer composed of four identical monomers, each of which contain a
heme moiety at the active site with a molecular weight of 62kD (Birben et al., 2012; Glorieux &
Calderon, 2017). It is able to catabolize H2O2 in a two-step process. First, catalase is oxidized to
a hypervalent iron intermediate which is subsequently reduced back to a balanced redox state by
a second H2O2 molecule forming water and oxygen (Glorieux & Calderon, 2017). Although the
mechanisms involved in the production of catalase have yet to be fully elucidated, evidence has
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been shown it is induced by oxidative insult (Glorieux & Calderon, 2017). When the level of
oxidant species rises within a cell, the endogenous antioxidant response system (i.e. Keap1/Nrf2)
is activated thus upregulating the transcription of second phase antioxidants including catalase
(Dreger et al., 2009; Pall & Levine, 2015; Xue et al., 2013; Yamamoto et al., 2018). Antioxidant
catalase’s beneficial effects have been shown by investigating its overexpression using both in
vivo and in vitro analysis. Previous studies in our own laboratory showed evidence for
prevention of oxidative damage to vascular cells (Meilhac, Zhou, Santanam, & Parthasarathy,
2000; Santanam et al., 1999) and in vivo in diet induced atherosclerosis and exercise intervention
in a LDL r−/− mouse model (Meilhac et al., 2001). We specifically observed that increased
redox stress/inflammation, as a result of a controlled insult, led to increased antioxidant
expression. In a majority of our analysis, the antioxidant upregulated was catalase (Meilhac et
al., 2001; Meilhac et al., 2000). In skeletal muscle tissue, function in aged rodents was improved
by overexpression of human catalase targeted to the mitochondria (Umanskaya et al., 2014).
Cancer progression was delayed where catalase was targeted to the mitochondria and attenuated
mitochondrial H2O2 signaling (Ge et al., 2015). A cardiac-targeted overexpression of catalase
prevented O.S. and decelerated aging effects in mice (Yao et al., 2015). Directly relevant to
obesity and increases in fat mass, overexpression of catalase specific to the mitochondria
attenuated mitochondrial ROS emission, preserved insulin signaling, and prevented
inflammation when mice were provided HFD (high saturated fat) (Paglialunga, Ludzki, RootMcCaig, & Holloway, 2015). It is hypothesized this effect may have been the result of catalase’s
ability to regulate the polarization of macrophages within adipose tissue which would result in
decreased inflammation and insulin resistance. Contrary to overexpression, in a mouse model
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devoid of catalase, an obese, prediabetic phenotype was displayed that was exacerbated with age
(Heit et al., 2017).
Although our knowledge is limited in the field of redox stress in the context of the
microbiome, we are aware that oxidants are required for normal function of the microbiome, but
as with the host, too high of levels is also damaging (Imlay, 2018). This was made clear by Yoon
et al. when their laboratory showed the level of ROS inside the host intestine must be carefully
regulated, yet, most interestingly, it can be controlled by a single-microbe gene product: catalase
(M. Y. Yoon et al., 2016). Additionally, research has shown specific organisms such as
Escherichia coli (E. coli), Salmonella, typhimurium, Bacillus subtilis, and Saccharomyces
cerevisiae are sensitive and damaged by excessive oxidant levels in their environment (Imlay,
2018). For example, E. coli. mutants that lack either SOD or catalase and peroxidase exhibit
distinctive inhibition of growth showing the specific injuries that O2 and H2O2 can produce
(Carlioz & Touati, 1986; Seaver & Imlay, 2001). Additionally, the Bacteroides thetaiotaomicron
is an oxygen-sensitive bacterium. When fully aerated, growth ceases, and it resumes only when
anoxia is restored. Within the gut, scavenging enzymes including catalase and NADH peroxidase
are induced when the environment becomes too highly oxidized. They largely suppress damage
of oxidants in air-tolerant bacteria, but sometimes the antioxidants are unable to counter the
higher rate of ROS production in obligate anaerobes (Zheng et al., 2001). Recently, it was also
shown that catalase-positive bacteria are vital to the establishment of certain Bifidobacteria in
non-anaerobic human niches of the infant gastrointestinal tract. When absent, health of the gut
and its host deteriorates (E. Rodriguez, Peiroten, Landete, Medina, & Arques, 2015). These
investigations provide evidence from human and animal models that catalase is an ideal
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antioxidant to study redox regulation in metabolic diseases (e.g. Obesity, cardiometabolic
disease, IR/T2D) and other chronic diseases for which there is no current universal therapy.
1.10 THESIS PROJECT
With redox stress being a major hallmark of obesity and its co-morbidities (McMurray,
Patten, & Harper, 2016), it was hypothesized that excess catalase (antioxidant) expression
would suppress redox stress mediated obesogenic pathways. Based on the current literature,
our laboratory generated the “Bob-Cat” stress-less mice model, a hybrid between catalase
transgenic mice [Tg(CAT)±] (X. Chen et al., 2003) and the leptin-deficient, obese mice
(heterozygous JAX 000632, B6.Cg-Lepob/J). Upon its generation, we developed three specific
hypotheses. First, we predicted that modulating redox stress by altering endogenous antioxidant
content (overexpression of catalase) alone would enhance adipose tissue function, glucose and
lipid signaling, and overall energy metabolism. The second hypothesis we developed was that by
modulating redox stress by antioxidant overexpression or dietary intervention with an enriched
OM3 diet (45%) vs. a HFD (45% lard) would positively modulate fatty acid signaling, glucose
and lipid homeostasis, energy metabolism, and overall metabolic function. Third, we
hypothesized antioxidant overexpression in addition to exercise would both enhance skeletal
muscle and adipose tissue function, alter appetite signaling, and shift the composition and
function of the gut microbiome thus improving overall energy metabolism in the ‘stress-less’
mice.
To better understand the interplay between redox regulation and dietary or exercise
intervention in metabolic pathways, we addressed our first hypothesis and characterized male
and female Bob-Cat mice where we showed the ubiquitous expression of human catalase in
addition to mouse catalase altered body composition measurements, overall energy metabolism,
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and adipose tissue function compared to WT controls. Details of the collected phenotyping data
is discussed in Chapter II. After realizing the insight that could be gained from further
analyzing this unique mouse model, we then tested our second hypothesis and compared the
redox effects of a high-fat omega 3-enriched diet (OM3) and high-fat lard diet (HFD) in both
male and female catalase-overexpressing ‘stress-less’ mice which can be found in Chapter III.
Our study showed that an OM3 enriched diet, in contrast to a HFD intervention, activated crosstalk between the free fatty acid receptor, GPR120, and redox-sensitive transcription factor, Nrf2,
to maintain balanced energy metabolism, normal circadian rhythm, and insulin sensitivity in
mice overexpressing catalase compared to their WT controls. Another prevention strategy and
therapy to counteract obesity and its co-morbidities is regular, moderately intense physical
activity. Therefore, with our novel mouse model, we tested our third hypothesis where we sought
to determine the synergistic effect of antioxidant overexpression and exercise on metabolic
signaling pathways and the “forgotten endocrine organ” - the gut microbiome. As with our diet
study, the overexpression of antioxidant catalase and exercise moved the field forward. We
showed evidence of crosstalk between key metabolic organs and that the microbiome is
significantly altered by overexpression of catalase and/or exercise intervention which will be
further discussed in Chapter IV. A timeline of the experiments involved in the investigation of
the newly generated mouse model is depicted in Figure 3. The conclusions derived from the
aforementioned investigations solidify our claim that overexpression of antioxidant catalase is a
beneficial adjuvant to an enriched OM3 diet/exercise intervention to suppress redox stressmediated obesogenic pathways by altering metabolic tissue function, maintaining glucose and
lipid homeostasis, and improving energy metabolism. Finally, we showed that antioxidant
overexpression and/or exercise intervention causes significant shifts in the gut microbiome in a
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manner that may be contributing to the observed improvement in obesogenic markers. Therefore,
it is evident the Bob-Cat mouse is an excellent model to study the effect of an altered redox
environment on pathways regulating energy metabolism. Future studies using this novel mouse
model with an altered redox status have the potential to direct the pathway to discovering
promising therapeutics involving alterations of diet, physical activity, and manipulation of the
gut microbiome to decrease risk of obesity, its comorbidities, and other chronic/debilitating
illnesses.

Figure 3. Timeline of proposed investigations of the novel ‘stress-less’ mouse. In order to
phenotype and investigate the effects of dietary and exercise interventions using the newly
generated mouse model overexpressing endogenous antioxidant catalase, an array of
experiments was conducted at specific timepoints. An outline of these investigations based on
the age of the mouse is shown in the figure above.
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CHAPTER II: CATALASE OVEREXPRESSION MODULATES METABOLIC
PARAMETERS IN A NEW ‘STRESSLESS’ LEPTIN-DEFICIENT MOUSE MODEL

A manuscript published in Biochim Biophys Acta: Molecular Basis of Disease
Amos, D. L., Robinson, T., Massie, M. B., Cook, C., Hoffsted, A., Crain, C., & Santanam, N.
(2017). Catalase overexpression modulates metabolic parameters in a new ‘stress-less’ leptindeficient mouse model. Biochim Biophys Acta, 1863(9), 2293-2306.
doi:10.1016/j.bbadis.2017.06.016

Reprinting for dissertation is part of the author’s rights in accordance with the copyright holder.
Deborah L. Amos, Tanner Robinson, Melissa B. Massie, Carla Cook, Alexis Hoﬀsted, Courtney
Crain, Nalini Santanam⁎
Department of Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University,
1700 3rd Ave., Huntington, WV 25755-0001, United States

⁎ Corresponding author: Department of Biomedical Sciences, Joan C. Edwards School of
Medicine, Marshall University, 1700 3rd Ave, 435S BBSC, Huntington, WV 25755, U.S.
E-mail addresses: amos23@marshall.edu (D.L. Amos), robinson329@live.marshall.edu (T.
Robinson), massie30@live.marshall.edu (M.B. Massie), schneide@marshall.edu (C. Cook),
hoﬀsted@live.marshall.edu (A. Hoﬀsted), crain1@marshall.edu (C. Crain),
santanam@marshall.edu (N. Santanam).

Received 8 March 2017; Received in revised form 1 June 2017; Accepted 19 June 2017
Available online 20 June 2017 0925-4439/ © 2017 Elsevier B.V. All rights reserved

43

ABSTRACT
Oxidative stress plays a key role in obesity by modifying the function of important
biological molecules, thus altering obesogenic pathways such as glucose and lipid signaling.
Catalase is an important endogenous antioxidant enzyme that catabolizes hydrogen peroxide
produced by the dismutation of superoxide. Recent studies have shown knockdown of catalase
exacerbates insulin resistance and leads to obesity. We hypothesized that overexpressing catalase
in an obese mouse will modulate obesogenic pathways and protect against obesity. Therefore, we
bred catalase transgenic [Tg(CAT)±] mice with Ob/Ob mice to generate the hybrid “Bob-Cat”
mice. This newly generated “stress-less” mouse model had decreased oxidative stress (oxidized
carbonylated proteins). ECHO-MRI showed lower fat mass but higher lean mass in “Bob-Cat”
mice. Comprehensive Lab Animal Monitoring System (CLAMS) showed light and dark cycle
increase in energy expenditure in Bob-Cat mice compared to wild type controls. Circulating
levels of leptin and resistin showed no change. Catalase mRNA expression was increased in key
metabolic tissues (adipose, liver, intestinal mucosa, and brain) of the Bob-Cat mice. Catalase
activity, mRNA and protein expression was increased in adipose tissue. Expression of the major
adipokines leptin and adiponectin was increased while pro-inﬂammatory genes, MCP-1/JE and
IL-1β were lowered. Interestingly, sexual dimorphism was seen in body composition, energy
expenditure, and metabolic parameters in the Bob-Cat mice. Overall, the characteristics of the
newly generated “Bob-Cat” mice make it an ideal model for studying the eﬀect of redox
modulators (diet/exercise) in obesity.
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2.1 INTRODUCTION
Rates of cardiometabolic diseases including obesity and Type 2 diabetes (T2D), are rising
in developed and developing nations (Arroyo-Johnson & Mincey, 2016; Smith & Smith, 2016).
In the United States of America (U.S.A), obese individuals make up approximately 35% of the
population and the levels will continue to rise without appropriate interventions (Arroyo-Johnson
& Mincey, 2016; Lewis, Edwards-Hampton, & Ard, 2016). The obese phenotype is a
consequence of a number of factors including genetics (Arroyo-Johnson & Mincey, 2016;
Pigeyre, Yazdi, Kaur, & Meyre, 2016) as well as environmental influences (Silventoinen et al.,
2016; Smith & Smith, 2016). Both of these factors impact physiological processes and the
function of biological molecules within an individual. When homeostasis is disrupted, body
function is compromised. Redox stress is an imbalance between antioxidants and oxidants,
leading to detrimental effects, such as increased production of oxidative species, alterations in
signaling pathways, increased inflammation, and eventually cell death. Redox stress is known to
play a role in various metabolic diseases including obesity (Santilli, Guagnano, Vazzana, La
Barba, & Davi, 2015; Spahis, Borys, & Levy, 2017).
Increased free radical generation (redox stress) leads to a progressive accumulation of
oxidative damage leading to increased adiposity stemming from an imbalance between prooxidants and antioxidants (Manna & Jain, 2015; McMurray et al., 2016; Santilli et al., 2015;
Savini et al., 2013). Increases in fat mass, manifested as an increase in white adipose tissue
(WAT), increases oxidative stress/oxidant production and results in an obese phenotype
(Paglialunga et al., 2015) characterized by a BMI (Body Mass Index) ≥ 30kg/m2 (Krueger,
Coleman-Minahan, & Rooks, 2014). The obese phenotype is accompanied by mitochondrial
dysfunction and increased lipid peroxidation, further leading to the dysfunction of other
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metabolic tissues such as liver, muscle, (Paglialunga et al., 2015; Shill et al., 2016) gut, and brain
(Ma, Yuan, Yu, Xi, & Xiao, 2014).
Strong evidence of the redox theory in obesity stems from research concentrated in
models with high levels of adiposity and altered appetite regulation as a result of increased
oxidative stress (Drougard, Fournel, Valet, & Knauf, 2015; Haas & Staels, 2016). Rodent body
weight changes were shown to alter appetite regulation with alterations in oxidative stress
markers (Diane et al., 2015). Redox stress has also been implicated in the process of
adipogenesis (X. Wang & Hai, 2015). Adipose dysfunction results in abnormal levels of
adipokines and cytokines secreted into circulation, such as leptin, adiponectin, resistin, monocyte
chemotactic protein-1 (MCP-1/JE), and interleukin 1 beta (IL1β). These molecules play key roles
in appetite and metabolic function, as well as inflammatory processes (Abella et al., 2017;
Bluher & Mantzoros, 2015). In turn, this can further impact superoxide release and promote
oxidative stress (Camargos et al., 2016; Fernandez-Sanchez et al., 2011). These molecules also
mediate their effects by acting on immune cells leading to local and generalized inflammation
thus impacting obesity related disorders (hypertension, diabetes, atherosclerosis, and insulin
resistance) (Trostchansky, Quijano, Yadav, Kelley, & Cassina, 2016).
The body activates defense systems such as the endogenous antioxidants in order to
counteract and prevent the negative consequences of increased redox stress. Antioxidants are
able to catabolize reactive oxidants and yield products that are less reactive/toxic. Numerous
studies have focused on the role of antioxidants in inhibiting disease pathways caused by
increased levels of free radical production (Haidara et al., 2011; Spychalowicz et al., 2012).
Catalase is one of the major endogenous antioxidant enzymes that detoxify the reactive oxygen
species (ROS) hydrogen peroxide (H2O2) to water and oxygen. Overexpression of catalase was
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shown to be beneficial in numerous studies. Our earlier studies have shown a role for catalase
overexpression in the prevention of oxidative damage in vascular cells (Meilhac et al., 2000;
Santanam et al., 1999) and in vivo in diet-induced atherosclerosis and exercise intervention in
LDL r-/- mice (Meilhac et al., 2001). Other evidence includes studies where mitochondria
targeted catalase showed a delay of cancer progression by attenuation of mitochondria-generated
H2O2 signaling (Ge et al., 2015). A cardiac-specific overexpression of catalase protected from
oxidative stress and displayed evidence of delayed cardiac aging in mice (Yao et al., 2015). In
regard to obesity, a mouse model expressing mitochondria specific catalase on a high fat diet
displayed attenuated mitochondrial ROS emission, preserved insulin signaling, and no
inflammatory response compared to wild type controls (Paglialunga et al., 2015). This may be
because overexpression of endogenous catalase was shown to regulate the polarization of
macrophages within adipose tissue and thereby inhibit inflammation and insulin resistance (Park
et al., 2016). On the other hand, mice devoid of antioxidant catalase developed an obese,
prediabetic phenotype that was exacerbated with age (Heit et al., 2017). All these evidences
suggest catalase as an ideal candidate for modulating redox stress in obesity.
Since high redox stress is one of the major hallmarks of obesity (McMurray et al., 2016), we
hypothesized that excess catalase (antioxidant) expression would suppress redox stress mediated
obesogenic pathways. In this study, catalase transgenic [Tg(CAT)±] mice (X. Chen et al., 2004;
X. Chen et al., 2003) expressing 3-4 fold higher levels of catalase were bred with the
heterozygous, leptin deficient, Ob/Ob mice to create a hybrid that expresses high levels of
catalase in an obese background (“Bob-Cat” mice). This newly generated mouse model showed
sex specific changes in redox stress and metabolic parameters. Our results suggest that this
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“stress-less” mouse model can be used as a good model to study the effect of modulators of
redox stress (diet or exercise) on obesogenic pathways.
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2.2 MATERIALS AND METHODS
2.2.1 Generation of “Bob-Cat” Mice
A successful breeding colony of the catalase transgenic [Tg(CAT)±] mice has been
established in our laboratory (a generous gift of a breeding pair from Drs. Arlan Richardson and
Holly Van Remmen at the University of Texas Health Sciences Center in San Antonio, TX). The
transgenic model that overexpresses Catalase was originally generated in C57Bl6 mice using a
33kb human CAT (hCAT) gene as well as the 41kb of 5’ and the 6 kb of 3’ flanking regions.
This mouse model was the first transgenic model with increased catalase expression in all tissues
(X. Chen et al., 2003).
Using the well-established colony at our facility, [Tg(CAT)±] mice and the heterozygous
Ob/+ mice (homozygous Ob/Ob are a leptin deficient, sterile model which spontaneously
develops obesity – Jackson Labs, B6.V-Lep/ob/J ) were bred to engineer a novel mouse model
with the goal of further understanding the mechanistic effect of lowering redox stress (by
increasing catalase) on obesogenic pathways. Through cross-breeding the two genotypes, we
developed a mouse model expressing the hCAT gene with a genetically obese background called
“Bob-Cat” mice. The “Bob-Cat” mouse model was generated by following the breeding plan as
described in Figure 4A. Four breeding pairs of the catalase transgenic mice [Tg(CAT) ±] were
crossbred with Ob/+ mice (purchased from Jackson Labs) (2-male [Tg(CAT)±] mice x 2-female
Ob/+ mice or 2-male Ob/+ mice x 2-female [Tg(CAT)±] mice) allowing the generation of the
novel hybrid “Bob-Cat” mice. Once the first generation was established, four breeding pairs
were used to sufficiently generate hybrid F2 pups for creating the F3 generation. Both F2 and F3
generation mice were used for further study purposes.

49

2.2.2 Characterization of “Bob-Cat” Mice
The newly generated hybrid “Bob-Cat” mice were compared to: i) Catalase transgenic
[Tg(CAT) ±] mice that over-express the hCAT gene by approximately 3-4 fold in comparison to

Figure 4. Generation of the Bob-Cat mouse. Four breeding pairs were mated (2-male
[Tg(CAT)±] mice x 2-female ob/+ mice) or (2-male ob/+ x 2-female [Tg(CAT)±] mice) to
create the F1 generation. F1 generation offspring were then bred to generate the F2
generation. F3 generations were produced by mating breeding pairs of the F2 generation. F2
and F3 generations were used in characterizing the novel “Bob-Cat” mouse. Pie charts
represent the percent of the males and females generated in the (B) F1 generation, F2
generation, and F3 generation of each genotype. The key denotes each genotype generated
from the breeding pairs. The figure provided displays each genotype generated from two
breeding pairs. However, multiple breeding pairs were used in the generation of the Bob-Cat
mice.
C57Bl6 (X. Chen et al., 2004), ii) wild type/C57Bl/6J mice (Jackson Lab stock number 000664)
and iii) Ob/Ob (Jackson Lab stock number 000632), leptin deficient obese mice purchased from
Jackson Laboratories (Bar Harbor, MA). Ob/Ob mice are homozygous for the mutant ob gene.
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They increase in weight rapidly after 4 weeks of age, and can become up to three times the size
of their parent strain C57Bl6 (Ioffe, Moon, Connolly, & Friedman, 1998). Along with
accumulation of fat, Ob/Ob mice express hyperphagia, hyperglycemia, glucose intolerance,
elevated plasma insulin (Ioffe et al., 1998), and increased hormone production from both
pituitary and adrenal glands. The mice are hypometabolic, hypothermic, (Jackson Laboratory)
and immunosuppressed (Lord et al., 1998). Due to the subfertility of Ob/Ob mice (Ingalls,
Dickie, & Snell, 1950), the heterozygous Ob/+ mice are generally used for breeding. All mice
were maintained on “standard chow” (Lab Diet Rodent Chow 5001) consisting of 30% protein,
13% fat, and 57% carbohydrate ad libitum. In the present study, the care and use of animals was
conducted according to protocols approved by Marshall University IACUC.
2.2.3 Genotyping
Four weeks post-birth, animals were ear marked for identification and genotyped by
collecting approximately 3-4 mm of the tail and isolating DNA. Tails were lysed in 300 µL of
tail lysis buffer and 15 µL of proteinase K then placed overnight in a 55˚C water bath followed
by centrifugation for 10 min. at 12,000g at room temperature. The supernatant was placed in
another eppendorf tube with 300 µL of 100% isopropanol. The tube was centrifuged again at
12,000g for 5 min at room temperature to pellet the DNA. Pellets were dried and subsequently
washed with 500 µL of 95% ethanol (EtOH) and centrifuged 5 min. at 12,000g. EtOH was
discarded and the DNA pellets were air dried. 10 µL of Tris-EDTA (TE) Buffer was added to
each tube and then all samples were placed into a 37˚C water bath 5-10 min. until the DNA was
completely suspended. DNA was quantified by NanoDrop (Nanodrop Technologies Inc.,
Thermo Scientific, Wilmington, DE, USA). For genotyping, 0.25 µg (1 µL) of each DNA sample
was added to a reaction mix of 18.125 µL RNase free H2O, 2.5 µL of 10X i Taq Buffer, 0.75 µL
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of MgCl2 50 mM, 0.5 µL dNTP mix 10 mM, 1 µL forward primer, 1 µL reverse primer, 0.125
µL i Taq DNA polymerase to prepare for amplification of DNA in the BioRad MyiQ (BioRad,
Hercules, CA). PCR protocol was conducted as described in previous publications (X. Chen et
al., 2003; Ellett, Evans, Zhang, Chavin, & Spyropoulos, 2009). Catalase primers: E12F: 5’GAGGTCCACCCTGACTACGGG-3’ and E13R: 5’-GCCTCCTCCCTTGCCGCCAAG-3’ (X.
Chen et al., 2003). Primers for Ob gene characterization: RFLP-F: 5’TGAGTTTGTCCAAGATGGACC-3’; RFLP-R: 5’-GCCATCCAGGCTCTCTGG-3’; WtLep-F:
5’-AATGACCTGGAGAATCTCC-3’; and Lepob-R: 5’-GCAGATGGAGGAGGTCTCA-3’
(Ellett et al., 2009). After amplification by PCR, agarose gel electrophoresis was used to
determine the presence of the hCAT gene (450bp), and the Lep Ob genes (heterozygous Ob with
WT-specific primer bands at 191 and 104bp and bands at 191 and 123bp for ob-specific primers;
homozygous Ob if band at 191bp for Wt-specific primer and bands at 191 and 123bp for the Obspecific primer). Catalase bands were detected on a 1.2% agarose gel and Ob related bands were
detected by use of a 3% agarose gel that also contained Ethidium Bromide (EtBr) that had been
electrophoresed at 100V for approximately one hour. Bands were detected using the ChemiDoc
and Image Lab Software (BioRad, Hercules, CA) (Figure 5).
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Figure 5. Genotyping [Tg(CAT)±] and Bob-Cat mice. Images show the ethidium bromidestained agarose gels of the PCR product during genotyping of: (A) Ob, WT, and (B) human
catalase (hCAT) genes. Molecular weight markers are shown in lane 1 (100bp ladder
Invitrogen) of images A and B. The sizes of the PCR markers are indicated on the side of each
panel. Image A displays the three-primer PCR products representing control and Wt Lep-F
primers which produce the control 191 bp product in all tail samples, but only produce the
wild-type-specific 104 bp product when a wild-type allele is present (+/+ and ob/+) indicated
in lanes 2-4. Lane 5 is no sample control. Three-primer PCR involving control and Lepob-R
primers produce the control 191 bp fragment in all tail samples, but only produce the Lepobspecific 123 bp product when a Lepob allele is present (Ob/+ and Ob/Ob) as seen in lanes 2-4.
Image B represents samples in lanes 2-11 that have the hCAT gene, while lane 12 is a wild
type (WT).
2.2.4 Body Weight and Body Composition (fat and lean mass)
[Tg(CAT)± ] and Bob-Cat mice were weighed weekly from weaning until 20 weeks of
age to determine differences in growth rate prior to full development. Growth rates of C57Bl6
and Ob/Ob mice were derived from studies conducted at Jackson Laboratory (where animals
were purchased). Body composition (fat and lean mass) was determined using magnetic
resonance imaging, ECHO-MRI (Magnetic Resonance Imaging) (Houston, TX). Mice were
singly entered in the MRI machine and five measurements were performed on each mouse. The
median values of fat and lean mass were computed per mouse, averaged per genotype, and
subsequently compared to one another by one-way ANOVA.
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2.2.5 Metabolic Parameters Using Comprehensive Lab Animal Monitoring System
(CLAMS)
Metabolic parameters were measured indirectly by determining Volume O2 consumption
(VO2) and Volume CO2 production (VCO2), respiratory exchange ratio (RER) as well as XAmbulatory counts (XAMB) using the CLAMS system (Columbus Instruments, Columbus, OH,
USA). Mice were supplied with a sufficient amount of ground standard chow (Lab Diet Rodent
Chow 5001) for the duration of the analysis (three days). Computations were made on the middle
48 hours of the three day CLAMS procedure that the mice were subjected to, from
approximately 0600 hours of the first day to 0600 hours of the third day. Heat production/energy
expenditure (EE), RER average, average food intake (FI) per day, as well as X-Ambulatory
locomotor activity per day (counts of movement made across the cage) were determined for each
mouse in all groups. Group averages were compared by using a one-way ANOVA.
2.2.6 Tissue Collection
Animals were anesthetized using isoflurane after overnight fasting. Blood was taken by
cardiac puncture, centrifuged, separated into red blood cells (RBCs) and plasma. Tissues
(kidney, lung, skeletal muscle, heart, adipose, liver, intestinal mucosa (IM), and brain) were
removed, weighed, and flash frozen in liquid nitrogen, followed by storage at -80˚C.
2.2.7 Blood Analysis
Whole blood was used to measure fasting glucose levels by a Precision Xtra Glucometer.
Blood was then centrifuged for 10 min. to separate the plasma and RBCs. 35 µL of plasma was
placed on a Cholestech cassette and read on a LDX Cholestech Machine (Cholestech
Corporation, Hayward, CA) to determine Glucose, HDL, LDL, Total Cholesterol (TC), and TG
levels. The remaining plasma was frozen at -80˚C.
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Circulating levels of IL-6, TNF α, MCP-1/JE, Insulin, Leptin, and Resistin were
measured in the plasma of C57Bl6, [Tg(CAT)±], and Bob-Cat mice by the use of a Milliplex
Mouse Adipokine Array (Millipore) by a Luminex 200 system (Millipore, Austin, TX).
2.2.8 Catalase RNA Expression
Catalase gene expression in various tissues (kidney, lung, muscle, heart, adipose, liver,
intestinal mucosa (IM), and brain) of C57Bl6 (C), [Tg(CAT)± ] (T), and Bob-Cat (B) mice (male
and female) was evaluated by PCR and gel electrophoresis. Total RNA was isolated using TriReagent (Sigma). RNA concentration was measured by the use of the NanoDrop 1000
(NanoDrop Technologies Inc., Thermo Scientific, Wilmington, DE, USA) followed by RT-PCR
for amplification (BioRad, Hercules, CA). Samples were evaluated for both Human (hCAT) and
Mouse (mCAT) Catalase using gel electrophoresis in comparison to the housekeeping gene βActin. Primers used were as follows: Human Catalase (hCAT) (Accession Number: NM-001752)
Forward: 5’- acatggtctgggacttctgg -3’ and Reverse: 5’- tttgcaataaactgcctccc -3’; Mouse Catalase
(mCAT) (Accession Number: NM-009804) Forward: 5’- agtcttcgtcccgagtctctc -3’ and Reverse:
5’- ctggtcggtcttgtaatggaa -3.’ β-Actin (Accession Number NM-007393) Forward: 5’ctacctcatgaagatcctcaccga -3’ and Reverse: 5’- ttctccttaatgtcacgcacgatt -3.’ Bands were detected
using the ChemiDoc and Image Lab Software (BioRad, Hercules, CA).
2.2.9 Abdominal Adipose Tissue mRNA Expression
RNA was isolated from 100 mg of abdominal adipose tissue using TRI Reagent
according to the manufacturer’s recommended protocol (Sigma). Concentrations of RNA were
measured by use of the NanoDrop 1000 (NanoDrop Technologies Inc., Thermo Scientific,
Wilmington, DE, USA). Reverse transcription of total RNA (1 µg) was performed using
iScript™ cDNA Synthesis Kit (Bio-Rad Hercules, CA, USA). RT-qPCR was conducted using iQ
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SYBR™ Green Supermix (Bio-Rad). The mouse primers for catalase, leptin, adiponectin, MCP1/JE, IL1β, and β-Actin include: Catalase (Accession Number: NM-009804) Forward: 5’agtcttcgtcccgagtctctc -3’ and Reverse: 5’- ctggtcggtcttgtaatggaa -3.’ Leptin (Accession Number:
NM-008493) Forward: 5’- ctcatgccagcactcaaaaa -3’ and Reverse: 5’- agcaccacaaaacctgatcc -3.’
Adiponectin (Accession Number NM-009605) Forward: 5’- gcagagatggcactcctgga -3’ and
Reverse 5’- cccttcagctcctgtcattcc -3.’ MCP-1JE (Accession Number: NM-011333.3) Forward:
5’- ttccttcttggggtcagcacagac -3’ and Reverse 5’- actgaagccagctctctcttcctc -3.’ IL1β (Accession
Number: NM-008361.3) Forward: 5’- aggagaaccaagcaacgaca -3 and Reverse 5’tgggtgtgccgtctttcatt -3.’ β-Actin (Accession Number NM-007393) Forward: 5’ctacctcatgaagatcctcaccga -3’ and Reverse: 5’- ttctccttaatgtcacgcacgatt -3.’ RT-qPCR was
performed in the Bio-Rad MyiQ or Bio-Rad CFX ConnectTM instrument. All samples were run
in duplicates or triplicates. Results were calculated using the Pfaffl Equation (2−ddCt) (Pfaffl,
2001), and expressed as fold change compared to the control wild type/C57Bl6 mice.
2.2.10 Western Blot
Approximately 50 mg of abdominal adipose tissue was homogenized in 100 µL
Radioimmunoprecipitation assay buffer (RIPA buffer) supplemented with protease inhibitor
cocktail. Protein concentrations were determined by the Lowry Method (Lowry, Rosebrough,
Farr, & Randall, 1951). Based on these concentrations, predetermined amounts of protein (40-50
µg) per sample were prepared in loading buffer (90% Laemmli and 10% 2-mercaptoethanol) and
boiled for 5 min. Samples were run on a SDS-PAGE and separated on 12% or 12.5% EZ Run
Protein Gel Solution (Fisher), at 120V for 60-90 minutes. Electrophoretic transfer of the proteins
onto a nitrocellulose membrane was performed at 100V for 60 min. on ice. Thermo Scientific
Memcode Stain: Pierce MemCodeTM Reversible Protein Stain Kit was then used as a loading
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control. Membranes were blocked with 1X Tris Buffered Saline (1X TBST), 0.05% Tween 20,
pH 7.6, and 5% dry milk for one hour at room temperature. Blots were then incubated overnight
at 4˚C with rabbit anti-bovine catalase antibody (1:3000 in 1X TBST and 5% dry milk) (VWR
Rockland) which cross-reacts with both mouse and human catalase. After washing with 1X
TBST, membranes were incubated with secondary anti-rabbit IgG (1:1000) in 1X TBST and 5%
dry milk for 60 min. at room temperature. The immunocomplex was detected with LuminataTM
Forte Western HRP (Millipore, Billerica MA). Densitometry of the bands was quantified using
BioRad Image Lab Software (BioRad, Hercules, CA) and normalized to MemCode Stain of total
protein in each lane.
2.2.11 Catalase Enzymatic Activity
Catalase enzymatic activity was measured according to the method of Aebi (Aebi, 1984).
A standard curve was first generated using 1-5 units of bovine catalase (Sigma, 9001-9502).
Approximately 50 mg of abdominal adipose tissue from each mouse was homogenized in 100
µL of 50 mM KH2PO4, 5 ug/µL Aprotinin, and 2 µL of 0.1 M PMSF. Appropriate dilutions were
made and 8 µL of each homogenate was added to 1 mL of 25 mM Hydrogen Peroxide (H2O2)
solution (Sigma) and analyzed on a Shimadzu Spectrophotometer for one minute. Initial rate of
disappearance of H2O2 was recorded at a wavelength of 240 nm during the 1 minute (∆A240
nm/min). Each sample was analyzed in duplicate or triplicate. Change in absorbance was
recorded for each tissue sample and specific activity was calculated based on protein estimation
of the homogenate by the Lowry Method.
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2.2.12 Protein Carbonylation Using OxyBlot
Approximately 50 mg of abdominal adipose tissue per sample was prepared by
denaturing and derivatizing the proteins with a solution of 12% Sodium Dodecyl Sulfate (SDS)
and Dinitrophenylhydrazine (DNPH) according to OxyBlot (Millipore) protocol. Neutralization
solution was used to terminate the derivatization reaction after 15 min. The separation of proteins
was achieved using a 12.5% EZ Run Protein Gel Solution (Fisher) or 12% mini PROTEAN TGX
12% (BioRad) at 100V for 50-60 minutes followed by transfer to a nitrocellulose membrane at
100V for 90 minutes. To determine equal loading and transfer efficiency, Pierce MemCodeTM
Reversible Protein Stain was used to visualize proteins in a BioRad ChemiDoc and analyzed
using BioRad Image Lab (BioRad, Hercules, CA). Non-specific binding sites were blocked with
1X Phosphate Buffered Saline and Tween 20 (1X PBST) and 10% Bovine Serum Albumin
(BSA) rocking for one hour. A 1:500 dilution of primary antibody, Rabbit-Anti-DNP (Millipore
OxyBlot Kit) was added and rocked overnight at 4˚C, followed by washes with 1X PBST. Blots
were conjugated with a 1:300 dilution of goat anti-rabbit IgG (Horseradish Peroxidase
conjugated) for one hour at room temperature with rocking. Bands were visualized with
LuminataTM Forte Western HRP (Millipore, Millerica, MA) using BioRad Chemidoc and Image
Lab (BioRad, Hercules, CA). OxyBlot data of oxidized proteins were expressed as the
densitometric ratio of the dinitrophenylhydrazone (DNP) bands to total protein in each lane
obtained by the Memcode stain.
2.2.13 Statistical Analysis
Results for body composition and enzymatic activity are presented as mean ± standard
error of the mean (S.E.M.) and plotted using GraphPad Prism. One-way ANOVA and Multiple
Comparisons were used to evaluate the differences between the genotypes with Bonferonni post
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hoc analysis. p<0.05 was considered statistically significant. For RT-qPCR analysis, expression
was determined by use of the Pfaffl equation 2^−ddCT (Pfaffl, 2001) and represented as fold
change with significance denoted as differences in delta CT/genotype.
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2.3 RESULTS
2.3.1 Breeding Outcomes for the Bob-Cat Mouse Model
The breeding scheme depicted in Figure 4A was used to generate Bob-Cat mice for three
generations. Ratios of genotype of each generation of breeding pairs is depicted in Figure 4B.
Approximately 50:50 ratios of males to females were observed in each of the F1-F3 generations.
The first and second generations of pups were approximately 60% Bob-Cat while the third
generation, F3, consisted of 100% Bob-Cat. In addition to “Bob-Cat” which is heterozygous for
the ob gene, there was also the generation of mice that were homozygous for the ob gene that
overexpressed catalase (Big-Bob). However, this genotype was rare in occurrence and was more
skewed towards females than males (7% F1 and 2% F2 generations). In an effort to elucidate
high antioxidant (catalase) effect in a leptin-resistant model, we are continuing to cross-breed, to
generate more homozygous ob mutant mice overexpressing catalase.
3.2 Mouse and Human Catalase Gene Expression in Various Tissues
Bob-Cat (B) male and female mice were evaluated for the expression levels of human
and mouse catalase in various tissues and compared to C57Bl6 (C) and [Tg(CAT)±] (T) mice.
Mouse catalase (mCAT) as well as human catalase (hCAT) mRNA levels were analyzed and
compared by densitometry ratios to β-Actin using BioRad Image Lab (BioRad, Hercules, CA).
Male Bob-Cat mice generally had higher levels of hCAT in comparison to the other genotypes of
mice. However, levels of mCAT trended to be lower in comparison to the other two genotypes
(Figure 6A-F). In general, female Bob-Cat mice showed no statistical difference in hCAT across
most tissues, but there was a trend for increase in the brain, significant increase in the liver, and a
decrease in muscle compared to C57Bl6. Additionally, there was a decrease in intestinal mucosa
(IM) compared to [Tg(CAT)±] (Figure 6 G-L). With regard to mCAT in female Bob-Cat mice,
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levels trended to be lower except in the IM and brain where there was a significant increase in
comparison to both the other genotypes analyzed.

Figure 6. Mouse and human catalase gene expression in various tissues. (A)
Densitometric images of β-Actin, Human Catalase (hCAT) and Mouse Catalase (mCAT)
PCR products of kidney, lung, muscle, and heart. (B) and (C) show densitometry ratios of
hCAT and mCAT to β-Actin respectively from male mice. (D) Densitometric images of βActin, hCAT and mCAT PCR products of adipose, liver, intestinal mucosa (IM), and brain.
(E-F) show densitometry ratios of hCAT and mCAT to β-Actin respectively from female
mice. (G-L) The representative images from female mice are displayed. The genotype of the
mice groups are depicted as C for C57Bl6, T for [Tg(CAT)±], and B for Bob-Cat mice.
Densitometric ratios of catalase to β-Actin were determined using BioRad Image Lab. Data
are expressed as mean densitometric ratio of each group +/- SEM from n≥3 mice. Data were
analyzed by One-way ANOVA and differences between genotypes were significant at
p<0.05a*, p<0.01b*, p<0.001c*, p<0.0001d* to C57Bl6; p<0.05a#, p<0.01b#, p<0.001c#,
p<0.0001d# to [Tg(CAT)±].
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2.3.2 Body Composition and Tissue Weight
As seen in Table 1A and 1B, both male and female mice that overexpress antioxidant
catalase have significantly lower body weight in comparison to the Ob/Ob mice (background of
Bob-Cat mice) as do the control C57Bl6 mice. However, body weights of the novel Bob-Cat
mouse were not significantly different from the C57Bl6 or [Tg(CAT)±] mouse. The male
[Tg(CAT)±] mice on the other hand are slightly heavier than the C57Bl6 mice at adulthood as
seen in Table 1A. No significant differences were seen between Bob-Cat mice and C57Bl6 or
A.
Male

Body Weight (g)

Abdominal Adipose (g)

Liver Weight (g)

27.09 ± 0.79

0.77 ± 0.02

1.04 ± 0.07

33.32 ± 0.46

1.28 ± 0.11

1.55 ± 0.06

Bob-Cat

31.00 ± 1.02

1.73 ± 0.17

1.43 ± 0.05

Ob/Ob

54.45 ± 2.21d*#$

8.13 ± 0.71d*#$

4.35 ± 0.24d*#$

Female

Body Weight (g)

Abdominal Adipose (g)

Liver Weight (g)

C57Bl6/WT

22.74 ± 0.37

0.91 ± 0.12

1.05 ± 0.05

[Tg(CAT) ±]

21.18 ± 0.74

0.53 ± 0.06

1.05 ± 0.06

Bob-Cat

24.21 ± 0.24

1.12 ± 0.13

1.18 ± 0.06

Ob/Ob

51.71 ± 1.50d*#$

7.76 ± 0.21d*#$

2.61 ± 0.07d*#$

C57Bl6/WT
±

[Tg(CAT) ]

a*

B.

Table 1: Body weight and tissue weights. (A) Adult male (n≥4) body weight, adipose and
liver weights of C57Bl6, [Tg(CAT)±], Bob-Cat, and Ob/Ob (n≥4) mice. (B) Adult female
(n≥6) body weight, adipose weight, and liver weight of C57Bl6, [Tg(CAT)±], Bob-Cat, and
Ob/Ob (n≥6) mice. One-way ANOVA was performed on GraphPad Prism 7. Data reported as
mean ± S.E.M. and significant differences are displayed with letters indicating p values:
a=p<0.05, b= p<0.01, c=p<0.001, d=p<0.0001; symbols represent significant differences
between genotypes, *= to C57Bl6, #= to [Tg(CAT)±], $= to Bob-Cat.
[Tg(CAT)±] with regard to liver and adipose weight, but as expected, Ob/Ob adipose and liver
weights were significantly heavier than all other groups (p<0.0001). This effect was the same in
both genders (Table 1A and 1B).
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From 4 to 20 weeks of age, mice considerably gained weight. However, statistical
significance within the four genotypes of males is noted at 5 weeks of age between the Ob/Ob
mice and the other three genotypes (p<0.05) (Figure 7A). Female mice, shown in Figure 7B, on
the other hand, showed a significant difference in body weight beginning at 4 weeks between the
Ob/Ob mice and every other genotype (p<0.0001). C57Bl6 and Ob/Ob body weights were
obtained from Jackson Labs: (C57BL/6J https://www.jax.org/jax-mice-and-services/straindatasheet-pages/body-weight-chart-000664; B6 Cg-Lepob/J https://www.jax.org/jax-mice-andserviceccs/strain-data-sheet-pages/body-weight-chart-000632).

Figure 7. Weekly body weights. (A) Male and (B) Female weekly body weight of
(n≥7/group) C57Bl6, [Tg(CAT)±], Bob-Cat, and Ob/Ob mice. C57Bl6 and Ob/Ob measured
by Jackson Laboratories. One-way ANOVA was performed on GraphPad Prism 7. Data
represented as mean ± S.EM. and considered significant at p<0.01a*, p<0.0001d* to C57Bl6.
2.3.3 Body Composition (ECHO-MRI)
ECHO-MRI was used to determine the lean and fat mass of all genotypes. A significant
difference was observed in the fat mass of the Ob/Ob mouse group compared to both genders of
the other genotypes. The lean mass was observed to be greater (p<0.04) for each male genotype
that overexpresses antioxidant catalase in comparison to both C57Bl6 and Ob/Ob mice (Figure
8A1 and A2), revealing a difference in body composition that should be further investigated. In
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the female groups, Bob-Cat mice have a significantly higher fat mass compared to [Tg(CAT)±],
and lean mass compared to C57Bl6 and [Tg(CAT)±] genotypes (p<0.02) (Figure 8B1 and B2).
The sex differences in body composition are intriguing and worth investigating in the future.

Figure 8. Body composition: fat and lean mass. Male (A1) Fat Mass and (A2) Lean
Mass (g) of each genotype (n≥4/group). Female (B1) Fat Mass and (B2) Lean Mass (g) of
each genotype (n≥4/group). Data represented as mean +/- SEM and considered significant
at p<0.05a* to C57Bl6, p<0.05a# to [Tg(CAT)±].
2.3.4 Metabolic Parameters Analyzed by CLAMS
Although body weight and fat mass did not significantly differ between C57Bl6 and mice
overexpressing antioxidant catalase, significant changes were seen in metabolic parameters as
determined by CLAMS within the adult genotypes (Figure 9). Overall (combination of both
light/dark cycles) analysis of CLAMS data showed that neither male nor female mice
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significantly differed with regard to FI per day. Significant differences were observed in the
energy expenditure levels and XAMB counts in male Ob/Ob mice compared to the other
genotypes. RER was not significantly different in either gender.

Figure 9. Metabolic parameters. Male- (A1) Food Intake of C57Bl6, [Tg(CAT)±], Bob-Cat,
and Ob/Ob averaged per day; (A2) Metabolic Energy Expenditure of each genotype averaged
kcal/h over the middle 48h; (A3) XAMB Counts of each genotype over 48h; (A4)
Respiratory Exchange Ratio (RER) average over 48h; Female- (B1) Food Intake of each
genotype averaged grams (g) per day; (B2) Metabolic Energy Expenditure of each genotype
averaged kcal/h over the middle 48h; (B3) X-AMB Counts of each genotype over 48h; (B4)
RER average over 48h. Data represented as mean ± S.E.M. p<0.05a*, p<0.01b*, p<0.0001d*
to C57Bl6; p<0.01b# to [Tg(CAT)±]; p<0.001c$ to Bob-Cat.
Independent analysis of CLAMS data collected during the light and dark cycle (Table 2
and Figure 10), showed that the FI and RER did not significantly differ among genotypes of
either gender. However, significant differences in EE were seen among the male groups in both
light and dark cycles. Bob-Cats showed a trend towards higher levels and [Tg(CAT)±] showed
significantly higher levels of EE (p<0.008) compared to C57Bl6 males. The same effect was
noted for the dark cycle where, Bob-Cats and [Tg(CAT)±] did have statistically higher levels of
energy expenditure in comparison to C57Bl6 mice (p=0.021). In assessment of physical activity,
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Group
Male
C57Bl6/WT
[Tg(CAT) ±]
Bob-Cat
Ob/Ob
Female
C57Bl6/WT
[Tg(CAT) ±]
Bob-Cat

LIGHT

DARK

FI (g)

EE
(kcal/h)

XAMB

1.43 ±
0.196
1.34 ±
0.042
1.35 ±
0.042
1.04 ±
0.146

0.366 ±
0.010
0.442 ±
0.008 b#
0.422 ±
0.010
0.503 ±
0.013 b$

7398 ±
963
9581 ±
2770
5088 ±
1209
874.4 ±
112.4

d*#

a*#

0.398 ±
0.019
0.362 ±
0.020
0.387 ±
0.017

4791 ±
405
4502 ±
910
11206
± 2440

1.78 ±
0.137
1.67 ±
0.140
1.74 ±
0.218

RER
(VCO2/
VO2)
0.886 ±
0.005
0.871 ±
0.006
0.899 ±
0.010
0.867 ±
0.014

0.924 ±
0.015
0.932 ±
0.022
0.891 ±
0.010

FI (g)

EE
(kcal/h)

XAMB

3.07 ±
0.271
2.64 ±
0.208
2.98 ±
0.247
3.10 ±
0.444

0.445 ±
0.009
0.509 ±
0.009 a*
0.508 ±
0.008 a*
0.589 ±
0.015

24858
± 3432
24392
± 4911
17000
± 3340
2421 ±
243.7

a*b#$

a$b#c*

0.453 ±
0.017
0.421 ±
0.022
0.477 ±
0.021

17357
± 1136
14556
± 3845
40300
± 8352

2.82 ±
0.109
2.97 ±
0.137
2.80 ±
0.323

RER
(VCO2/
VO2)
0.942 ±
0.009
0.920 ±
0.009
0.952 ±
0.009
0.913 ±
0.016

0.939 ±
0.024
0.973 ±
0.017
0.910 ±
0.008

a*#

Table 2. Light and dark cycles of metabolic parameters. Male and female averaged light
and dark cycles of food intake (FI) as average grams (g) of chow consumed per cycle,
metabolic energy expenditure kcal/h of each mouse group, counts of physical movement as
XAMB / cycle, and average Respiratory Exchange Ratio (RER) as VCO2/VO2 per cycle.
One-way ANOVA was performed using Graph-Pad Prism 7. Data are represented as mean ±
S.E.M. and significant differences are displayed with letters indicating p values: a=p<0.05,
b= p<0.01, c=p<0.001, d=p<0.0001; symbols represent significant differences between
genotypes, *= to C57Bl6/WT, #= to [Tg(CAT)±], $= to Bob-Cat.
there was also a trend for higher levels of activity (XAMB) in Bob-Cat males in comparison to
the Ob/Ob mouse group; most notably in the light cycle (Figure 10A1-A4). Ob/Ob male mice
also had significantly lower activity levels (XAMB) in both the light and dark cycles compared
to [Tg(CAT)±] and C57Bl6 mice (p<0.01) yet higher levels of energy expenditure compared to
all other groups (p<0.01). Within females, all measured parameters with the CLAMS did not
significantly differ between the groups except that XAMB counts were much higher in the Bob-
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Figure 10. Two hour time interval analysis of metabolic parameters. (A1) Food Intake
grams/day (A2) Metabolic Energy Expenditure averaged kcal/h over the middle 48h (A3) XAMB Counts over 48h (A4) Respiratory Exchange Ratio (RER) average over 48h of male
C57Bl6, [Tg(CAT)±], Bob-Cat, and Ob/Ob. (B1) Food Intake averaged g/day (B2) Metabolic
Energy Expenditure averaged kcal/h over the middle 48h (B3) X-AMB Counts of each
genotype over 48h (B4) RER average over 48h of female mice of each genotype. Data
represented as mean ± S.E.M.
Cat female group (p<0.04) compared to both female C57Bl6 and [Tg(CAT)±] in both light and
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dark cycles (Figure 10B1-B4).
Data comparing the Bob-Cat (het Ob/+) to Big Bob (homozygous Ob/Ob) genotypes
mice overexpressing catalase is displayed in Table 3. Big Bob mice have significantly higher
body weight and fat mass. CLAMS data showed a trend toward an overall increase in FI and
decrease in XAMB (combined light and dark cycles) as well as significantly higher levels of EE
compared to the Bob-Cat mice.
Genotype

Bob-Cat (n≥4)

Big Bob (n≥3)

Adult Images

Body Weight (g)

31.0 ± 1.02

49.7 ± 2.4d$

Fat Mass (g)

3.28 ± 0.33

22.6 ± 1.11d$

Lean Mass (g)

27.8 ± 0.86

24.5 ± 1.69

24h RER VCO2/VO2

0.927 ± 0.01

0.934 ± 0.01

24h EE (Kcal/h)

0.46 ± 0.01

0.55 ± 0.03a$

24h FI (g/24h)

4.28 ± 0.26

4.953 ± 0.60

24h XAMB (counts/24h)

22238 ± 4686

12408 ± 9760

Table 3. Characteristics of Bob-Cat and Big Bob mouse models. Data are reported as
average ± S.E.M. An unpaired t test was performed for each parameter on GraphPad Prism 7.
Data reported as mean ± S.E.M. and significant differences are displayed with letters indicating
p values: a=p<0.05 and d=p<0.0001; symbols represent significant differences between
genotypes: $= to Bob-Cat.
2.3.5 Circulating Metabolic Profile
Blood glucose levels did not significantly differ between the Bob-Cat mice of either sex
compared to C57Bl6 or [Tg(CAT)±] (Table 4A-4B). However, the Ob/Ob mouse group had
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significantly higher levels of plasma glucose compared to all other genotypes. HDL and TC
levels were significantly elevated in both sexes of the Ob/Ob mouse strain compared to all other
genotypes. Interestingly, male [Tg(CAT)±] mice had significantly higher levels of plasma TG
(Table 4A) compared to the other male groups, while Bob-Cat mice were highly similar to the
C57Bl6 control mice.

A.
Male
C57Bl6/WT
[Tg(CAT) ±]

Total Cholesterol
(mg/dL)
<100
<100

HDL
(mg/dL)
61.8 ± 9.68
64.8 ± 2.38

TG (mg/dL)
46.3 ± 1.08
95.3 ± 15.9 a*

Glucose
(mg/dL)
188.4 ± 9.1
220.1 ± 14.1

Bob-Cat

<100

65.8 ± 4.56

47.5 ± 0.9 b#

203.4 ± 7.3

Ob/Ob

150 ± 7.49 d*#$

≥ 98.8 ± 1.08

67.5 ± 8.5

319.8 ± 27.1

a#$b*

a#b*$

B.
Female
C57Bl6/WT
[Tg(CAT) ±]
Bob-Cat
Ob/Ob

Total Cholesterol
(mg/dL)
<100
<100
<100
119.4 ± 3.8 d*#$

HDL
(mg/dL)
48.63 ± 3.45
51.42 ± 3.2
47.45 ± 2.93
≥93.43 ± 3.87
d*#$

TG (mg/dL)
47.4 ± 2.22
50.2 ± 2.72
54.8 ± 3.27
80.3 ± 9.23 c*#

Glucose
(mg/dL)
192.9 ± 13.0
225 ± 9.0
176.3 ± 12.4
367.8 ± 44.6
d*#$

Table 4. Blood lipid profile and glucose level. A) Total Cholesterol, High Density
Lipoprotein (HDL), Triglyceride (TG), and Glucose levels in C57Bl6/WT, [Tg(CAT)±], BobCat, and Ob/Ob mice (n≥4/group) (B) Total Cholesterol, High Density Lipoprotein (HDL),
Triglyceride (TG), and Glucose levels in C57Bl6/WT, [Tg(CAT)±], Bob-Cat, and Ob/Ob
female mice (n≥6/group). Data reported as mean ± S.E.M. and significant differences are
displayed with letters indicating p values: a=p<0.05, b= p<0.01, c=p<0.001, d=p<0.0001;
symbols represent significant differences between genotypes, *= to C57Bl6/WT, #= to
[Tg(CAT)±], $= to Bob-Cat.
Milliplex Mouse Adipokine Array was used to measure circulating levels of IL-6, TNF α,
MCP-1/JE, insulin, leptin, and resistin in blood plasma. Results shown in Figure 11A revealed
that [Tg(CAT)±] and Bob-Cat mice trended to have similar levels of insulin. There were no
statistically significant differences for plasma levels of leptin or resistin which are two major
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adipokines released from adipose tissue, between the control C57Bl6 parent group and mouse
groups that over express catalase. The trend was similar in females (Figure 11B); however, it is
intriguing to note, the levels were higher compared to male groups. Ob/Ob had significantly
higher levels of insulin and resistin and very minimal leptin compared to all other groups. IL-6,
TNF α, and MCP-1/JE were undetected or no trends were seen between mouse groups.

Figure 11. Circulating levels of metabolic parameters. Circulating levels of insulin, leptin,
and resistin were measured using an adipokine array on a Luminex system: (A) C57Bl6, BobCat, [Tg(CAT)±], and Ob/Ob male mice; (B) C57Bl6, Bob-Cat, [Tg(CAT)±], and Ob/Ob
female mice. Data displayed as mean ± S.E.M. p<0.05a*, p<0.01b*, p<0.0001d* to C57Bl6,
Bob-Cat, and [Tg(CAT)±].
2.3.6 Catalase mRNA, Protein Expression, and Enzyme Activity in Adipose Tissue
Being a key metabolic tissue that plays a role in obesity, catalase mRNA expression was
determined in visceral adipose tissue (WAT) obtained from both male and female mice of all
genotypes using RT-qPCR on a Bio-Rad MyiQ. In male mice, catalase mRNA expression was
upregulated by about 35 fold in Bob-Cat mice and was about 5 fold higher in the Ob/Ob mice
compared to C57Bl6 (Figure 12A1). Western blot showed increase in catalase protein in
[Tg(CAT)±] and Bob-cat mice but lower levels in the Ob/Ob mice (Figure 12B). Catalase
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Figure 12. Catalase mRNA expression, protein, and enzyme activity in adipose tissue.
(A1) Male and (A2) Female Catalase mRNA expression measured by RT-qPCR of the
adipose tissue in [Tg(CAT)+/-], Bob-Cat, and Ob/Ob mice and depicted as fold change
compared to C57Bl6 mice (n≥4/genotype) by ddCT Method. (B) Western Blot of catalase
protein as shown by densitometric ratio of anti-Catalase and memcode stain of each genotype
(n=3/group). Catalase enzyme activity as measured by Aebi method (C1) Male and (C2)
Female specific activity of catalase (n≥7/group). Data reported as mean +/- SEM. p<0.05a*
p<0.01b*, p<0.001c* considered significant to C57Bl6; p<0.01b$ to Bob-Cat.
enzyme activity, as determined by measuring the decomposition of H2O2, showed varying
activities in the adipose tissue (Figure 12C1). No significant differences were detected, but BobCat mice trended to have higher activity levels compared to C57Bl6 mice. In contrast, females
displayed no significant difference in catalase mRNA and protein expression in adipose tissue
(Figure 12A2 and B). However, mice overexpressing catalase trended to have higher levels
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within adipose tissue in comparison to C57Bl6 and Ob/Ob mice. With regard to enzyme activity,
catalase activity in females was highest in the Ob/Ob mice, but all genotypes trended to have
higher levels than the C57Bl6 mice (Figure 12C2).
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2.3.7 Oxyblot Detection of Oxidized Proteins in Adipose Tissue
Oxidized carbonyl groups are a commonly used marker of oxidative stress. Carbonylation
of proteins in the adipose tissue was detected using oxyblot and evaluated based on densitometry
ratios for each genotype. Male [Tg(CAT)±] had significantly lower (p<0.05) and Bob-Cat mice
trended to have lower levels of carbonylated proteins within adipose tissue compared to the
C57Bl6 control group (Figure 13A1-3). However, Ob/Ob mice had significantly higher levels of
oxidized carbonyl groups than the Bob-Cat mice as well as the other two genotypes within the
males (p<0.001). Female Bob-Cat mice showed no significant differences in oxidized proteins
(Figure 13B1-3).
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Figure 13. Oxyblot of oxidized proteins. (A1) Oxyblot of oxidized carbonyl groups; (A2)
Memcode stain of total proteins; (A3) Densitometric ratios of oxidized proteins to total
proteins (memcode) in adipose tissue of C57Bl6, [Tg(CAT)+/-], Bob-Cat, and Ob/Ob male
mice; (B1) Female memcode stain of each genotype followed by (B2) blot of oxidized
carbonyl groups and the (B3) Respective densitometric ratios per group. Error reported as
mean +/- SEM. p<0.05 a* considered significant to C57Bl6; p<0.0001 d# to [Tg(CAT)+/-].
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2.3.8 mRNA Expression of Metabolic Genes in Adipose Tissue
The mRNA expression of genes involved in adipose function: leptin, adiponectin, MCP1/JE, and IL1β was evaluated by RT-qPCR. In males, leptin, a key regulator of fat mass, was
increased by about 4 fold in [Tg(CAT)±], approximately 188-fold in the Bob-Cat mice, and 88
fold in the Ob/Ob genotype compared to the C57Bl6 controls (Figure 14A1). In female mice,
there was a significant increase in leptin in both the Bob-Cat and Ob/Ob mice; approximately 69
and 169-fold respectively (Figure 14B1).
Adiponectin, an anti-inflammatory adipokine which plays a key role in glucose and lipid
signaling was also increased in the male Bob-Cat mice compared to C57Bl6 and [Tg(CAT)±]
mice (Figure 14A2). A similar trend was also noted in female mice (p<0.05). Female Bob-Cat
mice had significantly higher adiponectin levels than C57Bl6 mice (p<0.01) followed by the
Ob/Ob female mice (p<0.01) (Figure 14B2). Both IL1β and MCP-1/JE, key pro-inflammatory
adipokines, showed no significant differences between any of the lean genotypes in either sex;
however, increased levels were seen in Ob/Ob mice (Figure 14A3-4, B3-4).
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Figure 14. Adipocytokine mRNA expression levels in adipose tissue. Gene expression
levels of (A1 and B1) leptin, (A2 and B2) adiponectin, (A3 and B3) IL1B, and (A4 and B4)
MCP-1 levels in C57Bl6, [Tg(CAT)+/-], Bob-Cat, and Ob/Ob male (A) and female (B) mice,
n≥3 /genotype and gender. Data reported as mean +/- SEM. Results considered significant at
p<0.05a*, p<0.001c*, p<0.0001d* to C57Bl6, p<0.01b#, p<0.001c# to [Tg(CAT)+/-],
p<0.05$ to Bob-Cat.
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2.4 DISCUSSION
Obesity, which is at its all-time peak worldwide, increases the risk to other metabolic
diseases such as T2D, dyslipidemia, hypertension and atherosclerosis (Lewis et al., 2016; Manna
& Jain, 2015). Adipose tissue expansion and dysfunction is a hallmark of obesity. Over the
years, researchers have attempted to understand the pathophysiology of obesity and how it leads
to increased cardiometabolic diseases with the hope of finding preventive or treatment strategies
(Lewis et al., 2016; R. L. Martin, Perez, He, Dawson, & Millard, 2000; Santilli et al., 2015).
Redox stress is one such common phenomenon that has been associated with obesity and its comorbidities and is attributed to excess adipose mass and meta-inflammation (Fernandez-Sanchez
et al., 2011).
Mitochondrial generation of superoxide or hydrogen peroxide is a major intermediate
between intracellular metabolism and insulin signaling (Hoehn et al., 2009). Modulating
mitochondrial energetics by using mito-targeted antioxidants or excess catalase lowered
metabolic and energy imbalance and improved insulin sensitivity (Anderson et al., 2009).
Overexpression of Superoxide Dismutase (SOD) in mice prevented insulin resistance but had
very little impact on mitochondrial function (Y. Liu, Qi, et al., 2013). Except for studies that
showed that overexpression of catalase in a leptin resistant diabetic mouse model (db/db mice)
prevented diabetic nephropathy (Brezniceanu et al., 2008; Godin et al., 2010; Lau et al., 2012)
and that a catalase knockout mice developed obesity and prediabetic phenotype (Heit et al.,
2017), the effects of increased endogenous catalase expression in obesity models are
understudied.
In this study, we successfully generated a new mouse model with an obese parent
(Ob/Ob) background that expresses the hCAT gene, named Bob-Cat. Due to its increased
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catalase activity, it has lower “redox stress,” hence remains “stress-less.” As depicted in Figure
4 and the representative pie charts, Bob-Cat mice (heterozygous to Ob and expressing hCat)
dominated the F2 and F3 generations. It was interesting to note that extremely low numbers of
mice homozygous for the Ob gene and carrying the catalase gene were obtained during breeding.
It is presumptive to assume that this skewness towards heterozygous mice might be due to higher
catalase expression.
Confirmation of increased catalase expression in key metabolic tissues (liver, IM,
adipose, and brain) of Bob-Cat mice makes this an excellent model to study obesogenic
pathways. Phenotyping showed no obvious differences in body weights between the genotypes at
weaning ages but ECHO-MRI showed obvious differences in body composition. There were sex
differences in overall fat and lean mass. Male Bob-Cat mice had a similar fat mass compared to
C57Bl6 mice but lower compared to the Ob/Ob mice. In contrast, female Bob-Cats had a higher
fat mass compared to [Tg(CAT)±]. The higher lean mass in male Bob-Cat compared to C57Bl6
mice and in female mice compared to both C57Bl6 and [Tg(CAT)±] was intriguing. As expected,
only Ob/Ob mice had a significantly higher body weight and fat mass beginning at 4 weeks of
age in comparison to C57Bl6.
It has been shown that even though body weights may not be different, the metabolic
parameters may be functioning more efficiently in an individual with increased BMI. In contrast,
individuals whose BMI falls within a “normal range” may still be metabolically unhealthy
(Denis & Hamilton, 2013). Therefore, we measured the metabolic parameters using CLAMS
technology, and determined the VO2 intake, CO2 output, RER (VCO2/VO2), EE (kcal/h), average
FI per day, and the XAMB (physical activity) within each genotype. Catalase overexpression, by
virtue of lowering redox stress levels, altering adipocyte secretion of key adipokines, and
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modulating appetite regulation, was expected to increase EE and lower levels of FI. FI did not
differ significantly between any genotypes, however, the antioxidant overexpressing mice
trended towards decreased FI. Both groups of male mice that overexpressed catalase,
[Tg(CAT)±] and Bob-Cat, significantly used more energy in heat production. The [Tg(CAT)±]
genotype trended to have a higher activity level (though not statistically significant) in
comparison to the other two genotypes. This may be due to the body’s response to the trend in
higher body weight observed in adult [Tg(CAT)±] mice. The same could be noted for the Ob/Ob
genotype. Heterozygosity of Lepob mice has been shown to display increased FI and altered
glucose homeostasis, although mice did not differ in body weights compared to wild type (Flatt
& Bailey, 1981). The adult Ob/+ mice had increased fat mass compared to wild types which
might be attributed to lower leptin protein production in these mice (Chung et al., 1998). BobCat mice, in spite of its heterozygous Ob/+ genotype, did not significantly differ from the control
mouse in respect to RER. Less differences in RER and EE were seen in female Bob-Cats.
Cumulatively, CLAMS showed that catalase overexpression has a positive influence on energy
metabolism.
Bob-Cat mice also did not significantly differ in blood glucose, HDL cholesterol, or TC
levels in comparison to C57Bl6 mice or [Tg(CAT)±]. However, Ob/Ob mice had higher levels
indicative of a healthier phenotype, the overall ratio of HDL cholesterol and TC is more
important, explaining why the Ob/Ob mice do not have a healthier lipid profile in comparison to
antioxidant-excess or control mice. It was interesting to note that [Tg(CAT)±] mice had
significantly higher levels of TG in comparison to C57Bl6, Bob-Cat, and even Ob/Ob mice.
Insulin, leptin, and resistin levels did not differ significantly between mice overexpressing
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catalase (Bob-Cat and [Tg(CAT)±]) compared to C57Bl6. However, females seemed to have a
trend towards slightly lower levels of circulating insulin and leptin.
Catalase expression and activity in the adipose tissue, which is one of the key metabolic
tissues in obesity, showed differences between the genotypes. The mice overexpressing catalase
had higher catalase expression compared to the parent strains. Males had increased expression
compared to female mice. Catalase expression was almost 35 fold higher in the adipose tissue of
Bob-Cat compared to C57Bl6 mice. The 5 fold increased expression observed in Ob/Ob mice
may be the result of a compensatory response to higher levels of oxidative stress in these mice
due to increased fat mass and production of pro-inflammatory cytokines (Espinosa-Diez et al.,
2015). Catalase activity was increased in Bob-Cat mice compared to C57Bl6 mice in male and
females. This increase in activity validated the genetic overexpression of endogenous catalase.
The increases in catalase activity and lowered oxidative stress, as shown by decreased
oxidatively modified proteins in the Bob-Cat mice (Figure 13), make this a novel “stress-less”
mouse model.
Leptin and adiponectin are two adipokines that play a key role in adipose function. Leptin
is a fundamental regulatory hormone that is primarily produced by adipocytes within WAT of
both humans and rodents (Birsoy et al., 2011). The concentration of circulating leptin is directly
proportional to total body fat (J. M. Friedman & Mantzoros, 2015). The hormone’s main
function is demonstrated within the arcuate nucleus of the hypothalamic region of the brain
where it is able to decrease appetite and increase energy expenditure (Spiegelman & Flier, 2001)
through signaling systems involved in the orexigenic and anorexigenic pathways (Frago &
Chowen, 2015). Oxidative stress modulates leptin’s action leading to changes in fat mass,
metabolic parameters, and inflammatory status (Drougard et al., 2015). Like leptin, adiponectin
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is most abundantly expressed in WAT, yet is downregulated during obesity (Nigro et al., 2014).
Adiponectin protects against diseases such as diabetes and atherosclerosis (Z. V. Wang &
Scherer, 2016). Specifically, administration of adiponectin has been shown to both elicit glucose
lowering effects and ameliorate insulin resistance (Y. Liu, Turdi, et al., 2013). In other studies,
suppression of adiponectin signaling pathway resulted in decreased oxidative stress detoxifying
enzymes such as catalase (Iwabu et al., 2010). Leptin and adiponectin expression in the WAT
were elevated in both sexes of Bob-Cat mice (p<0.0001) in comparison to the control C57Bl6
mice. There was a significant increase in adiponectin in the Bob-Cat genotype in comparison to
C57Bl6 mice (p<0.05). Due to elevated leptin and adiponectin expression in Bob-Cat adipose
tissue and an increase in catalase expression in other metabolic tissues such as brain, this mouse
model can be used to study appetite regulation through the adipose-brain axis. With lower levels
of the pro-inflammatory genes, IL1β and MCP-1/JE levels, the Bob-Cat mouse is also ideal for
studying metabolic changes resulting from dietary interventions or exercise. Table 5 provides a
summary of the metabolic characteristics of the novel “stress-less” mouse model. The
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differences in phenotype observed between the two sexes are intriguing and require further
explanation.
Male Characteristics

Female Characteristics
Bob-Cat

-

Lean mass +
Metabolic energy expenditure +
Catalase mRNA in adipose
tissue +
Catalase enzymatic activity
trend +
Oxidative stress in adipose tissue
trend Leptin mRNA in adipose tissue
++++
Adiponectin mRNA in adipose
tissue +

-

Adipose weight +
Lean mass +
Physical activity trend +
Catalase protein expression
trend +
Enzymatic activity in adipose
tissue trend +
Leptin mRNA in adipose tissue
+
Adiponectin mRNA in adipose
tissue +

Table 5. Key characteristics of the novel ‘stress-less’ Bob-Cat mouse. Bob-Cat genotype
compared to C57Bl6 mice increase depicted as (+). Significance represented as p<0.05 +,
p<0.0001 ++++.
Caution should be placed on the knowledge that excess oxidative stress induces
antioxidant defense which in turn tilts the balance towards excess reductive stress (Margaritelis
et al., 2014). Reductive stress in turn then leads to increased oxidative stress and has been
implicated in various diseases (Korge et al., 2015). This vicious cycle might have been at play in
some of the previous studies using antioxidant overexpressing mouse models such as the study
where excess glutathione peroxidase-1 showed increased body weight and insulin resistance
(McClung et al., 2004). Increased quenching of ROS in these mouse models interfered with
insulin signaling pathways (Lei & Cheng, 2005). Therefore, the Bob-Cat mouse model can also
be used as a good model to study the role of reductive stress in metabolic diseases.
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2.5 CONCLUSION
Overall, based on the phenotypic results obtained in the Bob-Cat mice, it is apparent that
the overexpression of catalase in an obese genotype modulated body composition while retaining
a similar body weight in relation to the C57Bl6 and [Tg(CAT)±] mice. Significant changes in
energy expenditure and activity levels of Bob-Cat mice compared to other genotypes suggest
catalase is playing a role in appetite regulation of this novel “stress-less” mouse model.
Significant differences in metabolic profile and oxidative stress make it a good model to study
dietary and exercise interventions.
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CHAPTER III: OMEGA 3 RICH DIET MODULATES ENERGY METABOLISM VIA
GPR120-NRF2 CROSSTALK IN A NOVEL ANTIOXIDANT MOUSE MODEL
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ABSTRACT
With obesity rates reaching epidemic proportions, more studies concentrated on reducing
the risk and treating this epidemic are vital. Redox stress is an important metabolic regulator
involved in the pathophysiology of cardiovascular disease, Type 2 diabetes, and obesity. Oxygen
and nitrogen-derived free radicals alter glucose and lipid homeostasis in key metabolic tissues,
leading to increases in risk of developing metabolic syndrome. Oxidants derived from dietary fat
differ in their metabolic regulation, with numerous studies showing benefits from a high omega 3
rich diet compared to the frequently consumed “western diet” rich in saturated fat. Omega 3
(OM3) fatty acids improve lipid profile, lower inflammation, and ameliorate insulin resistance,
possibly through maintaining redox homeostasis. This study is based on the hypothesis that
altering endogenous antioxidant production and/or increasing OM3 rich diet consumption will
improve energy metabolism and maintain insulin sensitivity. We tested the comparative
metabolic effects of a diet rich in saturated fat (HFD) and an omega 3-enriched diet (OM3) in the
newly developed ‘stress-less’ mouse model that overexpresses the endogenous antioxidant
catalase. Eight weeks of dietary intervention showed that mice overexpressing endogenous
catalase compared to their wild-type controls when fed an OM3 enriched diet, in contrast to
HFD, activated GPR120-Nrf2 cross-talk to maintain balanced energy metabolism, normal
circadian rhythm, and insulin sensitivity. These findings suggest that redox regulation of
GPR120/FFAR4 might be an important target in reducing risk of metabolic syndrome and
associated diseases.
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Figure 15. Redox regulation of GPR120-Nrf2 cross-talk in an OM3 fed catalase
overexpressing mice. Overexpression of catalase in the Bob-Cat mouse model coupled with
an enriched diet of OM3 fatty acids was shown to be metabolically beneficial. Energy
homeostasis seen in this model was the result of induction of the GPR120/FFAR4, which by
interacting with Nrf2 pathway (redox-sensitive) in adipose tissue resulted in redox balance,
improved insulin sensitivity, anti-inflammation, enhanced circadian rhythm, decreased body
weight and healthy fat mass.
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3.1 INTRODUCTION
The overwhelming prevalence of diet-induced obesity (DIO) and insulin resistance (IR)
is strongly associated with the increased morbidity and mortality related to metabolic syndrome
(Smith & Smith, 2016). This is of great concern in the United States of America where the
obesity rates are rising and is currently approximately 39.8%, with over 93.3 million adults
affected, and there is still a lack of understanding of its etiology (Division of Nutrition, 2018).
Redox regulation is key for systemic metabolic homeostasis. Furthermore, redox stress is an
important mediator of metabolic changes seen in obesity and its comorbidities which comprise
the metabolic syndrome (Carrier, 2017). Oxygen and nitrogen-derived free radicals alter glucose
and lipid homeostasis in key metabolic tissues such as adipose, liver, brain, and skeletal muscle.
During conditions of high redox stress, the body naturally attempts to compensate by increasing
the production of endogenous antioxidants (including superoxide dismutase-SOD, catalase etc.)
to counteract the excess free radicals that could damage signaling pathways necessary for energy
production. It is believed that an increased level of reactive oxygen species (ROS) plays a key
role in IR, since human and rodent models of IR are typically characterized by an imbalance in
ROS compared to antioxidants/reducing agents (Rochette, Zeller, Cottin, & Vergely, 2014;
Teodoro, Rolo, & Palmeira, 2013). However, recent studies have also shown the importance of
maintaining adequate ROS production for intracellular signaling (McMurray et al., 2016).
Furthermore, the concept of reductive stress, an imbalance in the oxidative state where the ratio
of oxidized to reduced molecules is too low (Brewer et al., 2013; Korge et al., 2015; Lipinski,
2002), is also shown to be associated with an altered metabolic state such as hyperglycemia (L. J.
Yan, 2014) or IR (Williamson, Kilo, & Ido, 1999). Therefore, a balance between free radicals
and antioxidants is key in maintenance of tissue function and systemic metabolic homeostasis.
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In addition to redox stress, nutritional intake plays a key role in modulating energy
metabolism. DIO animal models are commonly used to study altered metabolic changes
consequential to fat storage within various fat pads. In general, diets containing > 40% high-fat
lard, milk, and butter promote excess lipid accumulation in adipose tissue leading to adipocyte
hyperplasia and hypertrophy, alterations in adipokine secretion, hypoxia, and elevated circulating
free fatty acids (FFA) in less than 8 weeks of ad libitum diet intervention (Choe et al., 2016;
Heydemann, 2016). Furthermore, inflammatory pathways within the adipose tissue are activated
as a consequence of excess lipid accumulation, which in turn drives a pro-inflammatory state
provoking IR and inflammation in other metabolic tissues including liver, skeletal muscle, and
pancreatic β-cells (Z. Chen et al., 2017; Snel et al., 2012). The severity of the consequences to a
high-fat diet is dependent on the composition, length, and degree of fatty acid saturation
(McArdle et al., 2013; Yeop Han et al., 2010). Contrary to the negative effects seen in diets with
high levels of saturated fat (lard, milk fat, and butter), high-fat diets predominately composed of
omega 3 (OM3) polyunsaturated fatty acids (PUFA) have been shown to have beneficial effects
on metabolic function (Albracht-Schulte et al., 2018; Luo et al., 2016; Saini & Keum, 2018;
Shahidi & Ambigaipalan, 2018). In general, diets comprised of fish oil, which is high in OM3,
lower systemic IR (Oliveira et al., 2015), decrease fasting TG (Bargut et al., 2016) and
cholesterol levels (Ide & Koshizaka, 2018; Tani et al., 2018), and reduce inflammation (Oliveira
et al., 2015). These beneficial outcomes are in contrast to diets with high levels of saturated fats
(Bargut et al., 2016; Yeop Han et al., 2010). Further understanding of the possible mechanisms
by which OM3 fatty acids promote metabolic health came when Olefsky’s group discovered that
GPR120/FFAR4, a free fatty acid receptor (highly expressed in adipose tissue) for which long
chain omega 3 fatty acids are ligands, improved adipose tissue function and energy metabolism
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by its insulin sensitizing and anti-inflammatory effects (D. Y. Oh & Olefsky, 2012; D. Y. Oh et
al., 2010; D. Y. Oh et al., 2014). OM3 fatty acids also alter the balance of reductive and
oxidative species, and are additionally critical in glucose and lipid metabolism (D. Y. Oh et al.,
2010). Furthermore, alterations in redox homeostasis through increased intake of OM3 fatty
acids have been linked to activation of the nuclear factor E2-related factor 2 (Nrf2) pathway
(Cipollina, 2015). Nrf2 is a transcription factor, key in regulating redox homeostasis (Seo & Lee,
2013) by inducing the transcription of endogenous antioxidants including catalase, glutathione
transferase, HO-1, and NAD(P)H: Quinone Oxidoreductase 1 (S. E. Lee et al., 2015; Yamamoto
et al., 2018; Zhu et al., 2008). These studies pointed to the plausible mechanisms by which
varying dietary fat composition can influence metabolic homeostasis by modulating redox stress.
In our previous studies investigating dietary or exercise interventions in atherosclerotic
mice models, we observed that increased redox stress or inflammation led to an increased
antioxidant response by the tissues affected by the insult (for example vasculature). Our results
showed that in most instances, the major endogenous antioxidant upregulated in response to the
insults was catalase (Meilhac et al., 2001; Meilhac et al., 2000). Catalase is a major antioxidant,
endogenously produced by various tissues, to neutralize excess H2O2 produced by dismutation of
superoxide, yielding water and oxygen (X. Chen et al., 2004). In addition to our studies,
numerous other studies have shown that catalase (mouse) overexpression for example, targeted
to mitochondria (mCAT) in mice provided evidence of being an anti-cancer agent by delaying
the progression of transgenic oncogene and syngeneic tumors (Ge et al., 2015), while
overexpression of catalase (human) in mitochondria showed improvements in skeletal muscle
function in aged rodents vs their WT littermates (Umanskaya et al., 2014). In the context of
cardiovascular disease, restoration of catalase activity in the vascular aortic wall profoundly
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reduced inflammatory markers and prevented abdominal aortic aneurisms through modulation of
matrix metalloproteinase activity (Parastatidis, Weiss, Joseph, & Taylor, 2013). On the other
hand, negative metabolic consequences occur in systems devoid of catalase. Within the context
of DIO, a catalase knockout rodent model had exacerbated IR, amplified oxidative stress, and
accelerated macrophage infiltration in epididymal white adipose tissue (Park et al., 2016)
indicating catalase is a key antioxidant vital for glucose homeostasis and adipose tissue function.
More recently, Heit et al. showed mice devoid of catalase developed an obese, pre-diabetic
phenotype, further showing the importance of antioxidant catalase in metabolic regulation (Heit
et al., 2017). These evidences support catalase as an ideal antioxidant for investigating the
effects of redox balance in obesity and its associated comorbidities due to its vital role in
metabolic homeostasis in both humans and rodent models. The findings discussed in these
studies led us to generate a mouse overexpressing catalase which will serve as a good model to
study redox regulation of metabolic diseases. We hence generated the “Bob-Cat” ‘stress-less’
mouse model: a hybrid between catalase transgenic mice [Tg(CAT)±] (X. Chen et al., 2003) and
leptin-deficient, Ob/+ mice (heterozygous JAX 000632, B6.Cg-Lepob/J). We have earlier shown
that this novel mouse model had lower redox stress and improved adipose function compared to
the Ob/Ob phenotype (JAX 000632, B6.Cg-Lepob/J) and expressed both human and mouse
catalase (D. L. Amos et al., 2017).
We hypothesized that modulating redox stress by altering endogenous antioxidant content
(overexpression of catalase) and/or via dietary intervention will improve energy metabolism,
adipose tissue function, and overall glucose and lipid homeostasis. To better understand the
interplay between redox regulation and dietary intervention in improving energy balance and
maintaining insulin sensitivity, we compared the redox effects of a high-fat lard diet (HFD) and a
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high-fat omega 3-enriched diet (OM3) in a catalase-overexpressing ‘stress-less’ mouse model
(D. L. Amos et al., 2017). In this model, we previously showed the ubiquitous overexpression of
catalase altered body composition parameters, overall energy metabolism, as well as adipose
tissue function in both male and female mice compared to WT controls (D. L. Amos et al.,
2017). These characteristics make this mouse model an excellent method for studying dietary
effects of high fat lard and fish oil diets on metabolic homeostasis of both male and females, now
critical for all clinical trials. Our study showed that OM3 enriched diet, in contrast to the HFD
intervention, activated the GPR120-Nrf2 cross-talk to maintain balanced energy metabolism,
normal circadian rhythm and insulin sensitivity in mice overexpressing catalase compared to the
WT controls. Therefore, increasing endogenous antioxidant production in combination with an
OM3 rich diet will maintain energy balance, improve adipose tissue function, and lower risk of
obesity and its comorbidities.
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3.2 MATERIALS AND METHODS
3.2.1 Mouse Model and Diets
A successful breeding colony of both catalase transgenic [Tg(CAT)±] and the ‘stress-less’
Bob-Cat mice, which ubiquitously express both human and mouse catalase, has been established
in our facility (D. L. Amos et al., 2017). The care and use of animals was performed according to
protocols approved by Marshall University IACUC. To ensure relevance to human clinical
studies conducted on obese adults, it was necessary to use fully developed mice (thus being
between 12-24 weeks of age which correlates with a 20-30 year old human (Jackson et al.,
2017)) and a 45% high fat diet. According to the Center for Disease Control (CDC database
derived from NHANES studies), obese individuals typically consume a 45% fat diet (the
“Western Diet”) (Eicher-Miller & Boushey, 2017). Therefore, sixteen week old [Tg(CAT)±],
Bob-Cat, and their control C57Bl6/WT mice (n≥8/group/sex) were maintained on a 12h
light/dark cycle and fed ad libitum either normal chow-NC (Lab Diet-5001, St. Louis, MO),
High-Fat Lard-HFD diet (Envigo TD06415, Somerset, NJ) containing 45 kcal% Lard, or Omega3 rich-OM3 diet (Envigo TD130700, Somerset, NJ) containing 45 kcal% of Menhaden Fish Oil,
for 8 weeks (Table 6). Both male and females were used due to the differences in overall
regulation of energy homeostasis and metabolism of essential fatty acids (such as OM3) between
the two sexes (B. F. Palmer & Clegg, 2015; M. Yoon et al., 2002). In order to investigate chronic
effect of the dietary intervention, we conducted an 8 week feeding study. Animal body weights
and food consumption were recorded weekly. Energy consumed per diet group was determined
by dividing the grams of chow consumed by kcal per grams (g) of chow.
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Calories Provided By:
Protein
Carbohydrate
Fat

NC (5001)
kcal%
29.8
56.74
13.4

HFD (TD:06415)
kcal%
19.0
36.2
44.8

OM3 (TD:130700)
kcal%
19.0
36.2
44.8

Total Kcal/gm

4.09

4.6

4.6

Diet Formulas
Casein
L-Cystein
Corn Starch
Maltodextrin
Sucrose
Lard
Fish Oil
Soybean Oil
Cellulose
Mineral Mix, AIN-93G-MX
(94046)
Calcium Phosphate, dibasic
Vitamin Mix, AIN-93-VX
(94047)
Choline Bitartrate
Red Food Color
Green Food Color

HFD (TD:06415)- g/Kg
245
3.5
85
115
200
195
0
30
58
43

OM3 (TD: 130700)- g/Kg
245
3.5
85
115
200
0
195
30
58
43

3.4
19

3.4
19

3
0.1
0

3
0
0.1

234
1064.9
Cholesterol, ppm
SFA, g/Kg
80
59.2
MUFA, g/Kg
103.5
51.2
PUFA, g/Kg
40.8
100.0
n-3, g/Kg
4.35
65.7
n-6, g/Kg
36.2
23.9
35.4
19.4
Linoleic Acid, g/kg
Linolenic Acid, g/kg
4.3
5.9
0.78
4.4
Arachidonic Acid, g/kg
Eicosapentaeoic Acid, g/kg
0
31.2
0
21.06
Docosahexaenoic Acid, g/kg
*HFD and OM3 diets obtained from Harlan Laboratories and NC diet obtained from LabDiet

Table 6. Diet composition. High-fat lard diet (Envigo TD06415-HFD), high-fat Omega-3
rich diet (Envigo TD130700 -OM3), and standard chow diet (LabDiet 5001-NC).
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3.2.2 Fat and Lean Body Mass-ECHO-MRI
Body composition (fat and lean mass) was determined using magnetic resonance
imaging, ECHO-MRI (Houston, TX) according to manufacturers’ recommendations. Each
mouse was individually placed within the MRI machine and three or more measurements were
taken. Median values of fat and lean mass readings were calculated per mouse and subsequently
averaged per genotype and diet. Comparisons between groups were made by one or two-way
ANOVA.
3.2.3 Metabolic Parameters (Comprehensive Laboratory Animal Monitoring SystemCLAMS)
Changes in metabolic parameters in response to the dietary interventions were
determined during the final week of the study using indirect calorimetry by measuring O2
consumption (VO2) and CO2 production (VCO2), respiratory exchange rate (RER), Food Intake
(FI), Energy Expenditure (EE), as well as X-Ambulatory counts (XAMB, physical activity)
using the CLAMS system (Columbus Instruments, Columbus, OH, USA). As recommended in
the instruction manual, each mouse was placed individually in the metabolic cages and was
supplied with a sufficient amount of their respective diet for the duration of the data collection
(three consecutive days). Analyses were made using the data collected during the middle 48
hours of the 72-hour procedure, which is from approximately 0600 hours of the first day to 0600
hours of the third day. These time points allowed for both adequate time to acclimate to the
CLAMS environment and provide accurate data for assessment of all measured parameters. Food
intake (FI) was measured by CLAMS and energy intake was calculated by dividing the grams of
food consumed by the kcal of energy per gram of each laboratory diet. RER is calculated as the
ratio of carbon dioxide production and oxygen consumption. Carbohydrate (CHO) oxidation was
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calculated using the formula ((4.585*VCO2) − (3.226*VO2))*4, and similarly, fat oxidation was
calculated using the formula ((1.695*VO2) − (1.701*VCO2))*9 as described by Peronnet &
Massicotte (Peronnet & Massicotte, 1991). EE (heat production) was calculated as the Cal/h/lean
mass (g) to account for the lean body weight. Average values of EE, RER, FI per day, as well as
XAMB locomotor activity per day (counts movement made across the cage measured with
infrared sensors) were determined for each mouse in all groups. Results were further broken
down into light and dark cycles at 2 h time intervals for a total of 48 hours per mouse. One and
two-way ANOVA was used to determine comparative changes between the various genotypes
fed NC, HFD or OM3 diets.
3.2.4 Blood and Tissue Collection
At the end of 8 weeks, animals were fasted overnight and anesthetized using isoflurane
immediately prior to cardiac puncture. Blood was collected in heparinized tubes, centrifuged,
plasma separated, and stored. Tissues including adipose and liver were removed, weighed, and
flash frozen in liquid nitrogen, followed by long-term storage at -80˚C.
3.2.5 Circulating Metabolic Parameters
Whole blood was used to measure fasting glucose and ketone levels (Precision Xtra
Glucometer) then centrifuged for 10 min. to separate the plasma and red blood cells. Thirty-five
µL of plasma was placed on a Cholestech cassette and read on a LDX Cholestech system
(Cholestech Corporation Hayward, CA) to determine Glucose, High Density Lipoprotein (HDL),
Low Density Lipoprotein (LDL), and Total Cholesterol (TC) levels. If data collected fell outside
the range (sensitivity of the assay), the less than (“<”) or (“>”) was used to best represent the
results. The remaining plasma was frozen at -80˚C for further analysis of circulating markers.
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Triglyceride (TG) levels were assessed in plasma using a Triglyceride Colorimetric
Assay Kit (Cayman Chemicals, Ann Arbor, MI). Plasma insulin was analyzed using an
ultrasensitive mouse Insulin ELISA kit (Crystal Chem, Downers Grove, IL). The end point
colorimetric assays were performed using a BioRad Benchmark Plus microplate reader
according to manufacturer’s instructions.
HOMA-IR is a surrogate measure of insulin resistance routinely used in research studies
(Antunes, Elkfury, Jornada, Foletto, & Bertoluci, 2016; Cacho, Sevillano, de Castro, Herrera, &
Ramos, 2008; M. Y. Lee et al., 2008). HOMA-IR was calculated using the formula: fasting
insulin [μlU/ml] x fasting glucose [mmol/L])/22.5.
Circulating FGF-21 was assessed using Mouse and Rat FGF-21 ELISA (Biovendor,
Modrice, Czech Republic) according to manufacturer’s protocol. Absorbance was read using a
BioRad Benchmark Plus microplate reader. Calculations were conducted in accordance with the
best-fit line created from the standard curve of plotted absorbance values against the known
concentrations of standards.
3.2.6 Adipose mRNA Expression
RNA was isolated from 100 mg of perigonadal adipose tissue using TRI Reagent
according to the manufacturer’s recommended protocol (Sigma, Saint Louis, MO). RNA
concentration was determined using the NanoDrop 1000 (NanoDrop Technologies Inc., Thermo
Scientific, Wilmington, DE, USA). Reverse transcription of total RNA (1 µg) was performed
using iScript™ cDNA Synthesis Kit (Bio-Rad, Hercules, CA). RT-qPCR was conducted using
iQ SYBR™ Green Supermix (Bio-Rad, Hercules, CA). The mouse primers used in this study are
provided in Table 7. 18S and β-Actin primers were used as the housekeeping reference genes.
All samples were analyzed in duplicate or triplicate in the Bio-Rad MyiQ or Bio-Rad CFX
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ConnectTM (Bio-Rad, Hercules, CA) instrument and a transcript was considered non-detectable
when the CT value was ≥ 40. The mRNA level of the gene of interest for each group was
normalized to that of the referenced control using the comparative Pfaffl Equation (2^-ddCT)
(Pfaffl, 2001) and expressed as fold change compared to the control C57Bl6/WT mice fed
normal chow (WT NC) or C57Bl6/WT within each dietary group.
Primer
Name
MuAdiponec
tin
MuGPR120
Mu-NrF2
Mu-HO-1
Mu-FGF21
Mu-BActin
Hu-18S

Accession
Number
NM009605
NC_0011
95755.1
NM_0109
02
NC_0000
22.11
NC_0000
19.10
NM007393
NR_0032
86.2

Forward

Reverse

5’- gcagagatggcactcctgga -3

5’- cccttcagctcctgtcattcc -3’

5’- tgtgtgctctagtgctggtg -3’

5’- gcgctggtgaagagcaaatc -3’

5’- ccagaagccacactgacaga -3’

5’- ggagaggatgctgctgaaag -3’

5’- cacgcatatacccgctacct -3’

5’- ccagagtgttcattcgagcac -3’

5’- cgtctgcctcagaaggactc -3’

5’- aatcctgcttggtcttgggg -3’

5’- ctacctcatgaagatcctcaccga 3’
5’- gcaattattccccatgaacg -3’

5’- ttctccttaatgtcacgcacgatt 3’
5’- ggcctcactaaaccatccaa -3’

Table 7. Primer sequences for quantitative RT-PCR.

3.2.7 Western Blot
Approximately 50 mg of perigonadal adipose tissue was homogenized in 100 µL of
Radio-immunoprecipitation assay buffer (RIPA buffer) supplemented with protease inhibitor
cocktail. Protein concentrations were determined by the Lowry Method (Lowry et al., 1951). For
each sample, 50-60 µg protein, were prepared in loading buffer (90% Laemmli and 10% 2mercaptoethanol) and boiled for 5 min. at 100˚ C. Samples were run using SDS-PAGE and
separated on 12% Precast Gel (BioRad, Hercules, CA), at 100 V for 60-70 min. Electrophoretic
transfer of the proteins onto a nitrocellulose membrane was performed at 100V for 60 min. on
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ice. Thermo Scientific Memcode Stain: Pierce MemCodeTM Reversible Protein Stain Kit
(Thermo Fisher Scientific, Rockford, IL) was used as a loading control. Membranes were
blocked with 1X Tris Buffered Saline (1X TBST), 0.05% Tween 20, pH 7.6, and 5% dry milk
for one hour at room temperature. Blots were incubated overnight with mouse GPR120 antibody
(1:250 in 1X TBST and 5% dry milk) (Santa Cruz, Dallas, TX). After washing with 1X TBST,
membranes were incubated with secondary anti-mouse IgG (1:3000 in 1X TBST and 5% dry
milk) for 60 min. at room temperature. Membranes were washed and the immunocomplex was
detected with LuminataTM Forte Western HRP (Millipore, Billerica MA). Densitometry of the
bands was quantified using BioRad Image Lab Software (BioRad, Hercules, CA) and normalized
to MemCode Stain of total protein.
3.2.8 Catalase Enzymatic Activity
Catalase activity was measured in perigonadal adipose tissue protein lysates using the
method of Aebi (Aebi, 1984). Approximately 50 mg of adipose tissue was homogenized in 100
µL of 50 mM KH2PO4, 5 ug/µL Aprotinin, and 2 µL of 0.1 M PMSF. Eight microliters of each
homogenate was added to 1 mL of 25 mM of Hydrogen Peroxide (H2O2) and analyzed on a
Shimadzu Spectrophotometer for one minute. The initial rate of disappearance of H2O2 was
recorded for 1 min. at a wavelength of 240 nM. Each sample was measured in duplicate or
triplicate. A standard curve was generated using 1-5 units of bovine catalase (Sigma, Saint Louis,
MO). Specific activity of catalase was calculated based on the standard curve and total protein
used based on the Lowry’s Method (Lowry et al., 1951).
3.2.9 Quantification of Oxidized Proteins
Carbonylated proteins are a hallmark of redox stress (Fedorova, Bollineni, & Hoffmann,
2014). Oxidized proteins were measured in lysates of perigonadal adipose tissue by determining
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the presence of carbonylated proteins using the Protein Oxidation Detection OxyBlot kit
(Millipore, Billerica, MA) in accordance with the manufacturer’s instructions. The method is
based on the principle that proteins modified by oxidative stress result in an addition of carbonyl
groups to their side-chains. The carbonyl groups are detected after derivatization to 2,4dinitrophenylhydrazone (DNP) by treating with 2,4-dinitrophenylhydrazine (DNPH). An
antibody specific to DNP is then used to determine carbonylated proteins (relative oxidative
stress levels) in each sample. Briefly, each lane was loaded with 20 µg of the derivatized protein
and ran on a 12% BioRad Precast Gel. After gel electrophoresis, proteins were transferred to a
nitrocellulose membrane at 100 V for 60 min. Equal loading and transfer efficiency was
evaluated by use of the Pierce MemCodeTM Reversible Protein Stain Kit (Thermo Fisher
Scientific, Rockford, IL). Non-specific binding sites were then blocked for one hour with 1X
Phosphate Buffered Saline (1X PBST) and Tween 20 and 10% Bovine Serum Albumin (BSA).
A 1:500 dilution of primary antibody, Rabbit-Anti-DNP (Millipore OxyBlot Kit, Billerica, MA)
was added and rocked overnight at 4˚C, followed by washes with 1X PBST. Blots were
conjugated with a 1:300 dilution of goat anti-rabbit IgG (Horseradish Peroxidase conjugated) for
1 h rocking at room temperature. Membranes were washed and the immunocomplex was
detected with LuminataTM Forte Western HRP (Millipore, Burlington, MA). All images were
acquired and analyzed by a BioRad ChemiDoc and Image Lab Software (BioRad, Hercules,
CA). Oxidized proteins were expressed as the ratio of the optical density of
dinitrophenylhydrazone (DNP) to total protein as determined by the Memcode stain.
3.2.10 Statistical Analysis
Data were statistically analyzed using one and two-way ANOVA followed by
Bonferroni’s multiple comparison tests using Version 7 of GraphPad Prism among all mouse
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groups. Data are presented as mean ± standard error of the mean (S.E.M.) unless fold change or
percent of WT was provided. p<0.05 was considered statistically significant. RT-qPCR gene
expression was determined by use of the Pfaffl equation (Pfaffl, 2001) and represented as fold
change with significance denoted as differences in delta CT/genotype and diet. GPR120 protein
and oxidized carbonyl protein analysis was represented as percentage of the WT control mouse
group normalized by total protein quantified by memcode stain.
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3.3 RESULTS
3.3.1 Body Weight and Body Composition
Sixteen week old male mice overexpressing (human and mouse) antioxidant catalase
([Tg(CAT)±] and Bob-Cat) (D. L. Amos et al., 2017) were fed either normal chow (NC), high-fat
lard (45% kcal, HFD), or high-fat omega 3 enriched (45% kcal, OM3) diet, ad libitum for a
period of 8 weeks. Changes in body weight and body composition (fat and lean mass ratio) in the
catalase overexpressing mice were compared to the control wild type (WT) mice fed similar diets
over the 8 week intervention. Body weight was recorded each week and averaged per
intervention group. As shown in Figure 16, all three genotypes maintained their body weights
when fed NC over the 8 week period. However, WT and [Tg(CAT)±] mice consuming a high-fat
lard diet (HFD) gained significantly more weight (8 and 10 fold, p<0.0001) compared to their
NC fed littermates (Figure 16A and 16B), but interestingly, Bob-Cat mice on HFD only gained
approximately 5 fold increase in body weight (not significant) compared to their NC fed
littermates. In contrast, when mice were fed OM3 (45% kcal menhaden fish oil), an increase in
body weight was only observed in the WT mice group. In fact, there was a loss in body weight in
both [Tg(CAT)±] (5 fold lower) and Bob-Cat (>1 fold lower) mice fed OM3 diet compared to
their NC fed littermates. Even more interesting was the significant decrease in body weight
observed in the [Tg(CAT)±] (>5 fold, p<0.0001) and Bob-Cat (>2 fold, p<0.01) mice fed OM3
diet compared to the WT mice fed the same diet. These dietary influences were observed in both
the overall change in body weights (Figure 16A) as well as the average weekly changes in body
weight measured throughout the study (Figure 16B), showing a general trend of increased body
weight per week in the HFD and steady or decreased body weight in the OM3 fed groups among
the mice overexpressing catalase. Two-way ANOVA showed a significant difference in body
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weight between genotype (p<0.05) and diet (p<0.0001) groups in addition to the observed
interaction between the two (p<0.0001) factors.

Figure 16. Body weight and body composition (fat/lean mass) in male mice
overexpressing catalase. Body weight change (initial and final body weight) and body
composition (fat/lean mass) determined by ECHO-MRI: A. Changes in whole body weight
over 8 weeks; B. Overall weekly body weight measurements; C. Fat Mass (g) and; D. Lean
Mass (g) of WT, [Tg(CAT)±], and Bob-Cat male mice fed NC, HFD, and OM3 diets
(n≥6/group). Mice overexpressing catalase on an OM3 diet in contrast to the HFD fed
animals either had no change or lost body weight and fat mass compared to NC fed mouse
groups. One-way and two-way ANOVA was performed on GraphPad Prism 7. Data is
represented as mean ± S.E.M. Letters indicate significant p values, a=p<0.05, b=p<0.01,
c=p<0.001, d=p<0.0001; symbols represent significant differences between genotypes * =
compared to WT; an additional ‘h’ represents comparison to HFD fed WT.
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Body composition (total fat and lean mass) were determined for each mouse group by
ECHO-MRI at baseline, 4 week, and 8 week time points (Figure 16C and 16D). Within the
male mouse groups, there was a significant difference among the diet groups in fat mass by the 8
week time point (p<0.0001). When provided a HFD, mice gained a significant amount of fat
mass compared to the same genotypes provided NC (p< 0.05), but overall there was a trend for
the WT mice to accumulate more fat mass at a faster rate than mice overexpressing catalase
(Figure 16C). However, when provided an OM3 rich diet, the WT group gained only a 3 fold
increase in fat mass (p<0.05) compared to the 8-10 fold increase when fed HFD. This gain in fat
mass was even lower and not significantly different in [Tg(CAT)±] and Bob-Cat mice compared
to NC fed littermates (1-2 g) when fed OM3 rich diet. Lean mass measurements revealed NC fed
WT mice trended to gain the largest amount of lean mass. HFD did not significantly alter the
lean mass of any genotype, however, all male mice provided an OM3 diet gained lean mass from
baseline to the 8 week time point (≥ 0.5 g) with the exception of the [Tg(CAT)±] group (Figure
16D) which lost 2.2 g of lean mass. This loss in lean mass in the [Tg(CAT)±] was reflective of
their loss in total body weight when fed OM3 diet. Bob-Cat mice on OM3 rich diet gained 1.67 g
of lean mass at 4 weeks and then decreased almost back to baseline by the 8 week time point.
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Figure 17. Body weight and body composition (fat/lean mass) in female mice
overexpressing catalase. A. Changes in whole body weight over 8 weeks; B. Overall
weekly body weight measurements; C. Fat Mass (g) and; D. Lean Mass (g) of WT,
[Tg(CAT)±], and Bob-Cat female mice fed NC, HFD, and OM3 diets (n≥4/group). Mice
overexpressing catalase on an OM3 diet in contrast to the HFD fed animals either had no
change or lost body weight and fat mass compared to NC fed mice groups. One-way and
two-way ANOVA was performed on GraphPad Prism 7. Data is represented as mean ±
S.E.M. Letters indicate significant p values, a=p<0.05, c=p<0.001; symbols represent
significant differences between genotypes * = compared to WT; an additional ‘o’ represents
comparison to OM3 fed WT.
Similar to what was seen in males, the female WT, [Tg(CAT)±], and Bob-Cat mice of
each diet group also showed an overall significant difference in body mass with regard to diet
(p<0.0001) (Figure 17). The NC fed mice had minimal changes in body weight over the 8 week
period, while all genotypes provided HFD gained between 2.5 - 3.5 g of body weight (not
significant). Additionally, similar to males, female Bob-Cat mice provided an OM3 diet lost a
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significant amount of weight compared to every other genotype provided HFD (Figure 17A).
Weekly body weight changes (Figure 17B) showed that all mice fed an OM3 diet did not gain
more than one gram of weight over the entire 8 week period.
Similar to males, ECHO-MRI showed that females on HFD, regardless of genotype,
increased fat mass at a much faster rate and doubled the amount of fat gained in comparison to
both their NC and OM3 fed littermates (Figure 17C). Mice provided an OM3 diet did not gain
significant amounts of fat mass in comparison to the NC or OM3 fed WT groups. Interestingly,
Bob-Cat females on OM3 diet had a >9% increase in lean mass in comparison to NC fed BobCats and WT controls (p<0.05; Figure 17D) in spite of them losing the most body weight
(Figure 17A).
3.3.2 Liver and Adipose Tissue Weights
In addition to a gain in visceral adiposity, another hallmark of the metabolic syndrome is
the redistribution of ectopic fat in other metabolic tissues such as the liver. Therefore, visceral
adipose tissue and liver weights were measured during tissue collection from all groups. In
males, analysis by two-way ANOVA revealed a significant difference in visceral adipose tissue
weight among diet groups (p<0.0001). A threefold increase in visceral adipose tissue was
observed in all groups fed HFD in comparison to the NC fed WT group as displayed in Table 8.
In contrast, mice provided OM3 diet did not have significantly larger visceral fat depots than NC
fed mice groups. However, the [Tg(CAT)±] and Bob-Cat mice fed OM3 diet had much lower
levels of visceral fat in comparison to their respective HFD fed groups in addition to a twofold
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Male
NC
Tissue
Visceral
Adipose
Tissue
(g)
Liver
(g)

Visceral
Adipose
Tissue
(g)
Liver
(g)

WT

[Tg
(CAT)±]

HFD
BobCat

0.93
0.83
±
1.28 ± 0.02 ±
0.06
0.14

WT

[Tg
(CAT)±]

OM3
BobCat

WT

[Tg
(CAT)±]

BobCat

2.91
2.8 ± 2.03
1.11
±
3.78 ± 0.37
0.58
±
1.22
±
0.20
±
0.47 d*
b*
0.21
0.19
d*

1.18
1.21
1.41 ± 0.11
±
±
c*
0.06
0.04

1.11
1.25
1.56 ± 0.14
±
±
b*;c*h
0.07
0.08
Female

1.32
1.34
±
1.39 ± 0.08 ±
0.07
0.05

0.72
0.60
±
0.70 ± 0.04 ±
0.06
0.06

1.69
1.36
±
2.12 ± 0.39 ±
0.16
0.22

0.79
0.90
±
0.76 ± 0.07 ±
0.08
0.11

1.20
1.23
±
1.21 ± 0.05 ±
0.08
0.16

0.98
1.00
±
1.13 ± 0.07 ±
0.04
0.04

1.36
1.38
±
1.38 ± 0.05 ±
0.08
0.04

Table 8. Adipose tissue and liver weights of each mouse group. Visceral adipose tissue and
liver weights (g) were measured during tissue collection, at the end of 8 weeks of dietary
intervention, from all male (n≥6/group) and female (n≥4/group) mouse groups. Data are
represented as mean ± S.E.M. Letters indicate significant p values, a=p<0.05, b=p<0.01,
c=p<0.001, d=p<0.0001; symbols represent significant differences between genotypes * =
compared to WT; an additional ‘h’ represents comparison to HFD fed WT.
lesser weight compared to the OM3 fed WT group. This data correlated with the observed body
weight and fat mass (ECHO-MRI analysis) changes seen in these mouse groups. In regard to the
liver weight, analysis by two-way ANOVA showed a significant effect among the genotypes of
male mice (p<0.0001). It was intriguing that the NC and HFD fed [Tg(CAT)±] groups had much
larger livers (>17% increase, p< 0.001) compared to NC WT group. However, Bob-Cats and all
mouse groups provided OM3 diet did not show significant differences in liver weight.
Female mice showed similar trends with the highest visceral adiposity seen among the
HFD fed mice (Table 8). Significant increases in visceral adipose tissue was observed between
[Tg(CAT)±] on HFD and WT mice on NC diet (p<0.0001). OM3 fed female groups also did not
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significantly differ in adipose tissue weight compared to their NC fed littermates. Interestingly,
and contrary to male mice, females provided HFD had lower liver weights (no significance) and
mice provided an OM3 diet showed a trend towards higher liver weight compared to all other
diet groups.
3.3.3 Weekly Food and Energy Consumption
Weekly food and energy consumption for each mouse group were measured to determine
if caloric intake was responsible for the observed differences seen in body weight or fat/lean
mass. Two-way ANOVA showed an overall significant association between diet and genotype
(p<0.0001) in addition to a significant difference observed within the genotypes (p<0.0001) and
the various dietary interventions (p<0.0001). As depicted in Figure 18A, a significant increase in
average food intake was seen for NC fed [Tg(CAT)±] and Bob-Cat mice (p<0.0001 and p<0.01
respectively) compared to the NC fed WT group. Additionally, when provided a HFD or OM3
diet, all groups ate significantly less (p<0.01) grams (g) of food in comparison to NC fed
[Tg(CAT)±] and Bob-Cat mice. Figure 18B showed that as the study progressed, mice provided
HFD or OM3 diet ate less chow per week. Due to differences in the total calories between the
three diets (NC = 4.09 kcal/g compared to 4.6 kcal/g (HFD and OM3) shown in Table 6), the
average kcal/g consumed was also calculated for each mouse group to determine total energy
intake. Two-way ANOVA showed a significant difference with regard to male mouse genotype
(p<0.0001) and diet group (p<0.0001). As shown in Figure 18C, there was a general trend of
lower energy intake when mice were fed HFD or OM3 diet in comparison to NC. A significant
trend was observed when mice overexpressing catalase fed NC consumed more energy than all
groups fed HFD or OM3 diet.
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Weekly food intake among the female mouse groups (Figure 18 D-F) showed similar
eating patterns to those observed in the male mouse groups. There was a significant interaction
between diet and genotype (p=0.0013), genotype alone (p<0.001), and diet alone (p<0.0001).
The largest quantity of chow consumed was by the groups provided NC regardless of the
genotype (Figure 18 D). A significant reduction in food intake was seen in all mice provided a

Figure 18: Weekly food and energy consumption in male and female mice
overexpressing catalase. Weekly food and energy consumption measured in wildtype and
catalase overexpressing mice for 8 weeks: Male, A. average weekly food consumption for 8
weeks; B. weekly food consumption for 8 weeks, and C. calculated average energy
consumption per mouse (n≥6/group). Female, D. average of overall food consumption for 8
weeks; E. weekly food consumption for 8 weeks, and; F. calculated average energy
consumption per mouse (n≥4/group). WT, [Tg(CAT)±], and Bob-Cat mice fed NC, HFD, and
OM3 diet were analyzed for each gender. One-way and two-way ANOVA was performed on
GraphPad Prism 7. Data is represented as mean ± S.E.M. Letters indicate significant p values:
a=p<0.05, b=p<0.01, c=p<0.001, d=p<0.0001; symbols represent significant differences
between genotypes * = compared to WT; an additional ‘h’ represents comparison to HFD fed
WT.
HFD or OM3 diet (p<0.0001) in comparison to the NC fed WT group. This trend was similar
between males and females. Regarding energy intake, there was a significant interaction between
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the genotype and diet group (p=0.0017), as well as between genotype alone (p<0.001), and
between diet groups (p<0.0001) (Figure 18F). Female mice provided HFD or OM3 diet
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Male
NC
Parame
ter

WT

[Tg(
CA
T)±]
<100 <100

HFD
BobCat

WT

[Tg(CA
T)±]

BobCat

WT

[Tg(C
AT)±]

BobCat

<100

134.6
± 7.98

162.3 ±
9.16

144 ±
10.8 b*

<100

<100

<100

>91.2
± 3.61

66.6 ±
3.50

61.5 ±
3.35

>77.89
± 4.78

61.2 ±
2.85

41.5 ±
3.36

223.2
± 9.40

TC
(mg/dL)
HDL
(mg/dL)

TG
(mg/dL)
Ketone
(mmol/
L)

OM3

d*;d*h

55.3
±
4.30
60.7
±
5.48

65.2
±
1.62
81.7
±
5.68

55.83
± 2.15
225.7
± 25.0

>82.9
±
6.51d*
73.2 ±
4.87

>93.3 ±
6.36 d*

c*

79.5 ±
3.66

d*

353.4
±
24.87

d*; d*o

d*;d*h

0.55
±
0.28

0.38
±
0.08

1.18 ±
0.07 b*

1.25 ±
0.14

0.56 ±
0.08

0.35 ±
0.43

1.6 ±
0.23 b*

1.01 ±
0.13

a*h

2.1 ±
0.11
d*a*o

Female
TC
<100 <100
(mg/dL)
48.3 55.8
HDL
±
3±
(mg/dL) 5.48 2.15
234. 197.
TG
1±
7±
(mg/dL) 34.3 10.3
Ketone 1.35 0.98
(mmol/
±
±
L)
0.39 0.12

<100
40.7 ±
3.98

125 ±
0.38
>61.9
± 5.67

164.8
± 10.9
1.48 ±
0.14

<100

<100
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<100

>81.0 ±
5.41

117.5
± 4.79
>69.4
± 7.84

>64.3
± 4.29

62.1 ±
3.71

>75.2
± 4.45

220.6
± 21.2

195.5 ±
7.8

254.4
± 15.5

134.9
± 9.29

190.4
± 17.3

194.1
± 3.0

1.67 ±
0.30

1.0 ±
0.08

0.65 ±
0.56

0.9

1.2 ±
0.23

1.93 ±
0.10

Table 9. Circulating levels of metabolic parameters. Lipid Profile of Total Cholesterol
(TC) and High Density Lipoprotein (HDL) determined using the Cholestech kit, Triglyceride
levels (TG) using the Triglyceride Colorimetric Assay Kit in plasma of Male (n≥6/group)
and Female (n≥4/group) mice. Ketone levels using a glucometer in plasma of Male
(n≥4/group) and Female (n=2-9/group) mice. Measurements were performed in WT,
[Tg(CAT)±], and Bob-Cat mice fed NC, HFD, and OM3 diets for 8 weeks. One-way and
two-way ANOVA was performed on GraphPad Prism 7. Data is represented as mean ±
S.E.M. Letters indicate significant p values, a= p<0.05, b= p<0.01, c= p<0.001, d=
p<0.0001; symbols represent significant differences between genotypes * = compared to
WT; an additional ‘h’ or ‘o’ represents significant differences between HFD and OM3 fed
WT mice respectively.
consumed less energy compared to NC fed littermates. However, the decrease in food and energy
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intake did not correlate with the increase in body weight and adiposity seen in HFD fed animals
compared to NC and OM3 diet fed littermates.
3.3.4 Blood Lipid Profile and Ketones
Post-surgery, the lipid profile was measured on plasma samples collected from each
mouse fasted at least 12 h prior to the surgery using an LDX Cholestech kit. As shown in Table
9, all mouse groups fed HFD (p<0.001) had significantly higher Total Cholesterol (TC) levels in
comparison to the NC fed WT mice and all mouse groups on OM3 rich diet. In the groups fed
HFD or OM3, the Bob-Cat mice had the highest levels of HDL followed by the HFD fed
[Tg(CAT)±]. This is also true when comparing the OM3 Bob-Cat group to every group provided
NC. Two-way ANOVA analysis of plasma triglyceride (TG) levels showed there was a
significant genotype (p<0.0001) and diet (p<0.01) interaction among the groups. Interestingly,
male Bob-Cat mice, regardless of diet, had the highest levels of plasma TG. In fact, within each
diet group, Bob-Cat male mice had 3 fold higher TG levels compared to the other two genotypes.
As shown in Table 9, female TC level was < 100 mg/dL for all mouse groups except the
HFD fed WT and Bob-Cat groups. The female HFD fed [Tg(CAT)±] mice displayed much lower
TC (<100 mg/dL) compared to the male mice (162.3 ± 9.16 mg/dL) fed the same diet. (It is to be
noted, when individual mice readings fell outside the assay’s range of sensitivity, the less than
(“<”) or (“>”) was used to best represent the average results from each mouse group.)
Assessment of HDL revealed a significant diet interaction (p<0.003). Female mice trended to
have a little lower HDL levels in comparison to males. However, consistent with males, highest
levels of HDL was found in the [Tg(CAT)±] HFD fed females. Another interesting trend
observed was that within the OM3 diet fed groups, the Bob-Cat male and female groups had the
highest levels of HDL. Data analysis of TG levels revealed a significant interaction between diet
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and genotype (p=0.01) within the female mouse groups. There was an overall trend for HFD
mice to have equal or increased levels of plasma TG in comparison to their respective genotypes
on NC or OM3 diet. However, it was interesting that OM3 diet only showed a trend towards
lower TG levels compared to NC and HFD in the WT group. There was also a gender effect
where female WT and [Tg(CAT)±] mice, regardless of diet, expressed higher levels of TG in
comparison to the males. However, Bob-Cat females had lower levels of circulating TG in
comparison to male Bob-Cats.
Ketone levels of NC fed [Tg(CAT)±] mice were lower (not significant), but the Bob-cat
group (p<0.05) were significantly higher than the NC fed WT male group. When mice were
provided HFD, each genotype doubled its ketone level compared to their NC littermates with the
exception of the HFD fed Bob-Cat mice, which showed the lowest levels within the HFD groups
(3 fold decrease, p<0.05). OM3 diet feeding also increased plasma ketone levels (2 fold increase)
in comparison to littermates provided NC. Specifically, the OM3 fed WT group (p<0.01) had
significantly higher levels than the NC fed WT, and the OM3 Bob-Cat males having the highest
levels of all groups [> 3 fold compared to the NC fed WT (p<0.0001) and ≈ 2 fold compared to
the NC fed Bob-Cat group (p<0.05)].
A significant interaction between diet and genotype was seen in fasting ketone levels
(p<0.01). Within females, the ketone levels showed a trend to be higher than males within each
respective mouse group with the exception of mice provided the OM3 diet.
3.3.5 Metabolic Parameters Using CLAMS
Metabolic parameters were determined at the end of the 8 week study using indirect
calorimetry by measuring O2 consumption (VO2) and CO2 production (VCO2), Respiratory
Exchange Rate (RER), Food Intake (FI), Energy Expenditure (EE), as well as X-Ambulatory
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counts (XAMB - physical activity) using the Comprehensive Laboratory Animal Monitoring
System (CLAMS) (Columbus Instruments, Columbus, OH, USA).
3.3.5.1 Food Intake (CLAMS)
A three-day assessment of Food Intake (FI) (Figure 19A-B) was conducted using
CLAMS, which allowed analysis of eating patterns and insight on circadian rhythm. All male
mice on HFD in the WT and [Tg(CAT)±] mouse groups ate at a more constant rate throughout
the 48 hour time period compared to mice provided NC and mice overexpressing catalase (fed
OM3 diet) which ate more frequently through the dark cycle and less during the light cycle. Most
intriguing, was the evidence that male Bob-Cat mice followed a similar eating pattern to the NC
fed group (decreased food intake during light cycle and increased during the dark cycle)
indicating that diet (NC or OM3) had not altered their circadian rhythm to the degree that was
observed in other two genotypes fed HFD and the WT mice fed OM3.
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As shown in Figure 19B, CLAMS analysis on female mice provided NC showed a
normal eating pattern (higher consumption in the dark vs light cycle). Similar to what was seen
in the male mouse groups, the female Bob-Cats on HFD showed a normal eating pattern in

Figure 19: CLAMS analysis of food intake over a 48 hour period in male and female
mice overexpressing catalase. Light and dark cycle analysis of CLAMS measurements for
48 hours are provided: Male, A. and Female, B. Food Intake as average grams/2h for 48
hours by WT, [Tg(CAT)±], and Bob-Cat mice fed NC, HFD, and OM3 diet (n≥3/group).
One-way and two-way ANOVA was performed on GraphPad Prism 7. Data is represented as
mean ± S.E.M. Letters indicate significant p values: a=p<0.05, b=p<0.01, c=p<0.001,
d=p<0.0001; symbols represent significant differences between genotypes * = compared to
WT; an additional ‘o’ represents comparison to OM3 fed WT.
contrast to the other two genotypes fed the same diet. However, when fed OM3 diet, the
differences in the eating pattern were lost. In general, a more stable pattern of energy
consumption occurred in mice with lower fat mass as shown previously in Figure 16 and 17.
3.3.5.2 Energy Expenditure and Physical Activity (CLAMS)
In addition to FI, Energy Expenditure (EE) and physical activity (XAMB) were also
analyzed using the CLAMS technology. As seen in Figure 20A, EE, calculated indirectly as
Cal/h/g of lean body mass in each male mouse group, did not significantly differ between
genotypes when provided NC diet. The HFD fed groups had significantly higher levels of EE in
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the dark cycle (p<0.01) compared to NC fed WT mice. However, during the light cycle, HFD
[Tg(CAT)±] mice had much lower levels than both groups overexpressing catalase provided
HFD. EE in all groups provided OM3 diet remained at intermediate levels to that seen in the NC
and HFD fed groups, yet levels were significantly higher than the NC WT group (p<0.05).
Overall, differences between groups were much greater during the dark vs. light cycle. Analysis
of the X-Ambulatory (XAMB) activity, depicted in Figure 20B, showed there was higher
activity in the [Tg(CAT)±] and Bob-Cat mice compared to NC WT mice (p<0.05). Interestingly,
these were also the two groups where the greatest weekly food intake and energy intake (Figure
18A & C) was also observed. Likewise, when all genotypes were provided HFD or OM3 diet,
the WT mice had the lowest activity levels, not reaching above 3000 counts per 2 hours,
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suggesting that the overexpression of catalase might have some influence on the activity levels
observed in the male groups.

Figure 20: CLAMS analysis of energy expenditure and total activity over a 48 hour
period in male and female mice overexpressing catalase. Light and dark cycle CLAMS
analysis of Energy Expenditure (EE) and X-Ambulatory Movement (XAMB) per 2h over a
48 hour time period are provided: Male, A. Metabolic EE averaged as Cal/h/Lean(g) body
mass and; B. XAMB Counts per 2h for 48 hours for WT, [Tg(CAT)±], and Bob-Cat mice fed
NC, HFD, and OM3 diet (n≥4/group). C&D. represent data of female mice of each genotype
and diet group (n≥3/group). One-way and two-way ANOVA were performed on GraphPad
Prism 7. Data is represented as mean ± S.E.M. Letters indicate significant p values:
a=p<0.05, b=p<0.01, c=p<0.001, d=p<0.0001; symbols represent significant differences
between genotypes * = compared to WT; an additional ‘h’ represents comparison to HFD fed
WT.
Overall, within female groups the analysis of EE showed less variation in circadian
rhythm (Figure 20C) in comparison to that observed within male groups. Similar to males,
females on HFD had higher levels of EE in comparison to the mice fed NC or OM3, with the
WT mice fed HFD showing the highest levels during both the light and dark cycles (p<0.05) and
116

the [Tg(CAT)±] mice mostly during the dark cycle (p<0.01). XAMB analysis among female
groups on NC and OM3 diet showed a trend for Bob-Cat mice to have higher activity levels than
WT or [Tg(CAT)±] mice. This may have accounted for the observed lower body weight in the
Bob-Cat mice shown earlier (Figure 17). Animals fed HFD had either similar or lower activity
levels compared to NC fed WT mice with the exception of the female HFD fed [Tg(CAT)±] mice
which displayed significantly higher activity during the dark cycle (3 fold, p<0.01).
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3.3.5.3 Respiratory Exchange Ratio (CLAMS)
Using CLAMS, we also determined the Respiratory Exchange Ratio (RER) for each
mouse group at the end of the 8 week study. RER, an indication of which type of fuel
(carbohydrate (CHO) or fat) is primarily being metabolized to supply energy demands, was
lowest in the male NC fed WT mice group as well as in all HFD fed mice (Figure 21A).
However, when groups overexpressing catalase were provided NC, the RER was significantly
higher compared to the WT mice during both light (p<0.01) and dark cycles (p<0.001). When
provided an OM3 enriched diet, the RER levels remained intermediate between the NC and HFD

Figure 21. CLAMS analysis of RER and substrate oxidation over a 48 hour period in
male mice overexpressing catalase. Light and dark cycle CLAMS analysis of average
Respiratory Exchange Ratio (RER) and calculated CHO and Fat Oxidation per 2h over a 48
hour time interval: A. RER (CO2 emission/O2 consumption); B. CHO Oxidation, and; C. Fat
Oxidation for WT, [Tg(CAT)±], and Bob-Cat mice fed NC, HFD, and OM3 diet (n≥4/group).
One-way and two-way ANOVA was performed on GraphPad Prism 7. Data is represented as
mean ± S.E.M. Letters indicate significant p values: a=p<0.05, b=p<0.01, c=p<0.001,
d=p<0.0001; symbols represent significant differences between genotypes * = compared to
WT; an additional ‘o’ represents comparison to OM3 fed WT.
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groups. As seen within the NC groups, the mice overexpressing catalase fed OM3 also had a
higher RER in comparison to the OM3 fed WT groups. Since RER levels reflect the circadian
patterns of food consumed, it also followed similar light and dark cycle patterns as seen with FI
(Figure 19). The NC fed groups followed a normal circadian pattern, but the HFD fed groups did
not. It was interesting to note that Bob-Cat mice fed NC or OM3 diet followed a normal pattern
which was not evident when these mice were fed HFD.
We further delineated the levels of CHO and fat oxidation based on the VO2 and VCO2
data derived from the CLAMS analysis. As seen in Figure 21B, the most significant differences
seen in CHO oxidation of male groups were observed during the dark cycle. However, in
comparison to the WT groups, mice overexpressing catalase provided NC had significantly
higher levels of CHO oxidation (p<0.0001) independent of the light or dark cycle. Conversely,
when provided HFD, there were no differences between genotypes, but all mouse groups had
significantly lower levels of CHO oxidation than the NC fed WT groups during the dark cycle.
Similar to that seen with the NC groups, OM3 diet also showed that mice overexpressing
catalase had significantly higher levels of CHO oxidation compared to both the NC fed WT mice
and OM3 fed WT mice independent of the time of day. Contrary to CHO oxidation, NC fed WT
mice had significantly higher levels of fat oxidation (p<0.0001) compared to every other group
during the light cycle and significantly higher levels compared to mice overexpressing catalase
(p<0.0001) on NC diet in addition to OM3 diet during the dark cycle. Mice provided HFD
showed a trend for having the highest levels of fat oxidation regardless of the genotype during
the dark cycle (not significant). When fed an OM3 diet, it was interesting that the mice
overexpressing catalase had significantly lower levels of fat oxidation in comparison to the WT
mice provided OM3 diet during both light and dark cycles. However, in comparison to

119

littermates provided NC, both groups overexpressing antioxidant catalase had significantly lower
levels of fat oxidation (p<0.01) during the dark cycle.
When comparing the various diets, female mice followed similar trends in RER
compared to what was seen in male mice (Figures 21& 22).

Figure 22. CLAMS analysis of RER and substrate oxidation over a 48 hour period in
female mice overexpressing catalase. Light and dark cycle CLAMS analysis of average
Respiratory Exchange Ratio (RER), and calculated CHO and Fat Oxidation for 48 hours: A.
RER (CO2 emission/O2 consumption); B. CHO Oxidation, and; C. Fat Oxidation for WT,
[Tg(CAT)±], and Bob-Cat mice fed NC, HFD, and OM3 diet (n≥3/group). One-way and twoway ANOVA was performed on GraphPad Prism 7. Data is represented as mean ± S.E.M.
Letters indicate significant p values: a=p<0.05, b=p<0.01, c=p<0.001, d=p<0.0001; symbols
represent significant differences between genotypes * = compared to WT; an additional ‘h’
represents comparison to HFD fed WT while an additional ‘o’ represents comparison to OM3
fed WT.
NC fed female diet groups had the typical circadian cycles. Although unlike male mice,
female NC fed Bob-Cats showed a trend for having a lower RER than the NC fed WT females
throughout the light and dark cycles. Within the female HFD groups, WT and [Tg(CAT)±] had a
significantly lower RER during both light and dark cycles (p<0.01), while Bob-Cats only showed
a trend. However, it was interesting that the HFD fed Bob-Cats had a significantly higher RER
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compared to the HFD fed WT group during the dark cycle (p<0.05). When provided an OM3
diet, Bob-Cat and WT groups had a significantly lower RER compared to NC fed WT mice
(p<0.01), but [Tg(CAT)±] mice only had significantly lower levels (p<0.05) during the dark
cycle. This was not seen in the male mouse groups overexpressing catalase fed OM3 diet, where
we observed higher levels of RER than the NC fed WT mice.
Calculations of CHO oxidation in females showed that in contrast to males, NC fed
female mice overexpressing catalase had similar or significantly lower levels of CHO oxidation
(NC fed Bob-Cat) compared to their WT littermates (Figure 22B). On the other hand, similar to
males, when fed a HFD, the CHO oxidation in each mouse group was significantly decreased in
the dark cycle compared to NC fed WT mice and no significant differences were seen among the
female genotypes fed HFD. Also, as observed in males, OM3 fed female [Tg(CAT)±] mice had
significantly higher levels of CHO oxidation (p<0.0001) compared to both NC and OM3 fed WT
mice, but levels did not significantly differ from NC fed WT mice. On the other hand, Bob-Cat
females either had similar or significantly lower levels of CHO oxidation compared to their NC
or OM3 fed WT control groups. With regard to fat oxidation, the same general trends occurred in
both female and male diet groups with the exception that female fat oxidation trended to be much
higher (kcal/h/g) than males on the same intervention. It is of special interest however, among
the female groups, the NC and OM3 Bob-Cat mice groups trended to have the highest levels of
fat oxidation regardless of the time of day. This may be an indication of why these groups
trended to have one of the lowest body weight and fat mass averages compared to the other
intervention groups (Figure 17).
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3.3.6 Insulin Sensitivity
Both redox stress and dietary interventions (HFD and OM3) can modulate insulin
sensitivity; hence we measured fasting levels of glucose and insulin and subsequently calculated

Figure 23. Insulin sensitivity in male and female mice overexpressing catalase.
Quantification of fasting blood glucose (glucometer), plasma insulin (ELISA), and calculated
HOMA-IR: Male, A. Glucose; B. Insulin, and; C. HOMA-IR in WT, [Tg(CAT)±], and BobCat mice fed NC, HFD, and OM3 diet (n≥5/group). Graphs D-F. show data collected from
female mice of each genotype and diet group (n≥4). One-way and two-way ANOVA was
performed on GraphPad Prism 7. Data is represented as mean ± S.E.M. Letters indicate
significant p values, a=p<0.05, b=p<0.01.
the HOMA-IR, an indirect measure of insulin sensitivity. As depicted in Figure 23A, a
genotypic (p<0.01) and dietary effect (p<0.0001) was observed in glucose levels. There was a
trend for lower glucose levels in mice fed OM3 diet compared to NC mouse groups, and
significantly lower levels in mice fed OM3 vs. HFD fed groups (p<0.01). Bob-Cat mice on OM3
diet had the lowest glucose levels in comparison to every other group. All genotypes on HFD
had increased levels of glucose compared to every other group. Similarly, a significant genotypic
(p=0.0005) interaction was seen in circulating insulin levels (Figure 23B). Interestingly, in spite
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of the large range within the group, the HFD fed [Tg(CAT)±] mice had the highest insulin levels
compared to any other mouse group (p<0.05). Calculated HOMA-IR (Figure 23C), revealed a
significant difference in genotype (p<0.001) and diet (p<0.05). As expected, due to the larger
range in the insulin levels within this group, the [Tg(CAT)±] mice on HFD also had the highest
calculated HOMA-IR (p<0.01). Interestingly, ketone levels showed no significant differences in
the [Tg(CAT)±] male and WT mice fed NC where insulin signaling was optimal (Table 9). In
fact, the ketone levels in the HFD fed WT male group were >2 fold higher than the levels in the
[Tg(CAT)±] group on HFD, thus indicating insulin is repressing ketone body production. Thus,
these mice may not be classified as insulin resistant or hyperinsulinemic (Puchalska & Crawford,
2017). In contrast, [Tg(CAT)±] mice on NC or OM3 had much lower insulin levels and
calculated HOMA-IR.
In female mice, glucose levels showed no significant differences between groups as
depicted in Figure 23D. However, when comparing diets, the [Tg(CAT)±] mice had the highest
levels of glucose within each dietary group. Also, as observed in males, there was a trend for
HFD fed mice of each genotype to have an overall increase and mice provided OM3 diet to have
an overall equivalent or reduced plasma glucose level compared to littermates placed on NC,
though none reached significance. An overall diet interaction was observed for insulin (Figure
23E) among female groups (p<0.001). Contrary to the highest levels of insulin in the
[Tg(CAT)±] males, the female mice had the lowest average insulin levels of all mice provided
HFD. Additionally, in contrast to males, female ketones did not significantly differ in the female
HFD fed [Tg(CAT)±] in comparison to any other female mouse group (Table 9). Bob-Cat mice
within each diet group showed the highest insulin levels among the genotypes, and were
significantly higher (p<0.05) compared to both the NC and HFD fed WT females. HOMA-IR
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calculations revealed an interaction between diet and genotype (p<0.05) as well as a genotype
interaction (p<0.0001). In contrast to the males, the female [Tg(CAT)±] had the lowest calculated
HOMA-IR and the HFD fed Bob-Cat groups had the highest, pointing to a possible sexual
dimorphism in regard to insulin sensitivity within the ‘stress-less’ mice models.
3.3.7 Diet-Redox Stress Interaction in Adipose Tissue
3.3.7.1 Redox Status
In order to determine if differences in redox environment, due to dietary intervention,
contributed to the observed metabolic changes in the ‘stress-less’ mouse models, we measured
signatures of adipose tissue redox stress: i.e. oxidized carbonyl groups, expression of Nrf2 (a
transcription factor and key regulator of redox homeostasis), and key targets reflecting the
activity of Nrf2: catalase activity and HO-1 (antioxidants transcribed upon activation of Nrf2).
Oxidized carbonyl groups, measured using the OxyBlot protein oxidation kit (Millipore),
interestingly showed that within male groups, there was no major induction of oxidized proteins
in the NC or HFD fed groups (Figure 24A). However, in mice fed an OM3 enriched diet, we
saw higher levels of oxidized carbonyls, with the highest levels seen within the OM3 fed WT
mouse group (p<0.05) compared to the NC and HFD groups followed by the OM3 fed Bob-Cat
group (not significant). Within females (Figure 24B), there was a trend for the mice
overexpressing catalase to have lower levels of oxidized carbonyl groups in comparison to the
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WT littermates. The only exception was the Bob-Cat mice fed OM3 diet, which showed a
significant increase (p<0.05) in oxidized carbonyl groups.

Figure 24. Adipose tissue oxidized carbonyl groups in male and female mice
overexpressing catalase. Male, A. and Female, B. oxidized carbonylated proteins in
perigonadal adipose tissue. Oxidized protein levels in all mouse groups are represented as %
of the oxidized proteins in WT mice fed NC. One-way and two-way ANOVA was performed
on GraphPad Prism 7. Letter a indicates significance at p<0.05.

When mRNA expression of Nrf2, a redox sensitive transcription factor was determined,
the male Bob-Cat mice showed an increase in Nrf2 induction when fed HFD (>4 fold) or OM3
(>9 fold) compared to its NC fed littermates and the other genotypes fed any diet. However, none
reached statistical significance (Figure 25A). Similar trends of Nrf2 induction were also seen in
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the Bob-Cat female mice where the levels increased to >50 fold when fed HFD and >120 fold
(p<0.05) when fed OM3 diet vs. the WT group (Figure 25B).

Figure 9: Redox Stress in Adipose Tissue
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Figure 25. Nrf2 signaling in adipose tissue of male and female mice overexpressing
catalase. Redox stress was evaluated in adipose tissue by measuring mRNA expression of
Nrf2 (transcription factor and redox regulator), Catalase enzymatic activity and mRNA
expression of HO-1 (downstream antioxidant targets of Nrf2): Male, A. and Female, B. Nrf2
mRNA expression level in the perigonadal adipose tissue measured by RT-qPCR. Male, C.
and Female, D. Catalase specific activity (U/mg protein) was measured and data for Catalase
activity is represented as mean ± S.E.M. of WT, [Tg(CAT)±], and Bob-Cat mice fed NC,
HFD, and OM3 diet (n≥3/group); Male, E. and Female F. HO-1 mRNA expression level in
the perigonadal adipose tissue measured by RT-qPCR. mRNA expression is depicted as fold
change compared to WT mice fed the same diet by ddCT method. One-way and two-way
ANOVA was performed on GraphPad Prism 7. Letters indicate significant p values,
a=p<0.05, b=p<0.01; symbols represent significant differences between genotypes * =
compared to WT; an additional ‘h’ or ‘o’ represents comparison to HFD or OM3 fed WT
mice respectively.
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Both antioxidant catalase and HO-1 are downstream targets activated by Nrf2. Therefore,
catalase activity and expression of HO-1 was measured in the adipose tissue of each mouse
group (Figure 25C-F). Catalase activity was down-regulated in HFD and OM3 fed WT and
[Tg(CAT)±] male mice. However, activity levels remained 10 fold higher (not significant) in the
Bob-Cat mice fed any diet, compared to the other two genotypes. Interestingly, the females
expressed at least 5 fold increased catalase activity in all the genotypes compared to their male
counterparts (Figure 25C-D). In addition, the mice overexpressing catalase trended to have
higher levels of catalase activity compared to the WT mice. HO-1 mRNA expression was shown
to be the highest in the male and female Bob-Cat mice groups (Figure 25F-G). Similar to the
mRNA of its transcriptional activator, Nrf2, in males, the Bob-Cat mice showed a gradual
increase in HO-1 induction when fed HFD (>3 fold) or OM3 (>15 fold, p<0.05) compared to the
controls on the same respective diets. Similar trends were seen among the Bob-Cat female mice.
An induction of HO-1 was observed in the Bob-Cat HFD group (>63 fold) and OM3 group
(>208 fold) compared to WT controls fed the same diet. The induction of both catalase and HO-1
observed in the Bob-Cat male and female mice fed an OM3 diet provides evidence that Nrf2 had
translocated to the nucleus and activated its downstream targets.
3.3.7.2 GPR120/FFAR4 expression
Our data thus far have shown that in general, mice overexpressing catalase fed OM3 diet
in comparison to mice fed HFD or WT mice fed any of the diets, had lower body weight and fat
mass, decreased energy consumption, and maintained normal glucose and insulin levels.
However, sexual dimorphism was observed within some of the measured metabolic parameters.
GPR120/FFAR4 is a lipid sensing, long chain fatty acid receptor highly expressed in adipose
tissue and macrophages and is attributed to the beneficial anti-inflammatory and insulin
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sensitizing effects of an OM3 diet (D. Y. Oh et al., 2010). Therefore, we investigated whether
GPR120 was contributing to the alterations in metabolic parameters seen within the antioxidant
overexpressing mice and to the observed sexual dimorphism. As shown in Figure 26A&C, the
male [Tg(CAT)±] mice had a lower expression of GPR120 at baseline (NC fed animals);
however the levels increased 2-3 fold higher (not significant) than WT mice, when fed HFD or
OM3 diets. In contrast, there was a gradual induction of GPR120 mRNA expression in Bob-Cat
mouse groups when fed NC or HFD (>12 fold induction, p<0.01) and over 108 fold (p<0.01)
when fed OM3 diet (Figure 26A). Western blotting of the protein expression of GPR120 showed
a genotypic effect (Figure 26B) among the male groups (p= 0.002). It was intriguing that,
regardless of the diet, Bob-Cat mouse groups had the highest levels of GPR120 protein
expression.
In females, the [Tg(CAT)±] group showed a slight decrease in GPR120 expression
(Figure 26D) when fed HFD or OM3 (p<0.05), compared to the NC fed diet groups. In contrast,
similar to the male mice, Bob-Cat female mice provided an OM3 diet had a significant increase
(p<0.05) in GPR120 mRNA expression compared to WT mice. As indicated in Figure 26 B&D,
Western blotting showed that the GPR120 protein level in the adipose tissue only had a trend
towards increased expression in NC fed female mice overexpressing catalase ([Tg(CAT)±] and
Bob-Cat), whereas those fed HFD had a lower expression compared to their WT littermates. As
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Figure 26. GPR120 mRNA and protein expression in adipose tissue of male and female
mice overexpressing catalase. Male, A. and Female, C. GPR120 mRNA expression
measured by RT-qPCR in the adipose tissue from WT, [Tg(CAT)±], and Bob-Cat mice fed
NC, HFD, and OM3 diet depicted as fold change compared to WT mice fed the same diet by
Pfaffl ∆∆CT method (n≥4 and 3/group respectively). Male, B. and Female, D. Western Blot
of GPR120 protein in adipose tissue, shown as % densitometric ratio of Anti-GPR120 and
total protein (memcode stain) per genotype to % ratio observed in WT mice fed similar diet
(n≥4 and 3/group respectively). One-way and two-way ANOVA was performed on
GraphPad Prism 7. Letters indicate significant p values: a=p<0.05, b=p<0.01; symbols
represent significant differences between genotypes * = compared to WT; an additional ‘o’
represents comparison to OM3 fed WT.
seen in the males, OM3 fed Bob-Cat female mice also showed a significant increase (p<0.05) in
GPR120 protein expression compared to NC fed WT mice.
3.3.7.3 Adipokine modulators of insulin sensitivity
Adipose tissue produces and secretes adipocytokines which play both an autocrine and
paracrine role in metabolic pathways involving insulin sensitivity as well as in inflammation
(Kern, Di Gregorio, Lu, Rassouli, & Ranganathan, 2003). Their levels can also be influenced by
an OM3 rich diet (Bargut et al., 2016; Chopra, Siddhu, & Tandon, 2014) and redox status of the
adipose tissue (D. L. Amos et al., 2017; Kern et al., 2003; Lawler et al., 2016; Marseglia et al.,
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2014; Ruan, Zheng, Li, Wang, & Li, 2015). We first measured adiponectin, which alleviates
insulin resistance by stimulating lipid oxidation and anti-inflammatory processes (Choe et al.,
2016). As shown in Figure 27A, within male groups, we saw both a significant difference

Figure 27. Adipose tissue mRNA expression and circulating levels of key adipokines
determined in male and female mice overexpressing catalase. Male, A. and C. and
Female, B. and D. of Adiponectin (n≥4/group) and FGF-21 (n≥4/group) respectively. Data
depicted as fold change compared to WT mice fed the same respective diet using the Pfaffl
ddCT method. Male, E. and Female, F. Circulating FGF-21 was measured using a mouse
FGF21 ELISA kit according to manufacturer’s protocol (n≥3/group). All analyses were
measured in WT, [Tg(CAT)±], and Bob-Cat groups fed NC, HFD, and OM3 diet. One-way
and two-way ANOVA was performed on GraphPad Prism 7. Data for serum FGF-21 levels
are represented as mean ± S.E.M. Letters indicate significant p values: a=p<0.05, b=p<0.01,
c=p<0.001, d=p<0.0001; symbols represent significant differences between genotypes * =
compared to WT; an additional ‘o’ represents comparison to OM3 fed WT.
among the genotypes (p<0.0001) in addition to the diet (p<0.05). Bob-Cat mice provided a NC
and OM3 rich diet had a >6 fold (p<0.05) and >19 fold (p<0.001) increase in adiponectin mRNA
levels respectively, compared to the WT groups fed similar diets. All female Bob-Cat groups
showed a trend to have the highest fold change (Figure 27B) in adiponectin expression
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compared to the WT mouse groups fed the same diet, but similar to males, the most significant
fold increase was within the OM3 fed Bob-Cat mouse group (>82 fold increase, p<0.01).
Adiponectin works in concert with Fibroblast Growth Factor 21 (FGF-21) (Hui et al.,
2016), both an adipokine and hepatokine, with paracrine effects on adipose tissue (X. Lin, Liu, &
Hu, 2017). It was most recently identified to be a stress response hormone (Gomez-Samano et
al., 2017) in addition to its known beneficial function as a metabolic regulator of glucose and
lipid homeostasis and insulin sensitivity (Z. Lin et al., 2013). Therefore, we investigated both the
adipose mRNA expression and the plasma levels of FGF-21. Within the adipose tissue from
male mice (Figure 27C), FGF-21 levels were not significantly different. However, there was a
trend for mice overexpressing catalase on a NC diet to have a lower FGF-21 expression while
littermates provided HFD or OM3 diet showed a >2 fold increase. The highest levels of FGF-21
within each diet group overexpressing catalase were within the HFD groups. Female mice
showed similar results with the exception of the HFD fed [Tg(CAT)±] group where there was a
lower expression of FGF-21 in comparison to the NC (p<0.05) and HFD (not significant) fed
WT mouse group. However, the most significant finding was that the OM3 fed Bob-Cat female
mice had a >60 fold increase (p<0.01) compared to the WT group fed the same diet (Figure
27D). With FGF-21 also being secreted by liver, we used an ELISA kit to measure circulating
levels of FGF-21. Within the male mouse groups, mice overexpressing catalase had significantly
lower levels (p<0.05) than the NC WT mice as seen in Figure 27E. However, when provided
HFD, [Tg(CAT)±] had significantly higher levels (p<0.05) compared to every other mouse group
provided HFD. Interestingly, Bob-Cat mice, regardless of the diet, showed a trend for having
lower plasma FGF-21 levels than the WT mice of each respective diet group. Circulating levels
of FGF-21 in female mouse groups were also measured (Figure 27F). Contrary to males, female
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mice overexpressing catalase provided NC diet did not have significantly lower levels of
circulating FGF-21 than their WT littermates. In fact, the NC fed [Tg(CAT)±] had the highest
levels of circulating FGF-21, which did not correlate with the mRNA expression of FGF-21 in
the adipose tissue. Perhaps the liver was a major source of the circulating FGF-21. It was also
surprising to find that when provided either high-fat diet (HFD or OM3) intervention, female
Bob-Cat mice trended to have higher levels of plasma FGF-21 compared to their WT littermates.
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3.4 DISCUSSION
Obesity and its comorbidities are characterized with increased levels of ROS that alter
lipid and glucose homeostasis in key metabolic organs (Barazzoni, Gortan Cappellari, Ragni, &
Nisoli, 2018; Carrier, 2017; Rani et al., 2016). This leads to increased body weight and fat mass
thus increasing risk for hyperglycemia, hyperlipidemia, hyperleptinemia, systemic inflammation,
and IR (Carrier, 2017). Both endogenous and exogenous antioxidant supplementation, known to
mitigate the negative effects of redox stress, were shown to lower the levels of ROS in these
metabolic diseases (Drummond, Selemidis, Griendling, & Sobey, 2011; Haidara et al., 2011;
Park et al., 2016; B. Patel, Mann, & Chapple, 2018). Additionally, in both lean and obese rodent
models, dietary interventions, such as those rich in OM3 fatty acids (including EPA and DHA) in
contrast to saturated fatty acids (lard diet), also lowered body weight and fat mass, increased
insulin sensitivity, and induced browning of white adipose tissue through anti-inflammatory
actions (Bargut et al., 2016; Hirabara et al., 2013; Luo et al., 2016; D. Y. Oh et al., 2010).
However, the mechanisms leading to these beneficial effects were not clearly defined. We
recently showed that mice overexpressing catalase in a genetically obese background (Bob-Cat),
in contrast to its wild-type littermates, significantly lowered redox stress (‘stress-less’ mice),
improved energy metabolism, and altered the expression of key adipocytokines (D. L. Amos et
al., 2017). The overexpression of catalase in this mouse model with a genetic obese background
was implicated to be the key factor responsible for these effects. Therefore, these mice presented
characteristics of an effective model to study the interaction between redox regulation and
dietary intervention, on adipose tissue function and glucose and lipid signaling in a “diet-induced
obesity” model. In the present study, eight weeks (chronic effect) of dietary intervention in the
‘stress-less’ mouse model overexpressing catalase, in comparison to their WT controls, showed

133

that the high-fat omega-3 enriched (OM3) diet, in contrast to the high-fat lard (HFD) diet,
stabilized body weight and fat mass, maintained balanced energy metabolism and normal
circadian rhythm, and sustained insulin sensitivity by regulating GPR120-Nrf2 cross-talk.
Administration of OM3 diet, in contrast to the HFD fed animals, for 8 weeks showed that
mice overexpressing catalase (male and female Bob-Cats), maintained or lowered body weight
and fat mass, similar to that observed in NC fed mice groups, despite a lower food intake (total g
and kcal/g consumed) of chow provided ad libitum. Decreased food intake when fed HFD in
comparison to a normal rodent diet has been reported in previous studies as the result of a higher
caloric and satiating diet (Pendergast et al., 2013). These observations support the importance of
the composition of a meal on fat accumulation and distribution during weight
management/weight loss therapies in humans (Goss et al., 2013). This is of particular interest in
obese subjects, where an excessive accumulation of visceral fat mass elevates the risk of
numerous health conditions including coronary heart disease, IR, osteoarthritis, and hypertension
(U. J. Jung & Choi, 2014), which further contributes to the 8 year reduction in life expectancy in
these individuals (C. H. Jung et al., 2017; Muzumdar et al., 2008; Tzanetakou, Katsilambros,
Benetos, Mikhailidis, & Perrea, 2012). In contrast, the increased life expectancy observed in
studies conducted in catalase overexpressing mice (Schriner & Linford, 2006) may be attributed
to the type of diet consumed.
Lean mass is representative of the muscle tissue mass equivalent of all the body parts
containing water, excluding fat, bone minerals, and such substances which do not contribute to
the NMR signal, such as hair, claws, etc. (ECHO-MRI (Houston, TX) user’s manual). It was
interesting that in the Bob-Cat male groups, we observed an increase in lean mass at 4 weeks and
decrease at 8 weeks independent of diet. Other studies have shown similar fluctuations in lean
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mass as the body begins to adapt to alterations in diet or food /caloric intake (V. P. Chen et al.,
2016). At the 4 week time point, the body likely had not completely adjusted to the diet, however
at around the 8 week time point, a complete response to the dietary intervention had occurred. In
addition to lean mass, other studies have also seen similar fluctuations in bone mass and density
(Weiss, Jordan, Frese, Albert, & Villareal, 2017). Nonetheless, it is unclear why only Bob-Cat
male mice behaved as such compared to the other genotypes. One can only speculate that it
might be a response to the differences in redox regulation in this novel mouse model.
CLAMS assessment of energy metabolism (energy intake vs. energy expenditure)
showed differences between the genotypes tested on various diets. The three day CLAMS
measurement of FI supported the earlier observation of lower weekly food intake by the HFD
and OM3 fed groups despite the genotype (Pendergast et al., 2013). In addition, it was observed
that HFD and OM3 feeding altered the eating patterns (circadian rhythm) in WT mice compared
to those fed NC. This is consistent with other studies that showed HFD feeding alters the
quantity, time of day, and how much chow is consumed during each visit to the food hopper
(Marvyn, Bradley, Mardian, Marks, & Duncan, 2016; Sasaki, 2017; M. So, Gaidhu, Maghdoori,
& Ceddia, 2011). However, this diet effect (HFD or OM3) on eating patterns was not altered in
either gender of the [Tg(CAT)±] and Bob-Cat mice, which followed similar circadian rhythm
patterns of eating as that seen in mice provided NC diet. This observation suggested that catalase
overexpression (i.e. redox balance) may be shifting the paradigm of a high-fat diet altering
circadian rhythm and patterns of food intake. This speculation is further supported by our
previously published observations where the secretion of key adipokines that modulate
hypothalamic appetite regulation was altered in mice overexpressing catalase (D. L. Amos et al.,
2017).
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In addition to measurement of FI, the CLAMS analysis also provided insights into the
differences in RER and EE in the various genotypes and diet interventions. We observed a
significant increase in RER as well as CHO oxidation (hence lower fat oxidation) in the NC fed
male mice overexpressing catalase compared to their WT groups fed NC. This might be
attributed to the increased expression of human catalase gene, since other studies have shown
changes in energy metabolism as a result of increased antioxidant catalase (D. L. Amos et al.,
2017; Heit et al., 2017) in addition to alterations in substrate utilization as a result of differences
in genetics (Albarado et al., 2004). In contrast, all groups on a high-fat diet intervention (lard or
fish oil), had a lower RER and levels of CHO oxidation (higher fat oxidation) which has been
reported in numerous other studies as a result of higher fat % available to be oxidized from the
HFD provided to the animals (Church et al., 2009; Hatori et al., 2012; Nilsson et al., 2016). The
ability of OM3 diet to lower the RER and increase fat oxidation within the male mice groups
overexpressing catalase and female Bob-Cats vs the Bob-Cat mice fed NC may have contributed
to the observed decrease in their body weights compared to their littermates that overexpress
catalase fed NC or HFD. On the contrary, male mice overexpressing catalase provided an OM3
diet, had significantly lower fat oxidation compared to WT mice provided a NC diet. This may
be a beneficial outcome from the intake of OM3 fatty acids termed “metabolic flexibility”; a
newer concept describing the body’s ability to match fuel oxidation to fuel availability (Carstens
et al., 2013). We believe this may have been acquired in our mouse model through intake of the
OM3 diet during the 8 week study period. Another plausible reason for the lower levels of fat
oxidation observed may be due to “altered metabolic partitioning” of fatty acids where there is a
reduction in oxidation and increased re-esterification of particular fatty acids dependent on their
structure (Forbes et al., 2006). This would also provide reasoning as to why the same effect was
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not seen in the HFD fed mice overexpressing catalase. In comparison to males, fat oxidation
trended to be elevated in females (kcal/h/g) even though all were provided the same type of diet
and the quantity consumed by females was not higher than what was consumed by males. Even
more interesting was the opposite effects of CHO vs. fat oxidation seen in male and female BobCat mouse groups provided an OM3 diet. We believe this was a result of sexual dimorphism (X.
Wang, Magkos, & Mittendorfer, 2011).
All HFD fed groups in our study, having significantly higher levels of EE (heat
production) is consistent with previous studies (Leibel, Rosenbaum, & Hirsch, 1995), where a
significant increase in EE was observed within just one week of HFD feeding (M. So et al.,
2011). It is hypothesized that this phenomenon is due to the increased body mass and amount of
oxygen necessary to facilitate normal cellular/tissue function in addition to higher energy
required to catabolize the 45% high-fat diet vs. the 13.4% fat in the NC diet. However, the
increase in EE of the HFD groups is not sufficient to create energy balance resulting in an
accumulation of body weight and fat mass. Though calorically (45% fat) similar to the HFD, EE
levels in OM3 fed mice remained intermediate to NC and HFD fed mice, yet EE levels were still
significantly higher than the NC fed WT group. Previous studies have also shown an OM3 rich
diet increases EE levels by enhancing thermogenesis via activating GPR120 (Bargut et al., 2016;
Quesada-Lopez et al., 2016). Male [Tg(CAT)±] and Bob-Cat mice also displayed significantly
higher activity (XAMB) levels compared to WT mice fed NC or high-fat (HFD or OM3) diets.
Furthermore, when provided HFD or OM3 diet, the WT mice had the lowest activity levels, not
reaching above 3000 counts per two hours. These results indicate that overexpression of catalase
might be increasing the activity levels within the male gender. Previous reports have suggested
that in rodent models, a high caloric diet can decrease XAMB counts of physical activity by up
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to 28% (M. So et al., 2011). It is also possible that the increased body weight and fat mass may
have been a secondary factor in the hypo-activity. Interestingly, the effect was not as severe in
groups overexpressing catalase; again, an indication of the beneficial effect of antioxidant
overexpression coupled with an OM3 diet. This is of great importance since research in human
obesity studies has shown that HFD promotes a more sedentary, less physically active lifestyle
in addition to alterations in sleep/wake cycles (Branecky, Niswender, & Pendergast, 2015).
Alterations in redox balance (as seen within the catalase overexpressing mice), such as by OM3
dietary interventions, might improve metabolic imbalance and circadian rhythm abnormalities in
obese humans.
Eight weeks of dietary intervention altered the circulating metabolic profile in the
catalase overexpressing mice. As seen in other studies, and expected with increased fat mass,
mice fed a HFD had the highest levels of TC (L. Wu & Parhofer, 2014). The only exception was
the female [Tg(CAT)±] mice fed HFD which had similar TC levels to all mouse groups fed NC
and OM3 diet. This female group also had significantly higher levels of activity (XAMB counts)
which might have influenced the lowering of cholesterol levels (Meissner et al., 2010). In
contrast to the HFD, and as previously documented (Tani et al., 2018), mice provided an OM3
diet did not alter TC and the levels remained similar to that seen in NC fed mice groups. HDL
levels were highest among the groups fed HFD in both genders, but among OM3 fed mice, there
was a higher ratio of HDL:TC compared to the HFD groups. Furthermore, among the OM3 fed
mice groups, Bob-Cat males and females had the highest levels of HDL making their HDL:TC
ratio the highest among all mice groups thus showing the significance of the regulatory
interaction between overexpression of antioxidant catalase and feeding OM3 diet on lipid profile.
There have been previous studies conducted in the leptin deficient Ob/Ob mice (parent group of
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the Bob-Cat mouse model) showing increases in HDL level (Nishina, Lowe, Wang, & Paigen,
1994; Silver, Jiang, & Tall, 1999). It has been postulated that although typically in human
obesity HDL levels are substantially lower, the decrease in functional leptin in the obese Ob/Ob
mice may be playing a role in the higher HDL (being the major lipoprotein in rodents) levels
(Silver et al., 1999). Since Bob-Cats are heterozygous for the Ob gene, it is plausible that leptin
is playing a role in modulating HDL levels. Surprisingly, male Bob-Cats had the highest TG
levels. A similar effect, although to a lower degree, was also seen in the NC and OM3 fed female
Bob-Cats and the other female genotypes on similar diet. In general, the mice provided OM3 diet
had lower plasma TG levels, which was expected as the result of a higher intake of OM3 fatty
acids (Bargut et al., 2016; Yeop Han et al., 2010). Bob-Cat mice, compared to the other
genotypes, also had increased levels of plasma ketones in all groups (except the HFD males), and
those provided an OM3 diet had the highest ketone levels independent of gender. Generally, high
ketone levels are classically associated with metabolic dysfunction and diabetes (Alberti, 1975;
Beylot, Sautot, Laville, & Cohen, 1988; Mahendran et al., 2013; P. Yan, Cheah, Thai, & Yeo,
1983), but more recent studies have shown that lower carbohydrate diets provoking ketosis cause
an inverse correlation between circulating ketones and plasma glucose levels, thus suggesting
higher levels of ketones are associated with more favorable effects on glycemic control (Paoli,
Rubini, Volek, & Grimaldi, 2013). Other studies have now recognized ketones as imperative
signaling molecules promoting metabolic function and regulating appetite (Newman & Verdin,
2014; Puchalska & Crawford, 2017). These studies further solidify the beneficial effects of an
OM3 diet coupled with antioxidant catalase overexpression on metabolic parameters.
Consistent with other studies on the metabolic effects of an OM3 enriched diet (D. Y. Oh
et al., 2010; Paniagua, 2016; Sundstrom et al., 2017), irrespective of gender, the lowest glucose
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levels were seen in the Bob-Cat groups fed OM3 diet. Sexual dimorphism was observed in
insulin levels. The highest average levels were in the HFD fed [Tg(CAT)±] males, while the HFD
[Tg(CAT)±] females had the overall lowest levels of plasma insulin. The same results were
reflected in the HOMA-IR. Furthermore, males in general had higher levels of insulin than
females regardless of diet or genotype. This could be a direct effect of the increased visceral
adipose tissue and liver weights in males compared to females (Snel et al., 2012). Insulin levels
are key in the metabolic function of the liver (Sheng et al., 2018), so it was interesting that the
males had an increase in liver weight, but not the females, as well as NC and HFD fed
[Tg(CAT)±] mice groups compared to WT littermates. Despite increases in insulin, plasma
ketone levels showed no significant differences in male HFD fed [Tg(CAT)±] mice compared to
the WT mice fed HFD. In fact, ketone levels were >2 fold in the WT vs [Tg(CAT)±] HFD group
indicating insulin is repressing ketone body production in the [Tg(CAT) ±] mice (Meidenbauer,
Ta, & Seyfried, 2014; Newman & Verdin, 2014). Nevertheless, most importantly, Bob-Cat mice
fed an OM3 rich diet maintained glucose and insulin homeostasis throughout the duration of the
8 week study. Mechanistically, this result was expected to occur in part by the production of
OM3-derived inflammatory resolution mediators (Cipollina, 2015), the higher ketones generated,
“metabolic flexibility (Carstens et al., 2013),” and potential alterations in “metabolic
partitioning” (Forbes et al., 2006) (indicated by the CLAMS fat oxidation analysis) in the BobCat mice. However, in addition to these effects, the major contributor to the favorable metabolic
profile of the Bob-Cat mice fed OM3 diet is through the activation of its receptor, GPR120
(Ichimura, Hasegawa, Kasubuchi, & Kimura, 2014; Miyamoto et al., 2016; D. Y. Oh et al.,
2010).
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GPR120 (FFAR4) is a long-chain fatty acid receptor highly expressed in adipose tissue
(D. Y. Oh et al., 2010) and activated by OM3 fatty acids (Imamura, 2010; D. Y. Oh et al., 2010;
Oliveira et al., 2015; Quesada-Lopez et al., 2016). It plays beneficial roles in anti-inflammatory
pathways in adipose tissue, food preference, glucose homeostasis, and insulin sensitivity, all of
which are interrelated to regulate metabolic energy homeostasis in both physiological and
pathophysiological conditions (Ichimura, Hara, & Hirasawa, 2014). Though there are
contradicting reports of GPR120 not required for these beneficial effects of OM3 fatty acids
(Paerregaard et al., 2016), the support for its role in OM3 mediated effects stems from genetic
studies performed in humans. The human studies showed that mutations in GPR120 were
associated with increased risk of obesity and IR (Ichimura, Hasegawa, et al., 2014). GPR120 is
also a novel risk factor for DIO (Ichimura et al., 2012; D. Y. Oh et al., 2010). For these reasons,
it was most compelling that within the OM3 fed Bob-Cat mouse group, which overexpresses
antioxidant catalase within an obese parent background, we observed the highest levels of both
mRNA and protein expression of GPR120 in the perigonadal adipose tissue. Based on our
measurements of redox stress markers, the OM3 fed Bob-Cat mice also had an increased level of
oxidized carbonyl groups within the adipose tissue. Together, this might suggest that redox
regulation is playing a role in the upregulation of GPR120 expression and beneficial outcomes of
the OM3 diet within the antioxidant-overexpressing mice of both genders. Redox regulation of
GPR120 has not been previously shown.
Furthermore, Nuclear factor erythroid-2-related factor 2 (Nrf2) is a redox sensitive
transcription factor activated by long chain fatty acids (including EPA and DHA), phenolic
antioxidants, and imbalances in redox stress (Cipollina, 2015; Uruno, Yagishita, & Yamamoto,
2015). Raising levels of Nrf2 by endogenous production of electrophilic products or
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pharmacological agents has been shown to prevent or act as therapy for type 2 diabetes,
metabolic syndrome, obesity, and cardiovascular disease through activating anti-inflammatory
pathways (Jimenez-Osorio, Gonzalez-Reyes, & Pedraza-Chaverri, 2015; Pall & Levine, 2015;
Seo & Lee, 2013; Silva-Palacios, Konigsberg, & Zazueta, 2016; Tarantini et al., 2018) in
addition to lowering body weight and fat mass (Valenzuela et al., 2012). Specifically, in the BobCat mouse groups, when fed a diet high in OM3 fatty acids, there were higher levels of adipose
tissue Nrf2 mRNA expression. We speculate this to have occurred as a result of the synergistic
effect of antioxidant overexpression and consumption of an OM3 rich diet. Studies concentrated
on the beneficial effects of polyunsaturated fatty acids (primarily EPA and DHA) have shown
that their oxidized derivatives regulate the redox environment by covalently and reversibly
reacting with nucleophilic residues on target proteins (Cipollina, 2015; Nanthirudjanar,
Furumoto, Hirata, & Sugawara, 2013). These reactions trigger the activation of cytoprotective
pathways, including the Nrf2 antioxidant response (Gao et al., 2007). Nrf2 activation
subsequently causes an upregulation of phase II enzymes/antioxidants thus balancing oxidant:
antioxidant ratios in addition to suppressing the NF-κB proinflammatory pathway (Cipollina,
2015). Both antioxidant catalase and HO-1 are two of the key antioxidants upregulated in
response to induction of Nrf2 (J. Chen et al., 2014; S. E. Lee et al., 2015; Zhu et al., 2008). In
our model, the Bob-Cat mouse group fed OM3 diet had the highest levels of catalase activity in
addition to mRNA expression of HO-1, providing further evidence of Nrf2 induction and
subsequent activation of the antioxidant and cytoprotective response.
With the administration of OM3 fatty acids, it has previously been shown that the
activation of GPR120 is linked to the secretion and circulating levels of the adipokine
adiponectin (Yamada et al., 2017) promoting anti-inflammation (downregulation of NF-κB) and
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insulin sensitivity (Itoh et al., 2007). Interestingly, Nrf2 also decreases inflammation through the
same pathway as GPR120 (Cipollina, 2015; Matzinger, Fischhuber, & Heiss, 2018), but no
previous study has shown the cross-talk between GPR-120 and Nrf2. In the Bob-Cat mice fed
OM3 diet, we saw a significant increase in adiponectin mRNA expression within the adipose
tissue. The combined results of high expression of GPR-120, Nrf2 (and its downstream
signaling-activation of catalase and HO-1) provide evidence for a potential cross-talk between
activation of GPR120 and Nrf2 synergistically decreasing inflammation within the adipose tissue
as well as modulating whole body metabolism in the Bob-Cat mice. Although Nrf2 has been
studied in depth in the brain (Q. Liu et al., 2014; Zgorzynska et al., 2017) and heart (J. Chen et
al., 2014; S. E. Lee et al., 2015), because of its cytoprotective and anti-inflammatory benefits, we
provide evidence for a similar role in adipose tissue. Furthermore, as observed from our current
findings from our novel mouse model fed OM3 diet, we believe there is an interaction between
Nrf2, GPR120, and adiponectin which could potentially give rise to new therapies in obesity, if
its induction could aid in mediating energy homeostasis through adipokine expression and
secretion.
Another metabolic regulator that is induced by both GPR120 and NRf2 is FGF21
(Furusawa, Uruno, Yagishita, Higashi, & Yamamoto, 2014; Quesada-Lopez et al., 2016). In the
current study, male mice overexpressing catalase trended to have increased FGF-21 mRNA
expression compared to WT diet group controls, but the highest expression was in the HFD
groups. Similar elevations in FGF-21 have been shown in studies investigating obese humans
and rodent models (Gomez-Samano et al., 2017; Tanajak, Pongkan, Chattipakorn, &
Chattipakorn, 2018; X. Zhang et al., 2008). Contrary to males, in female mice, the highest
mRNA expression was within the OM3 fed groups, and mainly in Bob-Cat mice. Additionally,
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we observed plasma levels in female [Tg(CAT)±] and Bob-Cat mice fed HFD had opposite
effects compared to males, yet, the FGF-21 levels were similarly increased when fed OM3 diet.
However, there are conflicting reports on the regulation of FGF-21 by redox stress/Nrf2
activation (Chartoumpekis et al., 2011; Furusawa et al., 2014; Yu et al., 2016; L. Zhang, Dasuri,
Fernandez-Kim, Bruce-Keller, & Keller, 2016) or whether increased FGF-21 is actually
metabolically beneficial.
It is of special importance to discuss the sexual dimorphism observed in the results of this
study within the Bob-Cat mouse groups. With gender differences in sex hormones (i.e. estrogen
vs. testosterone), distribution of fat pads, and the role of epigenetics, it is essential to study both
male and female genders to fully define energy–related metabolic signaling pathways (B. F.
Palmer & Clegg, 2015; M. Yoon et al., 2002). Additionally, to our knowledge, no study has
investigated the gender differences of supplementation of OM3 fatty acids in relation to redox
homeostasis, making the findings of the sexual dimorphism in the ‘stress-less’ model truly novel.
Figure 28 provides a schematic overview of the sexual dimorphism observed within the Bob-Cat
mice fed an OM3 enriched diet related to GPR120-Nrf2 crosstalk. As seen in humans (X. Wang
et al., 2011), we also observed higher plasma TG levels in the Bob-Cat mice fed OM3 diet.
Furthermore, males had significantly higher levels of plasma TG when provided an OM3 diet
compared to their WT littermates provided the same diet. Female Bob-Cat mice, in contrast,
trended to have lower levels compared to the female WT control group. This is of importance
since clinical vintrials show that in comparison to women, men have significantly lower levels of
plasma total lipids/phospholipids of α-linoleic acid (ALA) and DHA in addition to less potent
metabolic effects of the OM3 fatty acids EPA and DHA in decreasing risk for IR (Abbott et al.,
2016). Plasma analysis of FGF-21 showed that Bob-Cat males have lower levels compared to
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WT controls and the opposite was seen within females. This is most intriguing due to recent
studies showing that FGF-21 lowers TG levels within both human and rodent models (Schlein et
al., 2016). Additionally, CLAMS analysis revealed that RER and CHO/fat oxidation in females
trended to be higher compared to males regardless of the diet or genotype. In particular, we saw
significant gender differences within the Bob-Cat mice. When fed OM3 diet, Bob-Cat males had
much higher levels of RER/CHO oxidation and lower levels of fat oxidation compared to the
WT mouse group. However, in females, Bob-Cats fed OM3 diet had lower RER/CHO oxidation
and higher levels of fat oxidation. Previous reports have shown that males and females differ in
how they process polyunsaturated fatty acids (Abbott et al., 2016) and that females retain higher
levels of PUFA in circulation (Walker et al., 2014). Additionally, the differences in oxidized
substrates could also potentially play a role in modulating the circulating TG and FGF-21 levels
providing an explanation for why we saw differences between the genders of the Bob-Cat mice.
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Therefore, overall, among the many similarities (as seen in Figure 28), we have shown
differences in TG, FGF-21 levels, and oxidation of CHO/Fat between the Bob-Cat male and
female mice. Because the same general phenotypic results occurred (body weight, fat mass, lean

Figure 28. Sexual dimorphism observed in an OM3 fed ‘stress-less’ mouse model.
Schematic representation of the sexual dimorphism observed in the ‘stress-less’ mouse
model; Bob-Cat mice fed a diet enriched with OM3 fatty acids. These mice, when fed OM3
enriched diet, showed significant differences in circulating markers and CLAMS analysis of
substrate oxidation. However, these differences did not impact the GPR120/Nrf2 crosstalk
and downstream effects within this mouse model. Significance to WT mice fed NC and OM3
depicted as increase: +, ↑ while decrease: -, ↓ respectively. p values are represented as p<0.01
++, ↑↑, p<0.0001 ++++, ↑↑↑↑ and likewise for a significant decrease.
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mass, etc.) in both groups fed OM3 diet, we believe that the overexpression of catalase and
increase in OM3 fatty acids have synergistically enhanced the Bob-Cat mouse group’s ability to
regulate energy metabolism in using different signaling pathways. Future studies investigating
additional metabolic tissues such as the liver and skeletal muscle would help elucidate the
mechanisms involved in the sexual dimorphism observed in the Bob-Cat mouse models.
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3.5 CONCLUSION
Overall, this study provides compelling evidence that overexpression of catalase coupled
with an enriched diet of OM3 fatty acids are metabolically beneficial. This combination was
shown to increase adipose tissue expression of the GPR120/FFAR4, which by interacting with
the Nrf2 pathway, resulted in decreased body weight and fat mass, enhanced or maintenance of a
normal circadian rhythm, anti-inflammation and insulin sensitivity, and regulation of key
adipokines compared to HFD fed mice (Figure 15: Graphical Abstract). In fact, to our
knowledge, this is the first study to provide evidence that GPR120 expression may be modulated
by redox status in addition to providing evidence of the GPR120-Nrf2 cross-talk mechanism.
With the beneficial outcomes seen within the ‘stress-less’ Bob-Cat mouse model provided an
OM3 diet, we believe that this model is an excellent tool to further study adipose tissue function,
crosstalk with other metabolic tissues, and metabolic signaling pathways involving energy
homeostasis in both male and female mice. Also, in addition to obesity, inflammation in adipose
tissue has been linked to a number of types of carcinogenesis (Lengyel, Makowski, DiGiovanni,
& Kolonin, 2018) and cardiovascular events. (Figueroa et al., 2016; Ghantous, Azrak, Hanache,
Abou-Kheir, & Zeidan, 2015; Luna-Luna et al., 2015). Thus, using the ‘stress-less’ mice as a
novel model, future studies may be conducted to look at the combination of antioxidant
overexpression and other therapies for diseases of metabolic syndrome as well as lowering the
risk and progression of the metabolic syndrome-associated cancers and CVD.
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ABSTRACT
Obesity, a result of excess fat accumulation, disrupted energy metabolism, and imbalance
in oxidant: antioxidant ratio is now considered a chronic disease with no appropriate treatment.
The need to counteract obesity is of great importance due to its contribution to the progression of
cardiometabolic disease, chronic inflammation, neurological disorders, and cancer. Lifestyle
modification, such as exercise, decreases risk for obesity by reducing fat mass, lowering redox
stress, modifying metabolic tissue function, and regulating energy homeostasis (appetite and
energy expenditure). Current studies show the gut microbiome’s diversity and function play a
key endocrine role in host energy metabolism, where the diversity can be altered dependent on
physical activity level/intensity as well as redox stress. During prolonged exercise, Type 1 / Type
2 fiber type ratio increases and contracting skeletal muscle secretes “exercise-induced” myokines
(i.e. FGF-21, PGC1-alpha). Although the current literature suggests physical activity regulates
energy metabolism by altering myokine and adipokines levels, it is unknown how redox
modulated changes in the gut microbiota is involved in these interactions. We tested this
hypothesis by subjecting a novel stress-less obese mouse model (Bob-Cat) to eight weeks of
moderate exercise. Changes in the diversity of the gut microbiome due to exercise in these mice
were correlated to improvements in energy metabolism and skeletal muscle-adipose tissue-brain
crosstalk. We observed that when subjected to a moderate, 8 week treadmill exercise regimen,
mice overexpressing catalase ([Tg(CAT)±] and Bob-Cat), had lowered body weight and fat mass
(ECHO-MRI) and a healthier overall blood/lipid profile compared to sedentary controls.
Additionally, we observed an increase in Type 1 / Type 2 fiber ratio in association with an
induction of key myokines (FGF-21, PGC1-alpha, and FNDC5) in the exercised mice
overexpressing antioxidant vs. sedentary controls. There was also a concomitant induction in
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expression of adiponectin (p<0.05) in the adipose tissue and alterations in hypothalamic genes
that regulate appetite (NPY and POMC). Our key finding was a significant shift in microbial
diversity in all exercise mice groups and in particular in mice overexpressing catalase. Our
results thus far suggest a synergistic effect of exercise and catalase overexpression on the
diversity of the gut microbiome which results in improving overall energy metabolism via
promoting skeletal muscle-adipose-brain cross-talk.

152

4.1 INTRODUCTION
Obesity is now a worldwide epidemic with more than 35% of adults classified as obese
and rates expected to rise to 42% by 2030 (Organization, 2018). This is of great concern
considering that obesity leads to other serious, life-threatening health conditions such as
cardiometabolic diseases, which has the world’s highest morbidity and mortality rate
(Organization, 2018), responsible for more than 15.2 deaths per year (Writing Group et al.,
2016). Furthermore, there are no universally effective treatments currently available for obesity.
It is well known that the expansion of visceral adipose tissue is a major risk factor for
obesity and its comorbidities (Golbidi & Laher, 2014). Increased adipose mass also contributes
to pro-oxidant and pro-inflammatory states by increasing free radical production (FernandezSanchez et al., 2011). Reactive oxygen species (ROS) alters glucose and lipid metabolism by
modulating the functions of skeletal muscle, adipose tissue, brain, and the newly classified
“endocrine organ,” the gut microbiome, all leading to overall changes in energy homeostasis
(Alleman, Katunga, Nelson, Brown, & Anderson, 2014; Fernandez-Navarro et al., 2017;
Fernandez-Sanchez et al., 2011; Gyengesi, Paxinos, & Andrews, 2012; Manna & Jain, 2015).
Physical activity has been proven time and again to be the most efficacious approach and
recommended therapeutic option for individuals with metabolic disorders due to its weight loss
effects (Golbidi & Laher, 2014; Leal et al., 2018; Savini et al., 2013). Not only is it an effective
way to lower body weight and fat mass (Fiuza-Luces et al., 2013; Golbidi et al., 2012), improve
lipid profile (Sanchis-Gomar et al., 2015; Vina et al., 2012), decrease inflammation (Golbidi &
Laher, 2014), boost physical performance (Vina et al., 2012), and enhance neurological function
(Radak et al., 2013), it also paradoxically is beneficial by increasing redox stress which in turn
induces antioxidant synthesis (Done & Traustadottir, 2016; Gomez-Cabrera, Domenech, & Vina,
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2008; Ji, 2008; Savini et al., 2013; Shern-Brewer, Santanam, Wetzstein, White-Welkley, &
Parthasarathy, 1998).
Research has shown that increased skeletal muscle contraction during aerobic physical
activity shifts the muscle fiber-type ratio toward higher levels of Type 1 vs. Type 2 fibers (Fry et
al., 2017; Y. X. Wang et al., 2004) as well as production and secretion of key myokines involved
in metabolic homeostasis (Febbraio & Pedersen, 2005; Hoffmann & Weigert, 2017; Huh, 2018).
Similarly, in adipose tissue, moderate exercise regulates the expression and secretion of key
adipokines such as leptin and adiponectin (Golbidi & Laher, 2014; Lubkowska, Dudzinska,
Bryczkowska, & Dolegowska, 2015) that are involved in regulating energy storage, energy
expenditure, and appetite regulation (Bluher & Mantzoros, 2015; K. J. Oh et al., 2016).
Located within the hypothalamus of the brain are orexigenic and anorexigenic signaling
pathways that primarily control satiety. The orexigenic pathway contains neurons that co-express
Neuropeptide Y (NPY) and Agouti Related Peptide (AGRP), which lower satiety and energy
expenditure. On the contrary, the anorexigenic pathway contains neurons that express
Proopiomelanocortin (POMC) and Cocaine-Amphetamine Related Transcript (CART), which
suppress appetite and increase energy expenditure (Burke et al., 2016; Wilson & Enriori, 2015).
It is now known that both exercise-induced myokines, adipokines, and several secreted
metabolites affect appetite regulation and energy expenditure (Benite-Ribeiro, Putt, & Santos,
2016; Delezie & Handschin, 2018; Gorgens, Eckardt, Jensen, Drevon, & Eckel, 2015; Leal et al.,
2018; A. Rodriguez, Becerril, Ezquerro, Mendez-Gimenez, & Fruhbeck, 2017; A. Rodriguez et
al., 2015). Although we now understand some of the underlying pathways involved in the
metabolic benefits of regular physical activity, there are still gaps in knowledge in reference to
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how exercise is involved in metabolic tissue crosstalk (skeletal muscle-adipose-brain) and
regulation of energy metabolism.
Recent studies suggest there is a possible association between the microorganisms
residing within the gut and the beneficial effects of exercise (Allen et al., 2015; Zhao et al.,
2018). Although studies have shown the skeletal muscle-adipose axis (Leal et al., 2018; F. Li et
al., 2017; A. Rodriguez et al., 2017), adipose-brain axis (J. Friedman, 2016; Seoane-Collazo et
al., 2015; Spiegelman & Flier, 2001; Wilson & Enriori, 2015), and skeletal muscle-brain axis
(Delezie & Handschin, 2018; Huh, 2018; Pedersen & Febbraio, 2012) are all involved in
improving energy homeostasis, it is not yet fully investigated if gut microbes communicate with
these metabolic organs, if gut-derived metabolites are involved in these interactions (Kallus &
Brandt, 2012; Nehra, Allen, Mailing, Kashyap, & Woods, 2016), or how exercise and/or redox
stress modulate these interactions (Allen et al., 2015; Allen et al., 2018).
We recently developed a novel obese mouse model overexpressing the antioxidant
catalase (Bob-Cat) which by lowering redox stress improved overall energy metabolism (D. L.
Amos et al., 2017). We additionally showed that this mouse model potentiated the beneficial
effects of an omega 3 enriched fatty acid diet by inducing GPR120-Nrf2 crosstalk (D. Amos,
Cook, & Santanam, 2019). Very little is known at the current time about the relationship between
redox stress and the diversity and function of the microbiome, but it is evident that specific
species of bacteria use ROS as defense mechanisms and others can produce antioxidants that
scavenge free radicals. Additionally, some studies suggest that the gut microbiome can be altered
dependent on the redox state (Borrelli et al., 2018; Staerck et al., 2017; Y. Wang et al., 2017).
Therefore, in order to better understand the interplay between redox regulation and exercise
intervention on the gut microbiome and its potential effects in improving energy homeostasis, we
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subjected the catalase-overexpressing ‘stress-less’ mice and C57/WT mice to moderate exercise
regimen and compared their outcomes on skeletal muscle-adipose-brain crosstalk. Our studies
showed antioxidant overexpression in combination with exercise was beneficial in the
maintenance of energy homeostasis, regulating lipid metabolism, enhancing skeletal muscle and
adipose tissue function, and possibly by shifting the gut microbiome toward taxa with known
metabolically beneficial effects on energy metabolism.
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4.2 MATERIALS AND METHODS
4.2.1 Mouse Models and Exercise
Catalase Transgenic ([Tg(CAT)±]) mice, a gift from Dr. Arlan Richardson’s Laboratory
(X. Chen et al., 2004), were bred and housed in Marshall University Animal Facility. “Bob-Cat”
mice are a novel mouse model generated and bred in our laboratory by crossing [Tg(CAT)±]
mice with leptin deficient, Ob/+, heterozygous hybrids of the Ob/Ob leptin-resistant mice
(heterozygous JAX 000632, B6.Cg-Lepob/J) (D. L. Amos et al., 2017). C57Bl6 (C57/WT),
[Tg(CAT)±], “Bob-Cat,” and Ob/Ob male mice were housed in cages of 3 or 4 according to their
respective genotypes. WT mice were bred at our animal facilities or bought from Hilltop
Laboratories and acclimated to the mouse facilities at Marshall University. All groups were fed
normal rodent chow (NC - Lab Diet 5001) ad libitum. All guidelines were followed according to
IACUC rules and regulations in accordance with the approved study protocol. Each of the four
mouse models were divided into exercise and sedentary groups (n≥7/group) at the age of 16
weeks which is representative of a mature adult human 20-30 yrs of age (Jackson et al., 2017).
Sedentary mice remained in their respective cages in the same environment as the exercised
mice. Exercised mice were subjected to a 5 day acclimation period to the treadmill (Columbus
Instruments) prior to beginning the exercise protocol: 8 weeks of treadmill exercise, 5 days/week
for 30 min. at a rate of 15 m/min during the light cycle. This protocol was based on physical
activity level recommendations by the American Heart Association and World Health
Organization (Organization, 2019) in addition to the Mayo Clinic (Laskowski, 2018). Animals
were treated in compliance with Marshall University Animal Committee (Institutional Animal
Care and Use Committee) regulations.
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4.2.2 Body Weight and Body Composition
Body mass (g) was measured for 8 consecutive weeks to determine differences in total
body weights between groups: C57/WT, [Tg(CAT)±], Bob-Cat, and Ob/Ob (sedentary and
exercise) throughout the study. Body composition (fat and lean mass) was determined using
magnetic resonance imaging, ECHO-MRI (Houston, TX). Total water content and free water
content were also calculated. Each mouse was individually placed into the MRI machine, and
three or more measurements were taken per mouse. Median values of each parameter per mouse
were calculated using Microsoft Excel, then averaged per genotype and intervention.
Comparisons between groups were made by one or two-way ANOVA followed by Bonferonni
post hoc Analysis and t-tests.
4.2.3 Comprehensive Laboratory Animal Monitoring System (CLAMS)
Metabolic parameters were determined indirectly by assessing O2 consumption (VO2)
and CO2 production, respiratory exchange ratio (RER), food intake (FI), Energy Expenditure
(EE), as well as X-Ambulatory counts (XAMB - physical activity) using the CLAMS (Columbus
Instruments, Columbus, OH, USA). Mice were supplied with ground rodent chow (Lab Diet
5001) for three days as the analysis was conducted. Computations were made on the middle 48
hours the mice were subjected to the machine, which was approximately the 0600 hour of the
first day to the 0600 hour of the third day. Food intake was measured by CLAMS as chow
displaced from the food hopper. RER is given as the ratio of carbon dioxide production and
oxygen consumption. Carbohydrate (CHO) oxidation was calculated using the formula
((4.585*VCO2) − (3.226*VO2))*4, and similarly, fat oxidation was calculated using the formula
((1.695*VO2) − (1.701*VCO2))*9 (Peronnet & Massicotte, 1991). EE (heat production) was
calculated as the Cal/h/lean mass (g). EE average, RER average, average FI per day, as well as
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X-Ambulatory locomotor activity per day (XAMB – counts of movement across the cage) were
determined for each mouse in all groups. One and two-way ANOVA were used to determine
comparative changes between the various genotypes on the sedentary or exercise regimen.
4.2.4 Grip Strength Tests
The grip strength of each individual mouse was tested at the end of the 8-week study
period using an apparatus consisting of a ball of tangled fine gauge metal wire and a “scale
collector” (metal wire clip). At the time of the experiment, the scale collector was attached to one
chain length. The number of links range from one to five (additional weights may be added).
Links weighed approximately 25.7 (1 link), 34.97 (2 links), 44.24 (3 links), 53.51 (4 links), and
62.79 (5 links) grams. Mice were held by the middle/base of the tail and lowered toward the wire
mesh, which they were naturally attracted to, to determine whether the mouse could grasp and
hold the first weight (25.7g). The number of seconds the mouse held the weight was recorded (up
to 3 sec). A hold of three seconds was the criterion for success at that weight level. If the mouse
dropped the weight before 3 sec. passed, it was allowed to rest for 10 sec and retested with the
same weight. If the mouse was unable to hold the weight for three consecutive trials, it was
returned to the cage. If the weight was held for a minimum of 3 sec, then the mouse was tested
with the next set of links. A final total score was calculated as the product of the number of links
in the heaviest chain held for the full 3 sec, multiplied by the time (sec) it was held. If the
heaviest weight was dropped before 3 sec, an appropriate intermediate value was calculated
(Deacon, 2013).
4.2.5 Blood and Tissue Collection
After 12h fasting, mice were anesthetized using Isoflurane. Blood was obtained by
cardiac puncture and placed in heparin tubes; red blood cells (RBCs) and plasma were separated
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by centrifugation for 10 min. Mice were perfused intracardially with cold 1X PBS. Tissues
including skeletal muscle, adipose tissue, brain, and liver were removed, weighed, and flash
frozen in liquid nitrogen. All tissues were stored at -80˚C.
4.2.6 Blood Plasma Hormones and Metabolites
Whole blood was used to measure fasting glucose levels (Precision Xtra Glucometer)
then centrifuged for 10 min. to separate the plasma and RBCs. Approximately 35 µL of plasma
was placed on a Cholestech cassette and read on a LDX Cholestech Machine (Cholestech
Corporation, Hayward, CA) to determine Glucose, High Density Lipoprotein (HDL), Low
Density Lipoprotein (LDL), and Total Cholesterol (TC) levels. The remaining plasma was frozen
at -80˚C.
Triglyceride (TG) levels were measured in blood plasma using the Cayman Chemical
Triglyceride Colorimetric Assay Kit (Cayman, Ann Arbor, MI). Plasma insulin was analyzed
using an ultrasensitive mouse Insulin ELISA Kit (Crystal Chem, Downers Grove, IL). The end
point colorimetric assays were read using a BioRad Benchmark Plus microplate reader.
A Luminex 200 laser technology system was used to determine circulating leptin levels
using the Milliplex Mouse Adipokine Array (Millipore) in each mouse’s plasma according to
manufacturer’s protocol. Adipokine levels were calculated based on the known concentrations of
manufacturer’s standards.
Plasma irisin levels were determined using a commercially available Irisin ELISA Kit
(Biovendor Laboratory Medicine, Brno, Czech Republic). All procedures performed were in
accordance with the user manual. Absorbance was read using a BioRad Benchmark Plus
microplate reader. Calculations were conducted in accordance with the best fit line created from
the standard curve of plotted absorbance values against the known concentrations of standards.
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4.2.7 RT-qPCR Adipose Tissue, Brain, and Skeletal Muscle
RNA was isolated from ≈ 100 mg of abdominal adipose tissue, the hypothalamic region
of the brain, and the Gas muscle of each mouse using TRI Reagent according to the
manufacturer’s recommended protocol (Sigma). Concentrations of RNA were measured by use
of the NanoDrop 1000 (NanoDrop Technologies Inc., Thermo Scientific, Wilmington, DE,
USA). Reverse transcription of total RNA (1 µg) was performed using iScript™ cDNA
Synthesis Kit (Bio-Rad, Hercules, CA, USA). RT-qPCR was conducted using iQ SYBR™ Green
Supermix (Bio-Rad). The mouse specific primers for expression of leptin, adiponectin, FGF-21,
and UCP-1 in adipose tissue, POMC, NPY, and LepR within the hypothalamic region of the
brain, and PGC1-α, IL-6, FGF-21, and FNDC5 were used in skeletal muscle tissue. β-actin
expression within each tissue type was used as the house-keeping gene. All primer accession and
sequences are provided in Table 10. RT-qPCR was performed in the Bio-Rad MyiQ or Bio-Rad
CFX ConnectTM instrument. Transcription was considered nondetectable when the Cq value
reached ≥40. All samples were run in duplicate or triplicate. Results were calculated using the
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Pfaffl Equation (2^-ddCt) and expressed as fold change compared to either the WT control or the
sedentary control within each genotype.
Primer
Name
MuAdiponectin
Mu-FGF-21
Mu-UCP1
Mu-Leptin
Mu-POMC
Mu-NPY
Mu-LepR
Mu-BDNF
Mu-PGC1αlpha
MU-IL-6
Mu-GLUT
4
Mu-FNDC5
Mu-UCP-1
Mu-β-Actin

Accession
Number
NM-009605

Forward

Reverse

5’- gcagagatggcactcctgga -3

5’- cccttcagctcctgtcattcc -3’

NC_000019.1
0
NM_009463.
3
NM-008493
NM_0012785
84.1
NM_023456.
2
NM_146146.
2
NM_007540.
4
NM_008904.
2
NM_031168

5’- cgtctgcctcagaaggactc -3’

5’- aatcctgcttggtcttgggg -3’

5’- tttcgtgcccgcatcaggcaa -3’

5’- ttggagggcagagaggcgtga 3’
5’- agcaccacaaaacctgatcc -3’
5’– gtcaggcctagtctctgtcg –3’

NC_018928.2
NM_027402.
3
NM_009463.
3
NM-007393

5’- ctcatgccagcactcaaaaa -3’
5’- gcgacggaagagaaaagaggt -3’
5’- cgctctgcgacactacatca –3’
5’ –cttctggagcctgaacccat –3’
5’- tagcttgacaaggcgaaggg–3’

5’ –ttgttctgggggcgttttct –3’
5’ –cagggtctggtgtggtcaaa –
3’
5’- atttgcacgccgatcctttg–3’

5’- ccgagaattcatggagcaat–3’

5’- tttctgtgggtttggtgtga–3’

5’ –catgttctctgggaaatcgtgg- 3’
5’- gattctgctgcccttctgtc -3’

5’ –aacgcactaggtttgccgagta3’
5’- attggacgctctctctccaa -3’

5’ –tgttatagctctcttctgccgc- 3’

5’- ggtttctgatgcgctcttgg- 3’

5’ –tttcgtgcccgcatcaggcaa- 3’

5’- ttggagggcagagaggcgtga3’
5’- ttctccttaatgtcacgcacgatt 3’

5’- ctacctcatgaagatcctcaccga -3’

Table 10. Quantitative RT-PCR primer sequences.
4.2.8 Catalase Activity
The Shimadzu UV-1800 Spectrophotometer was used to determine the enzymatic activity
of catalase according to the method of Aebi (Aebi, 1984). Approximately 50 mg of tissue was
homogenized and 8 µL of each sample was added to 1mL of 25mM H2O2 solution and analyzed
for one minute in duplicate or triplicate. Change in absorbance was recorded and specific activity
was calculated based on protein estimation by the Lowry Method (Lowry et al., 1951).
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4.2.9 Oxidized Proteins in Adipose Tissue (OxyBlot)
Carbonylated proteins are a hallmark of redox stress (Fedorova et al., 2014). Oxidized
proteins were measured in epididymal adipose tissue by determining the presence of
carbonylated proteins using the Protein Oxidation Detection OxyBlot kit (Millipore, Billerica,
MA) as referenced in our previous study (D. Amos et al., 2019) in accordance with the
manufacturer’s recommendations.
4.2.10 Preservation and Cryostat Sectioning of Skeletal Muscle
During tissue collection, the Gas skeletal muscle was removed and subsequently weighed
(g) and measured (length in mm). Each individual muscle was preserved by subjecting it to
cooled isopentane and frozen slowly by lowering the isopentane in liquid Nitrogen. Once fully
frozen, the muscle was sliced into three segments. The middle segment was used for cryostat
sectioning after being frozen in O.C.T. (Optimal Cutting Temperature) medium and kept at 80ºC until cryostat sectioning. The other two segments were frozen in separate tubes for mRNA
and protein analysis. The Leica CM1900 Cryostat (Bannockburn, IL) was used to slice muscle
into 5-8 µm sections. Sections were transferred to room temperature slides that were kept at 80ºC until Myosin ATPase Staining was performed.
4.2.11 Myosin ATPase Staining and Microscope Analysis
Slides were warmed from -80ºC and the Myosin ATPase Protocol (Kelly Lab-ATPase
Histology Stain 2006) was followed to stain the right and left (R and L) side of each
Gastrocnemius (Gas) muscle. The pH 4.3 stain protocol was used to determine the fiber type
ratio of Type 1 (Oxidative) to Type 2 (Glycolytic) fibers within each mouse group. Myosin
ATPase stained slides were analyzed at 10X magnification using a Nikon Eclipse Ti Inverted
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Microscope (Melville, NY). Counts of muscle fiber type were determined using ImageJ Software
and saved as JPEG files.
4.2.12 Microbial DNA Extraction and Quantification
Fecal samples were collected at the 8 week time point which correlated with the final
analysis by MRI, and immediately frozen until shipment to Wright Labs, LLC. Nucleic acid
extractions were performed on approximately 0.25 g of each sample using a Qiagen DNeasy
Powersoil DNA Isolation kit following the manufacturer’s instructions (Qiagen, Frederick, MD).
The lysing step was performed using the Disruptor Genie cell disruptor (Scientific Industries).
Genomic DNA was eluted in 50 μl of 10 mM Tris followed by quantification using a Qubit 2.0
Fluorometer (Life Technologies, Carlsbad, CA) with the double stranded DNA high sensitivity
assay.
4.2.13 PCR Amplification
Illumina iTag Polymerase Chain Reactions (PCR) were performed based on the Earth
Microbiome Project’s 16S rRNA amplification protocol (Walters et al., 2016) where the
hypervariable regions V3-V4 of bacterial 16S rRNA genes were amplified by PCR using barcoded universal primers. The volume of each reaction was 25 μL containing the final
concentration of 1X PCR buffer, 0.8 mM dNTPs 0.625 U Ex Taq DNA Polymerase (Takara), 0.2
μM 515F forward primer, 0.2 μM 806R barcoded reverse primer and approximately 10 ng of
template DNA per reaction. PCR was performed using a T100 Thermal Cycler (Bio-Rad,
Hercules, CA) using the following cycling conditions: 98 °C for 3 min., 35 cycles of 98 °C for 1
min., 55 °C for 40 s, 72 °C for 1 min, and the final extension was at 72 °C for 10 min. PCR
products were held at 4 °C. A 2% agarose E-Gel was used with ethidium bromide (Thermo
Fisher Scientific) to visualize the PCR products for bands at approximately 400 bp.
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4.2.14 Library Purification, Verification, and Sequencing
PCR products were combined (pooled) in an approximate equimolar manner and run on a
2% agarose gel with Gel Star Nucleic Acid Gel Stain (Lonza) for visualization. Bands of
expected product length were cut from the gel using sterile scalpels and subsequently purified
using the QIAquick Gel Purification Kit (Qiagen, Frederick, MD). The pure library was then
quantified using the Qubit 2.0 Fluorometer double stranded DNA high sensitivity assay (Life
Technologies, Carlsbad, CA). Finally, each library on the sequencing run was combined
(multiplexed) into one sequencing library. This was completed by normalizing each library’s
input based on the number of samples per project to ensure even sequencing and coverage.
Libraries were quality checked using a 2100 Bioanalyzer high sensitivity DNA analysis kit
(Agilent Technologies, Santa Clara, CA) prior to sequencing. The sequencing library was stored
at -20˚C until shipment on dry ice to Laragen Inc (Culver City, CA) for sequencing.
Library pools were size verified using the Fragment Analyzer on the ABI3730 and were
quantified with a KAPA Library quantification kit (Kapa Biosystem, Wilmington, MA, USA).
After dilution with EBT (Illumina) to a final concentration of 2 nM, containing 15% PhiX V3
library control (Illumina, San Diego, CA, USA), the library pools were denatured for 5 min. in
an equal volume of 0.2 M NaOH, then further diluted to 8 pM in HT1 buffer (Illumina) and were
sequenced using an Illumina MiSeq V2 500 cycle kit cassette with 16S rRNA library sequencing
primers set for 250 basepair, paired-end reads. Overall sequencing run performance was
evaluated by determining if the sequencing run met the Illumina specifications for quality scores
and data output. Actual run performance varied based on sample type, quality, and clusters
passing filter. Specifications are based on the Illumina PhiX control library at supported cluster
densities.
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4.2.15 Quality Filtering and OTU Picking
Paired-end sequences were merged with a minimum overlap of 200 bases, trimmed at a
length of 253 bp, and quality filtered at an expected error of less than 0.5% using USEARCH
(Edgar, 2010). After quality filtering, reads were analyzed using the QIIME 1.9.0 software
package (Caporaso et al., 2010; Caporaso et al., 2011). Chimeric sequences were identified using
USEARCH61. Open reference operational taxonomic units (OTUs) were picked using the
USEARCH61 algorithm at 97% identity (Edgar, 2013), and taxonomy assignment was
performed using the Greengenes 16S rRNA gene database (13-5 release) (DeSantis et al., 2006).
Taxomony was assigned to OTUs and organized into a BIOM formatted OTU table, which was
summarized within QIIME 1.9.0. (Note: an OTU table contains each sample and the relative
abundance of each unique bacterial taxon identified within each sample).
4.2.16 Alpha Diversity Comparisons (16S)
Alpha diversity box plots were generated within the QIIME-1.9.0 sequence analysis
package using an unrarified OTU table. Samples with less than 10,000 sequences per sample
were excluded from alpha diversity analyses. Multiple rarefactions were conducted on sequences
across all samples to a maximum depth of 10,000 sequences, with a step size of 1,000, and 20
iterations at each step. Alpha diversities were then collated and plotted and compared using a
two-sample t-test and non-parametric Monte Carlo permutations (n = 999).
4.2.17 Beta Diversity Comparisons (16S)
Principal coordinates analyses (PCoA) plots and Adonis tests for significance were
generated from a weighted UniFrac distance matrix made within QIIME 1.9.0 from a CSS
normalized OTU table (Paulson, Stine, Bravo, & Pop, 2013).
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4.2.18 Taxonomic LEfSe Enrichment Plots
Relative abundances of bacterial taxa summarized at the genus level were multiplied by 1
million and formatted as described in Segata et al. 2011 (Segata & Huttenhower, 2011).
Comparisons were made between exercised and sedentary groups within each genotype in
addition to exercised groups compared to their control C57/WT sedentary and exercised mouse
groups. Alpha levels of 0.05 were used for both the Kruskal–Wallis and pairwise Wilcoxon tests.
Linear Discriminant Analysis (LDA) scores greater than 2.0 are displayed.
4.2.19 PICRUSt Enrichment Plots
Phylogenetic Investigation of Communities by Reconstruction of Unobserved States
(PICRUSt) functional predictions were generated from a closed-reference OTU table generated
within QIIME-1.9.0. Relative abundances of level 3 summarized predicted functional genes were
multiplied by 1 million and formatted as described in Segata et al. (2011) (Segata &
Huttenhower, 2011). Comparisons were made with “HLR_Group” as the main categorical
variable (“Class”). Alpha levels of 0.05 were used for both the Kruskal–Wallis and pairwise
Wilcoxon tests. LDA scores greater than 1.0 are described.
4.2.20 Statistical Analysis
Results are presented as mean ± standard error of the mean (S.E.M.). Data were evaluated
by one and two-way ANOVA followed by Bonferonni’s multiple comparison tests using
GraphPad Prism Version 7. T-tests were also performed between pre-determined individual
mouse groups in comparison to the sedentary groups. N indicates the number of animals per
group. Statistical significance was accepted at p<0.05. RT-qPCR gene expression was
determined by use of the Pfaffl equation (Pfaffl, 2001) and represented as fold change with
significance denoted as differences in delta CT/genotype and intervention. Catalase activity is
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represented as % of control group. Analysis of oxidized carbonyl groups are represented as the
ratio of oxidized carbonyls to the total protein memcode stain. Microbial analysis statistics are
defined per test used within each method subsection of that parameter.
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4.3 RESULTS
4.3.1 Body Weight and Body Composition
At sixteen weeks of age, mice expressing the human catalase gene ([Tg(CAT)±] and BobCat) (D. L. Amos et al., 2017) in addition to the C57/WT control and Ob/Ob mice, were put on

Figure 29. Weekly body weight changes. (A) Final whole-body weight (g); (B) Body
weight change (initial and final body weight); (C) Overall weekly body weight measurements
of WT, [Tg(CAT)±], Bob-Cat and Ob/Ob mice that remained sedentary or were exercised 8
weeks (n≥7/group). The WT, [Tg(CAT)±], and Bob-Cat mouse groups’ data are depicted on
the left vertical axis, while the Ob/Ob mice data is depicted on the right vertical axis. Mice
overexpressing catalase on an exercise regimen in contrast to WT S or their sedentary cohorts
showed no change or lesser gain in body weight over the eight week period. One and twoway ANOVA followed by Bonferonni post-hoc and preplanned t-tests were performed on
GraphPad Prism 7. Data is represented as mean ± S.E.M. Letters indicate significant p values,
a= p<0.05, b= p<0.01, d<0.0001; symbols represent significant differences between
genotypes *= compared to WT S; an additional ‘s’ represents comparison to sedentary
cohorts.
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an exercise regimen (30 min. of treadmill exercise, 5 days a week, at 15 m/min.) or remained
sedentary in the same environment for the 8 week study period. All mouse groups were fed ad
libitum normal chow diet. Changes in body weight and body composition (fat and lean mass) in
the mouse groups overexpressing catalase were compared to the control WT and leptin deficient
(Ob/Ob) mouse groups. Body weight (BW) was recorded each week and the final BW and
change in body weight is shown in (Figure 29A-B). Analysis of change in BW by two-way
ANOVA showed a significant interaction between genotype (p<0.0001). There was also a trend
for lower body weight shown with exercise intervention compared to their sedentary controls,
however, it did not quite reach significance (p=0.056). Bonferonni post hoc test did not show a
significant difference between the groups, but using the t-test on preplanned groups, in
comparison to the WT S and the sedentary cohorts within each genotype, the change in BW was
significantly lower in exercised mouse groups, especially within the mice overexpressing
catalase. Interestingly, the only group to actually lose body weight was the exercised [Tg(CAT)±]
mouse group. As expected, the leptin deficient Ob/Ob sedentary and exercised mouse groups
gained the highest amount of BW (p<0.0001) with the Ob/Ob sedentary group gaining the most
weight of all mouse groups. The overall changes are reflected in the plotted body weight
measurements taken per week (Figure 29C).
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Figure 30. Fat and lean mass (ECHO-MRI). Change in (A) Fat mass and (B) lean mass (0
and 8 week time point difference calculated by ECHO-MRI average measurements) in WT,
[Tg(CAT)±], Bob-Cat, and Ob/Ob mouse groups that were sedentary or exercised 8 weeks.
Mice overexpressing catalase on an exercise regimen in contrast to WT S or their sedentary
cohorts had no change or a lower gain in fat mass. Bob-Cat E and WT E mice showed a trend
for increased lean mass vs. their sedentary respective cohorts. One-way and two-way
ANOVA followed by Bonferonni post hoc analysis in addition to preplanned t-tests were
performed on GraphPad Prism 7. Data is represented as mean ± S.E.M. Letters indicate
significant p values, a= p<0.05, b= p<0.01, d= p<0.0001; symbols represent significant
differences between genotypes *= compared to WT S; an additional ‘s’ represents
comparison to sedentary cohorts.
Total fat and lean mass were determined for each mouse group at baseline, 4 week, and 8
week time points by ECHO-MRI. Total change in fat and lean mass between the beginning and
end points of the study are shown in Figures 30A-B. Analysis by two-way ANOVA and
Bonferonni post-hoc analysis showed a significant interaction in the change in fat mass between
genotype (p<0.0001) in addition to exercise (p<0.01). Preplanned t-tests were also used to
determine pair-wise differences between each exercise group and their sedentary controls.
Similar to the results of body weight measurements, overexpression of catalase caused a similar
change or loss in fat mass in comparison to the WT S control group. With exercise intervention,
however, there was a significantly diminished gain in fat mass compared to the sedentary groups
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(p<0.01). As with body weight, the [Tg(CAT)±] mice were the only group to lose fat mass which
was significantly lower than the WT S control group (Figure 30A). Similar to the [Tg(CAT)±] E
mice, the Bob-Cat E group had a significantly lower change in fat mass (Figure 30A). Ob/Ob S
and E mouse groups had the greatest increase in body fat (p<0.0001 and p<0.001 respectively).
Lean mass comparisons showed an interaction (p<0.01) between exercise and genotype in
addition to a significant difference between the genotypes (p<0.01). Between the genotypes, lean
mass calculations showed WT E groups gained a significant amount of lean mass compared to
their sedentary cohorts (p<0.05) and Bob-Cat groups showed a trend for increased lean mass
(Figure 30A).
4.3.2 Adipose, Liver, and Brain Weights
Differences in subcutaneous (SubQ) and visceral adipose tissue weights and an increase
in liver weight all play a key role in energy metabolism and are indicators of metabolic status
(Paniagua, 2016; Sheng et al., 2018). Exercise is known to lower adipose tissue weight (J. Chen
et al., 2018; Hoffmann & Weigert, 2017; Leal et al., 2018) and may play a role in maintaining
the liver weight by lowering the amount of ectopic fat deposition. Therefore, as shown in Table
11, adipose tissue and liver weights were measured during tissue collection at the end of the
study from all mouse groups. Analysis by two-way ANOVA followed by Bonferonni post hoc
tests and preplanned t-tests showed a significant genotype interaction (p<0.0001) in both SubQ
and visceral adipose tissue weight. It was interesting that in both the excised SubQ and visceral
adipose tissue, the [Tg(CAT)±] mouse groups had the lowest adipose tissue weight compared to
the control WT S group. Exercised [Tg(CAT)±] mouse had significantly lower grams of SubQ
adipose tissue, while the sedentary [Tg(CAT)±] had significantly lower grams of visceral adipose
tissue. This result was also reflected in MRI analysis of the [Tg(CAT)±] E mouse group where
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the greatest amount of fat mass was lost at the end of the study (Figure 30A). As expected, the
Ob/Ob sedentary and exercised mouse groups both had the highest levels of adipose tissue
weight (p<0.0001) with more than 7 times the amount of fat as the WT mice and mouse groups
overexpressing catalase. In addition to adipose tissue weight, analysis by two-way ANOVA
followed by Bonferonni post-hoc test showed a significant interaction between the mouse groups
in liver weight with regard to genotype (p<0.0001). Ob/Ob mice, independent of exercise
SubQ Adipose (g) Visceral Adipose (g)

Liver (g)

Brain (g)

WT S

0.33 ± 0.07

0.79 ± 0.07

1.19 ± 0.07

0.47 ± 0.003

WT E

0.51 ± 0.22

0.90 ± 0.20

1.15 ± 0.04

0.45 ± 0.009

[Tg(CAT)±] S

0.18 ± 0.06

0.48 ± 0.07 a*

1.07 ± 0.06

0.46 ± 0.01

[Tg(CAT)±] E

0.15 ± 0.04 a*

0.71 ± 0.13

1.18 ± 0.07

0.44 ± 0.01 a*s

Bob-Cat S

0.30 ± 0.04

1.02 ± 0.12

1.4 ± 0.13

0.47 ± 0.01

Bob-Cat E

0.31 ± 0.05

1.03 ± 0.07

1.31 ± 0.05

0.48 ± 0.01

Ob/Ob S

14.54 ± 0.47 d*

7.63 ± 0.17 d*

4.43 ± 0.18 d*

0.42 ± 0.003 d*

Ob/Ob E

13.93 ± 0.61 d*

8.07 ± 0.27 d*

4.16 ± 0.31 d*

0.42 ± 0.008 d*

Table 11. Tissue weights. Subcutaneous (SubQ) and visceral adipose tissue, liver, and brain
weights (g) were measured during tissue collection at the end of the 8 week study
(n≥7/group). One and two-way ANOVA followed by Bonferonni post hoc test and
preplanned t-tests were used for statistical analysis. Data are represented as mean ± S.E.M.
Letters indicate significant p values, a= p<0.05, d= p<0.0001; symbols represent significant
differences between genotypes *= compared to WT S; an additional ‘s’ represents
comparison to sedentary cohorts.
intervention, had significantly higher liver weights (p<0.0001). It is intriguing that the Bob-Cat S
and E groups showed trends for increased liver weight.
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Decreased brain weight could be an indicator of neurodegeneration or neurological
dysfunction since previous studies have found that individuals with decreased brain volume have
increased cortisol levels, are at higher risk for dementia, and tend to do poorer on cognitive tests
(Stern, 2012). Two-way ANOVA indicated a significant difference within genotype (p<0001). It
was surprising to find that among the control WT and groups overexpressing catalase, the
[Tg(CAT)±] E group was the only group with a lower brain weight. We also observed that both
sedentary and exercised Ob/Ob groups had significantly lower brain weight (10% decrease;
p<0.0001) compared to the WT S mice in addition to every other mouse group.

Figure 31. Weekly measurements of food consumed. (A) average weekly food
consumption for 8 weeks; (B) weekly food consumption for 8 weeks per mouse group
(n≥7/group). WT, [Tg(CAT)±], Bob-Cat, and Ob/Ob mouse groups remaining sedentary or
exercised were studied. One-way and two-way ANOVA followed by Bonferonni post hoc
analysis were performed on GraphPad Prism 7. Data is represented as mean ± S.E.M. Letters
indicate significant p values: a= p<0.05, b= p<0.01, d= p<0.0001; symbols represent
significant differences between genotypes * = compared to WT S; an additional ‘s’ represents
comparison to sedentary cohorts.

174

4.3.3 Weekly Food Consumption
Each week, the grams of food consumed were measured from each mice group. Figure
31A shows the average food intake of each mice group per day, and Figure 31B displays the
food intake per mouse group each week throughout the 8 week study. In comparison to the WT S
mice, the only group that consumed a significantly lower amount of chow was the [Tg(CAT)±]
sedentary group, which also had the lowest visceral fat mass (Table 11). On the other hand,
although the body weight and fat mass were significantly decreased, when put on exercise
intervention, it was intriguing the [Tg(CAT)±] E mouse consumed a similar amount of chow
compared to the WT S and WT E groups. Bob-Cat mice, independent of intervention, consumed
significantly more chow than the WT mice. As expected, Ob/Ob mice consumed more chow than
all other mouse groups (p<0.0001). However, when put on exercise regimen, the Ob/Ob mice,
trended to consume less food in comparison to the sedentary group. A similar effect was seen in
the Bob-Cat group (p<0.05). However, this opposite was observed in the other two genotypes
tested (WT and [Tg(CAT)±] mice).
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4.3.4 Circulating Markers
Numerous studies show physical activity improves the lipid profile and insulin sensitivity
in both rodents and humans (J. Chen et al., 2018; Hoffmann & Weigert, 2017; Meissner et al.,
2010). Therefore, to determine the overall effect of exercise on circulating metabolic parameters,
we measured plasma TC, HDL, and TG levels at the end of the 8 week study. All mice groups,
with the exception of the Ob/Ob mice, had TC levels under 100 mg/dL. (This was below the
detection limit of the kit, so the “<” sign was used to provide data for all groups.)

WT S
WT E
[Tg(CAT)±] S
[Tg(CAT)±] E
Bob-Cat S
Bob-Cat E

TC
(mg/dL)
n=7+
<100
<100
<100

HDL (mg/dL)
n=7+
46.13 ± 3.0
50.38 ± 2.65
52.9 ± 3.34
55.3 ± 3.14
(p=0.06)
60.6 ± 2.43 b*
61.5 ± 2.63 b*

TG (mg/dL)
n=5+
47.29 ± 2.8
43.27 ± 3.4
40.4 ± 3.4

Glucose
Insulin
(mg/dL) n=7+ (ng/mL) n=3+
178.4 ± 12.7
0.25 ± 0.05
207 ± 16.7
0.26 ± 0.13
197.1 ± 15.1
0.56 ± 0.18

<100
33.2 ± 2.6 a* 198.3 ± 13.5
0.31 ± 0.05
<100
46.5 ± 3.7
222.3 ± 22.2
0.80 ± 0.47
<100
38.7 ± 3.0 235.5 ± 20.5 a* 1.52 ± 0.58
142.3 ±
Ob/Ob S
5.12 d*
97.9 ± 1.32 d* 90.5 ± 16.8 d* 256.2 ± 15.8 c* 7.73 ± 2.01 c*
127.1 ±
Ob/Ob E
7.36 b*
90.1 ± 5.16 d* 64.7 ± 8.7 b* 279 ± 26.2 c* 4.47 ± 1.46 b*
Table 12. Circulating levels of metabolic markers. Total Cholesterol (TC) and High
Density Lipoprotein (HDL) levels were determined using the Cholestech kit, while plasma
Triglyceride (TG) levels were measured using the Triglyceride Colorimetric Assay Kit.
Fasting blood glucose was measured by glucometer and plasma insulin was measured by
ELISA. Data were collected from WT, [Tg(CAT)±], Bob-Cat, and Ob/Ob sedentary or
exercised mice for 8 weeks. One and two-way ANOVA followed by Bonferonni post hoc
analysis in addition to preplanned t-tests between exercise groups and sedentary controls
were performed on GraphPad Prism 7. Data is represented as mean ± S.E.M. Letters indicate
significant p values, a=p<0.05, b= p<0.01, c= p<0.001, d= p<0.0001; symbols represent
significant differences between genotypes *= compared to WT S; an additional ‘s’ represents
significant differences between sedentary cohorts.
As shown in Table 12, Ob/Ob mice had significantly higher levels than all other mouse
groups. However, exercise intervention showed a trend for decreasing the TC levels in the
Ob/Ob E mouse group (10%). HDL levels were significantly increased in the Bob-Cat genotype
Table “3”. Circulating Levels of …
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independent of exercise (p<0.01), although all mice overexpressing catalase had higher HDL
levels (not significant) compared to the WT S group. It was also interesting that exercise
increased the HDL level in every genotype on exercise with the exception of the Ob/Ob mice.
Although HDL was highest among the Ob/Ob mouse groups, the TC was also very high. All
mouse groups overexpressing catalase trended to have lower circulating TG levels compared to
the WT S mice, with the [Tg(CAT)±] mice on exercise intervention having the lowest levels
(p<0.05). This directly correlates with their lower adipose tissue weights compared to all the
other mouse groups. Exercise intervention not only lowered the TG levels (p<0.05), but the
effect was exacerbated in the mice overexpressing catalase. On the contrary, highest TG levels
were seen in the Ob/Ob sedentary mouse group (p<0.0001). Exercised Ob/Ob mice had
significantly higher TG levels than the WT S group (p<0.01), but levels were not as significantly
high as their sedentary cohorts.
Circulating levels of glucose and insulin were also measured and shown in Table 12
followed by one and two-way ANOVA and Bonferonni post hoc analysis. T-tests were also used
between preplanned mouse groups to compare exercised mice with their sedentary cohorts. No
significant differences were noted between the mouse groups regarding blood glucose levels with
the exception of the Bob-Cat E mice and both Ob/Ob mouse groups. Bob-Cat exercised mice had
higher (p<0.05) glucose levels than the WT S group, but the highest levels were observed in both
the Ob/Ob mouse groups (p<0.001). Plasma insulin levels were significantly higher (p<0.001) in
the Ob/Ob sedentary group of mice. The Ob/Ob mice on exercise had 8-fold higher levels
compared to the WT S group (p<0.01), but this was much lower than the insulin levels observed
in their sedentary cohorts. Therefore, exercise seemed to have a beneficial effect by lowering the
insulin levels in the Ob/Ob exercised mouse group. It is also interesting that we observed the
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lowest levels of circulating glucose and insulin in the WT S and [Tg(CAT)±] mice on exercise
intervention.
4.3.5 Comprehensive Animal Monitoring System (CLAMS) Analysis
4.3.5.1 Food Intake
At the end of the study, the Comprehensive Animal Monitoring System (CLAMS) was
used to conduct a three-day assessment of food intake (FI) per mouse and averaged for each
mouse group (Figure 32A-D). Results are displayed for two-hour time intervals for all mouse
groups and between each genotype in addition to 12 h light and dark cycles per mouse group.
Unlike the weekly food measures, while analyzed in the CLAMS, there were no significant

Figure 32. CLAMS analysis of food intake over a 48h time period. Light and dark cycle
CLAMS measurements of (A) WT (C57/WT), (B) [Tg(CAT)±], (C) Bob-Cat, and (D) Ob/Ob
sedentary and exercised mice food intake as average grams/2h for 48h (n≥7/group). One-way
and two-way ANOVA followed by Bonferonni post hoc analysis was performed on
GraphPad Prism 7. Data is represented as mean ± S.E.M. (n≥7/group)
differences between any mouse group. However, we found that on average, mice on exercise
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intervention consumed more food than their sedentary cohorts. The only exception was the
Ob/Ob group. Because rodents are nocturnal, we also averaged FI during both the light and dark
cycles as displayed in Table 13.
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FI
RER
Light Dark Light
Dark
0.46
0.20 ±
±
0.89 ± 0.95 ±
WT S
0.03
0.06
0.02
0.02
0.43
0.24 ±
±
0.91 ± 0.96 ±
WT E
0.03
0.07 0.01 a*
0.02
0.46
[Tg(CAT)±] 0.23 ±
±
0.91 ±
0.97±
S
0.05
0.08
0.02
0.02
0.53 0.93 ±
[Tg(CAT)±] 0.24 ±
±
0.02
0.99 ±
E
0.04
0.09 d*;b*s 0.02 d*
0.45
0.22 ±
±
0.86 ± 0.91 ±
Bob-Cat S
0.44
0.27 0.02 d* 0.02 d*
0.50 0.89 ± 0.94 ±
0.25 ±
±
0.01
0.01
Bob-Cat E
0.04
0.06 d*;d*s
a*s
0.46
0.18 ±
±
0.80 ± 0.85 ±
Ob/Ob S
0.05
0.07 0.04 d* 0.04 d*
0.45 0.87 ± 0.92 ±
0.16 ±
±
0.01
0.01
Ob/Ob E
0.03
0.05 b*;d*s d*;d*s
Group

EE
Light Dark
18.39
± 0.86
17.63
± 0.72
d*
16.81
± 1.12
d*
16.64
± 0.73
d*
16.63
± 0.79
d*
15.54
± 0.71
d*;a*s
20.27
± 0.81
d*
20.57
± 0.83
d*

XAMB
Light
Dark

21.29
± 0.8

593.3 ±
134

1931 ±
234

19.88
± 0.98
19.31
± 1.32
b*

809.2 +
294.4

1763 ±
359

635.5 ±
177.6

2169 ±
624

20.07
± 0.60

466.3 ±
91.8

19.99
± 0.74
18.87
± 0.61
c*
23.07
± 0.68
a*
22.94
± 0.76
a*

2064 ±
872 d*
1313.09
± 618.1
b*;b*s

1678 ±
1015
5002 ±
1631
d*

150.4 ±
24.45
157.3 ±
27.71

3944 ±
907 c*
413.4 ±
74.0 a*
374.23
± 59.7
a*

Table 13. Light and dark cycles of metabolic parameters. 2h light and dark cycle
averages of food intake (FI) as average grams (g) of chow consumed, average
Respiratory Exchange Ratio (RER) as VCO2/VO2, metabolic energy expenditure (EE) as
Cal/h/(g) lean mass of each mouse group, and counts of physical movement as XAMB /
cycle (XAMB) of each exercised and sedentary mouse group per light (0-12, 24-36h) and
dark (12-24,36-48h) cycle of the 48h analysis. One-way and two-way ANOVA followed
by Bonferonni post hoc test as week as pre-planned t-tests between each genotype and
sedentary control was performed using Graph-Pad Prism 7. Data are represented as mean
± S.E.M. and significant differences are displayed with letters indicating p values:
a=p<0.05, b= p<0.01, c=p<0.001, d=p<0.0001; symbols represent significant differences
between genotypes *= compared to WT S; an additional ‘s’ represents significant
differences between sedentary and exercise cohorts. (n≥7)
Again, although there were no significant differences, we found exercised mice trended
to consume more chow than their sedentary cohorts. It was also interesting to note that the
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exercised [Tg(CAT)±] and Bob-Cat mice consumed among the highest levels of food overall,
despite their low body weight, fat mass, and circulating levels of TG (Figures 29-30 and Tables
11 and 12).
CLAMS analysis can also be indicative of normal eating patterns and circadian rhythm
(can change based on the frequency of food consumption). It was surprising that the Ob/Ob
mice, contrary to expectation, did not significantly differ in their frequency of food consumption.
4.3.5.2 Respiratory Exchange Ratio, CHO Oxidation, and Fat Oxidation
RER is an indication of the type of fuel (carbohydrate (CHO) vs fat) being primarily
oxidized to supply energy demands. In comparison to the WT S group, shown in Table 13,
exercised mice within each genotype showed an increase in the RER (p<0.05). This was also true
of each exercised group compared to their sedentary cohorts. (Overall 2h time intervals are
reflected in Figure 33A-D.)
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Figure 33. CLAMS analysis of respiratory exchange ratio over a 48h time period. Light
and dark cycle CLAMS measurements of (A) WT (C57/WT), (B) [Tg(CAT)±], (C) Bob-Cat,
and (D) Ob/Ob exercised and sedentary mouse group’s Respiratory Exchange Ratio (RER) is
depicted as VCO2 emission / VO2 consumption. (n≥7/group) One and two-way ANOVA
followed by Bonferonni post hoc analysis was performed on GraphPad Prism 7. Results are
represented as mean ± S.E.M.
As expected, the RER of the Ob/Ob S mice was the lowest among all mouse groups, yet
the Ob/Ob E group had higher levels than their sedentary cohorts (Table 13, p<0.0001).
However, most interesting, was the RER measurements observed in the [Tg(CAT)±] and BobCat mouse groups on exercise intervention. While [Tg(CAT)±] E showed the overall highest
levels (p<0.0001) independent of the light or dark cycle, Bob-Cat E mice had increased levels
compared to their sedentary cohorts yet retained similar RER levels to the WT S group (Table
13).
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In addition to determining the RER, we further delineated the CHO and fat oxidation
levels using the VO2 and VCO2 obtained from the CLAMS measurements (Figure 34).

Figure 34. Substrate oxidation level over a 48h time period. Calculated oxidation levels of
carbohydrate (CHO) during the (A) light and (B) dark cycles as well as the oxidation of fat
during the (C) light and (D) dark cycles in WT (C57/WT), [Tg(CAT)±], Bob-Cat, and Ob/Ob
exercised and sedentary mice (n≥7/group). One and two-way ANOVA were performed
followed by Bonferonni post hoc analysis on GraphPad Prism 7. Data is represented as mean
± S.E.M. Significant differences are displayed with letters indicating p values b= p<0.01,
c=p<0.001, d=p<0.0001; symbols represent significant differences between genotypes *=
compared to WT S; an additional ‘s’ represents significant differences between sedentary
cohorts.
In comparison to the WT S mice, exercised mouse groups showed an overall trend for
higher levels of CHO oxidation and lower levels of fat oxidation independent of the light or dark
183

cycle. However, when comparing the two time periods, the highest levels of carbohydrate
oxidation were observed during the dark (wake) cycle while the highest levels of fat oxidation
were seen during the light cycle as the animals slept. Ob/Ob mice were expected to have the
lowest levels of CHO oxidation and the highest levels of fat oxidation due to their obese state.
However, it was unexpected that the Bob-Cat sedentary mouse group had the lowest level of
CHO oxidation and the highest level of fat oxidation (p<0.01). In fact, their level of fat oxidation
was even higher than the obese, leptin deficient Ob/Ob mouse groups.
Nonetheless, even more surprising was that the [Tg(CAT)±] E group had both the overall
highest levels of CHO oxidation and lowest levels of fat oxidation (p<0.0001) regardless of the
time of day. Bob-Cat E mice, on the other hand, showed the opposite effect in the dark cycle
with increased levels in fat oxidation compared to the WT S mouse group. These results indicate
antioxidant catalase and/or exercise is playing a role in modulating the metabolic pathways
involved in fuel oxidation within the antioxidant overexpressing mouse groups.
4.3.5.3 EE and XAMB
The CLAMS technology also provides measurements of Energy Expenditure (EE) as
well as physical activity levels (XAMB). EE, indirectly calculated as Cal/h/g of lean body mass,
was significantly different in each mouse group compared to the WT S mice. Figure 35A-E
depicts the 2h time point measurements for each of the mouse groups. With the exception of the
Ob/Ob mice, which had significantly higher levels (p<0.0001), all mouse groups overexpressing
catalase or on exercise intervention had decreased levels of EE compared to the WT S group
during the light cycle (Figure 35A and Table 13). The same trend was shown during the dark
cycle, although, not all levels reached significance (Table 13). Exercise showed a trend for
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decreasing the EE, and the exercised mouse groups overexpressing catalase (Bob-Cat and
[Tg(CAT)±]) had the lowest levels (Table 13).
XAMB, a count of beam breaks while the mice resided in the CLAMS chambers, was
averaged and showed that in comparison to the WT S group, all groups overexpressing catalase
showed a trend of having higher activity levels (Table 13 and Figure 36A-D). The only
exception was the [Tg(CAT)±] E group. As shown in Table 13 and reflected in Figure 36,

Figure 35. CLAMS analysis of energy expenditure over a 48h time period. Light and
dark cycle CLAMS analysis of Energy Expenditure (EE) per 2h over a 48h time period in (A)
WT (C57/WT), (B) [Tg(CAT)±], (C) Bob-Cat, and (D) Ob/Ob exercised and sedentary mouse
groups (n≥7/group). Metabolic EE averaged as Cal/h/Lean (g) body mass. One-way and twoway ANOVA followed by Bonferonni post hoc analysis were performed on GraphPad Prism
7. Data is represented as mean ± S.E.M.
Ob/Ob mice had the lowest levels of physical activity (p<0.05), independent of exercise
intervention and the time of day, compared to every other mouse group. As observed in other
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Figure 36. CLAMS analysis of total activity over a 48h time period. Light and dark cycle
CLAMS analysis of X-Ambulatory movement (XAMB) per 2h over a 48h time period in (A)
WT (WT/C57), (B) [Tg(CAT)±], (C) Bob-Cat, and (D) Ob/Ob exercised and sedentary
mouse groups. (n≥7/group). One-way and two-way ANOVA was performed on GraphPad
Prism 7. Data is represented as mean ± S.E.M.
metabolic measurements, mice overexpressing catalase continued to show intriguing results. As
previously mentioned, the [Tg(CAT)±] E mouse group had lower (light cycle) or similar XAMB
levels (dark cycle) to the WT S mice, but Bob-Cat mice independent of intervention had
significantly higher levels of activity compared to the WT S groups (p<0.01) (Table 13). This
further provides evidence of an antioxidant and exercise effect on metabolic pathways in this
novel mouse model.
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4.3.6 Synergistic Effects of Exercise and Antioxidant Catalase on Skeletal Muscle Function

Figure 37. Type 1 / Type 2 fiber type ratio in the gastrocnemius skeletal muscle. (A)
Skeletal muscle ATPase fiber type analysis (pH 4.3) images (black Type 1 vs. gray-shaded
stains of Type 2 fibers) of exercised and sedentary C57/WT, [Tg(CAT)±], Bob-Cat, and
Ob/Ob mouse groups and (B) fiber type analysis of Type 1 / 2 ratios evidencing antioxidant
and exercise intervention induced a general trend for higher Type 1 / 2 fiber ratios vs.
C57/WT sedentary mice. Data shown as % of Type 1 / Type 2 fiber type ratio vs. C57/WT
sedentary mice (n≥6). One-way and two-way ANOVA followed by Bonferonni post hoc tests
in addition to preplanned t-tests between exercised mice and their sedentary controls were
performed on GraphPad Prism 7. Significance was denoted as a*= p<0.05 to WT sedentary
(S) group.
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Exercise is known to induce morphological and physiological changes in skeletal muscles
that are beneficial for metabolic health (Schnyder & Handschin, 2015; B. So et al., 2014).
Therefore, we analyzed differences in muscle weight during tissue collection, grip strength
(Deacon, 2013), Type 1 / Type 2 fiber type ratio, and key myokine expression and secretion. No
differences were seen in average muscle weight of the Gas (0.12- 0.17g) or Soleus muscle (≤
0.01g) within each mouse group. In addition, there were no significant differences seen within
the various groups in the grip strength test. The Gas muscle is comprised of both Type 1 and
Type 2 muscle fibers, while the soleus muscle is predominately comprised of Type 1 muscle
fibers (Gollnick & Hodgson, 1986). Therefore, we used the Gas muscle to determine alterations
in fiber type as a result of exercise intervention and antioxidant overexpression. Post staining for
Myosin ATPase (pH 4.3), which provided visual evidence of Type 1 (dark) and Type 2 fibers
(shades of gray) (Figure 37), we observed a significant increase in the Type 1 / Type 2 fiber
ratio of all exercised mouse groups, except for the Ob/Ob E group (p<0.05). This observation
within the Ob/Ob E group may have been a result of their leptin mutation since leptin is an
adipokine involved in the skeletal muscle-adipose axis (A. Rodriguez et al., 2017). Most
interestingly, as shown in Figure 37, the [Tg(CAT)±] E and Bob-Cat E groups showed the
highest Type 1 / Type 2 muscle fiber ratio (p<0.05; 211% and 239% increase respectively vs WT
S). With these evidences, exercise and antioxidant overexpression had a synergistic effect on the
fiber type ratio within the Gas muscle.
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Increasing evidence indicates that Type 1 and Type 2 muscle fibers express and secrete
different proteins which can have both autocrine and paracrine effects (Hoffmann & Weigert,
2017; S. Jung & Kim, 2014; Mizgier, Rutti, Pinget, & Bouzakri, 2018). Therefore, as a direct
effect of exercise, and a synergistic effect with the combination of increased endogenous
antioxidant altering the fiber type ratio, we further analyzed key myokine mRNA gene
expression within the Gas skeletal muscle tissue using RT-qPCR (Table 14).
mRNA Expression Fold Change to WT S Controls
Mouse Group
C57/WT S

GLUT 4

IL-6

FGF-21

PGC1alpha

FNDC5

Plasma
(ug/mL)
Irisin

2.96 ±
0.48
C57/WT E
2.72 ±
2.5 b*
2.33
4.4
2.2
1.61 a*
0.12
[Tg(CAT)±] S
3.58 ±
1.32
1.48
1.52
0.33
0.92
0.09
[Tg(CAT)±] E
2.37
2.66 ±
2.51 b*
2.52
9.44 b*
2.35
a*a*s
0.20
Bob-Cat S
3.65 ±
1.33
1.79
2.42
1.7
1.23
0.66
Bob-Cat E
2.98 ±
1.68
1.15
3.73
2.13
1.83
0.05
Ob/Ob S
3.45 ±
0.92
0.78
6.06 a*
1.56
2.38
0.14
Ob/Ob E
2.40 ±
0.14 a*
1.66
5.54
1.12
2.36
0.29
Table 14. Gastrocnemius skeletal muscle myokine expression. Skeletal muscle mRNA
expression of exercise-induced myokines (GLUT 4, IL-6, FGF-21, PGC1-alpha, and
FNDC5) were determined within the gastrocnemius skeletal muscle of each sedentary (S)
and exercised (E) group by RT-qPCR. In addition, circulating levels of plasma irisin
(ELISA) were also evaluated. (n≥3). mRNA expression is depicted as fold change to
sedentary C57/WT mice by Pfaffl ddCT method. Levels of plasma irisin are represented
as mean ± S.E.M. One-way and two-way ANOVA was performed followed by
Bonferonni post hoc analysis in addition to preplanned t-tests between exercised mice and
their sedentary controls on GraphPad Prism 7. Significant differences are displayed with
letters indicating p values: a=p<0.05, b= p<0.01; symbols represent significant differences
between genotypes *= compared to WT S; an additional ‘s’ represents significant
differences between sedentary cohorts.
1

1

1
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GLUT 4 is a glucose transporter expressed in skeletal muscle tissue that aids in regulation
of glucose levels and is known to be induced by exercise (Ikeda et al., 2016). With oxidative
stress known to play a key role in glucose homeostasis (Grattagliano et al., 2008), we sought to
determine whether GLUT 4, being an exercise-induced myokine, significantly differed among
the mouse groups. As shown in Table 14, exercise intervention showed an increased fold change
(p<0.05) compared to the sedentary control groups. However, it was interesting to find the
plasma glucose levels were slightly elevated in all exercised mice compared to their sedentary
cohorts (Table 12).
IL-6 is another exercise-induced myokine that is also expressed in adipose tissue and
macrophages (Febbraio & Pedersen, 2005; Leal et al., 2018; Raschke & Eckel, 2013). As shown
in Table 14, within the Gas skeletal muscle, though not significant, IL-6 showed a trend for
increased expression in both mouse groups overexpressing catalase, with an exacerbated effect
observed in the [Tg(CAT)±] E group (>2.5 fold induction).
Another myokine increased by exercise (Leal et al., 2018), and previously shown to be
induced by alterations in redox stress, is Fibroblast Growth Factor 21 (FGF-21) (Gomez-Samano
et al., 2017). It plays a key role in systemic glucose homeostasis (X. Lin et al., 2017) and has
been shown to modulate adipose tissue function in addition to its browning, thus inducing
thermogenesis/energy expenditure (BonDurant et al., 2017; A. Rodriguez, Becerril, Ezquerro,
Mendez-Gimenez, & Fruhbeck, 2016). As shown in Table 14, exercise intervention in each
mouse group, apart from the Ob/Ob mice, caused an induction in FGF-21 levels in comparison to
the WT control. Specifically, within the [Tg(CAT)±] E and Bob-Cat E groups, there was > 8 fold
(p<0.01) and 3 fold change (not significant) respectively.
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With both groups expressing human antioxidant catalase, we expected oxidative stress
levels within the skeletal muscle tissue played a role in the induced FGF-21 gene expression.
Therefore, we also measured catalase activity using the established method of Aebi (Aebi, 1984).

Figure 38. Skeletal muscle catalase activity level. Catalase enzymatic specific activity
(U/mg protein) was calculated for each mouse using Aebi method. Data is represented as
percent specific activity to the WT (C57/WT) S mouse group. One-way and two-way
ANOVA followed by Bonferonni post hoc tests in addition to preplanned t-tests between
each exercised group and their sedentary cohorts were performed on GraphPad Prism 7.
Significance was considered as a*= p<0.05 to the WT sedentary (S) group.
Although not significant, specific activity calculations showed an increased level of Gas skeletal
muscle catalase activity compared to the WT S group in both [Tg(CAT)±] E and Bob-Cat E mice
(Figure 38).
In recent years, one key signaling pathway that has received attention is the PGC1alpha/FNDC5/Irisin pathway (Hoffmann & Weigert, 2017; Huh, 2018; Perakakis et al., 2017)
which has been shown to be activated by exercise (Leal et al., 2018) and FGF-21 (Fisher et al.,
2012; Sanchis-Gomar, Pareja-Galeano, Mayero, Perez-Quilis, & Lucia, 2014). With the
induction of FGF-21 shown in the exercised mice overexpressing catalase (Table 14), we first
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analyzed PGC1-alpha. Though not quite significant, an increased fold change in the mRNA
expression of PGC1-alpha was observed in all mouse groups subjected to exercise intervention
vs the WT S group and their sedentary cohorts. With this trend we further analyzed the mRNA
expression of FNDC5 and saw the same effect compared to the WT S mice (p<0.05) (Table 14).
Therefore, we further analyzed circulating plasma irisin levels since there has been evidence
showing increased levels with chronic endurance exercise interventions (Leal et al., 2018).
Surprisingly, we did not observe any significant differences within any mouse group.
4.3.7 Adipokine Expression and Adipose Tissue Redox Status
Not only does exercise play a role in skeletal muscle function, but it also decreases
adipose tissue mass in addition to altering expression and secretion of key adipokines related to
Fold
Protein
Fold Change Fold Change to
Change to
Expression
to WT S
WT S
WT S
(Plasma)
Mouse Group
Leptin
Leptin (pg/mL)
UCP-1
Adiponectin
mRNA
mRNA
mRNA
C57/WT S
1.00
29.6 ± 13.8
1.00
1.00
C57/WT E
1.78
84.2 ± 18.8
1.08
1.55
[Tg(CAT)±] S
2.01
14.9 ± 5.3
1.69
0.49
[Tg(CAT)±] E
0.60
113 ± 46.8 b*b*s
0.58 b*
0.73
Bob-Cat S
0.51
43.61 ± 6.5
1.80
0.44
Bob-Cat E
1.66
27.5 ± 5.5
5.44
0.56
Ob/Ob S
0.60
1.34 ± 0.62
6.29 a*
0.05 b*
Ob/Ob E
0.81
0.97 ± 0.01
1.81 a*s
0.1 b*
Table 15. Adipose tissue expression level of key adipokines. mRNA expression of key
adipokines (Leptin, UCP-1, and Adiponectin) involved in energy metabolism and/or
inflammatory signaling were evaluated in the adipose tissue of each sedentary (S) and
exercised (E) mouse group by RT-qPCR. (n≥3) mRNA expression is displayed as fold
change compared to C57/WT (WT) sedentary (S) mice determined by Pfaffl ddCT method.
Plasma leptin levels were measured using a Mouse Adipokine Array (Millipore) on a
Luminex system. One and two-way ANOVA followed by Bonferonni post hoc tests in
addition to preplanned t-tests between each exercised and sedentary control were performed
on GraphPad Prism 7. Significant differences are displayed with letters indicating p values:
a=p<0.05, b= p<0.01; symbols represent significant differences between genotypes *=
compared to WT S; an additional ‘s’ represents significant differences between sedentary
cohorts.
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energy metabolism (Golbidi & Laher, 2014). In recent years, evidence has indicated a crosstalk
between skeletal muscle and adipose tissue (Leal et al., 2018). Some of the key factors
speculated to be involved in the crosstalk include IL-6, FGF-21, irisin, and leptin (Hoffmann &
Weigert, 2017; Roca-Rivada et al., 2013; A. Rodriguez et al., 2016). With our novel model
showing decreased adipose tissue mass in each exercised mouse group (Figure 30 and Table
11), we sought to determine if there were differences in the adipokine leptin, a 42 kD protein
produced primarily in adipose tissue and a key regulator of energy homeostasis.
Leptin regulates appetite by hypothalamic signaling in the arcuate nucleus (Frago &
Chowen, 2015; Wilson & Enriori, 2015). More recently it has been shown to be involved in the
crosstalk between adipose tissue and secretion of myokines (A. Rodriguez et al., 2016).
Compared to the WT S group, the exercised, antioxidant-overexpressing mice showed opposing
effects (Table 15). Although not significant, the [Tg(CAT)±] E group showed a slight decrease in
expression while the Bob-Cat E, similar to the WT and Ob/Ob exercised groups, showed a trend
for increased expression. We further analyzed plasma leptin levels using a mouse adipokine
array and found that in circulation, the group with the highest leptin levels was the [Tg(CAT)±] E
while Bob-Cat E had similar levels in comparison to the WT S group (not significant).
On the other hand, with an upregulation of FGF-21 expression in the skeletal muscle
tissue of the antioxidant overexpressing mouse groups, we analyzed the downstream
modifications expected to occur in adipose tissue. FGF-21 is known to have a beneficial
metabolic effect in adipose tissue by inducing browning through upregulation of UCP-1 (Fisher
et al., 2012; P. Lee et al., 2014). We found this to have occurred within the Bob-Cat E mice with
a 5-fold increase (trend) in UCP-1 mRNA expression compared to the WT S group.
Interestingly, contrary to the Bob-Cats, [Tg(CAT)±] E mice had a significant decrease in UCP-1
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expression (p<0.05) vs the WT S group. Nonetheless, specifically within the Bob-Cat E group
we observed the highest fold change of FGF-21 in adipose tissue. This may also have been a
factor in the decreased body weight and fat mass at the end of the exercise study (Figure 29 &
30, Table 11). Additionally, a few studies have discussed the interaction between exerciseinduced myokine FGF-21 and adiponectin (Manole, Ceafalan, Popescu, Dumitru, & Bastian,
2018). Therefore, we also analyzed adipose tissue adiponectin levels. Although no significant
differences were noted between the genotypes, evidence was shown for an induction of
adiponectin (p<0.05) in exercised groups providing evidence of adipose - skeletal muscle
crosstalk.
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As analyzed in the skeletal muscle tissue, we also evaluated the oxidative state of the
adipose tissue by detecting oxidized carbonyl groups and measuring catalase activity levels
(Figure 39A-B).

Figure 39. Oxidized carbonyl groups and catalase activity in adipose tissue. (Left)
Oxyblot of oxidized carbonyl groups shown as densitometric ratios of oxidized proteins to
total proteins (memcode) in adipose tissue of C57/WT (WT), [Tg(CAT)±], Bob-Cat, and
Ob/Ob sedentary (S) and exercised (E) mouse groups. Error is reported as mean ± S.E.M.
(Right) Catalase enzymatic specific activity in adipose tissue (U/mg protein) was calculated
for each mouse using the Aebi method. Data is represented as percent specific activity of
each mouse group to the WT S group. One and two-way ANOVA followed by Bonferonni
post hoc analysis and preplanned t-tests were performed using GraphPad Prism 7.
Significance was considered as p<0.05, a*= p<0.05, d* p<0.0001 to the WT sedentary (S)
group; an additional ‘s’ represents significant differences between sedentary cohorts.
There were no significant differences in oxidative stress levels (oxidized carbonyl
groups) between the antioxidant-overexpressing groups and WT mouse groups, but the Ob/Ob
mouse groups had the highest levels of carbonylated proteins as shown in Figure 39A. Analysis
of catalase activity showed both WT E and [Tg(CAT)±] E mouse groups had significantly
increased catalase activity levels (Figure 39B) compared to the sedentary control group. BobCat E mice enzymatic activity levels were similar yet slightly increased compared to the WT S
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mouse group. These results indicate that specifically, antioxidant catalase may be playing a role
in adipose tissue function.
4.3.8 Hypothalamic Appetite Regulation
mRNA expression Fold Change to C57/WT S Controls
Mouse Group
NPY
LepR
POMC
BDNF
C57/WT S
1
1
1
1
C57/WT E
0.74
4.35 b*
5.54 a*
3.61 a*
[Tg(CAT)±] S
0.96
6.79 a*
5.89 b*
3.88
[Tg(CAT)±] E
0.76
3.09
8.29 a*
2.79
Bob-Cat S
1.2
6.7 a*
2.07
6.04
Bob-Cat E
0.94
2.83
3.52
1.34 b*
Ob/Ob S
1.65
4.15 a*
7.98 a*
2.18
Ob/Ob E
1.46
5.41 a*
12.77
3.64
Table 16. Hypothalamic mRNA gene expression. mRNA expression analysis of key genes
involved in hypothalamic appetite regulation and neurogenesis (NPY, LepR, POMC, and
BDNF) in the hypothalamic region of the brain by RT-qPCR. Expression levels within each
sedentary (S) and exercised (E) mouse genotype are depicted as fold change to sedentary
C57/WT (WT) mice by Pfaffl ddCT method. (n≥3). One-way and two-way ANOVA
followed by Bonferonni post hoc test and preplanned t-tests were performed on GraphPad
Prism 7. Significant differences are displayed with letters indicating p values: a=p<0.05, b=
p<0.01; symbols represent significant differences between genotypes *= compared to WT S
mice.
There is a well-known link between adipose tissue and hypothalamic signaling through
the satiety hormone leptin (J. Friedman, 2016; Kwon, Kim, & Kim, 2016). Although we did not
observe significant changes within the adipose tissue with regard to leptin mRNA expression nor
plasma leptin levels (Table 16), we did observe changes in body weight, fat mass, and metabolic
parameters which are impacted by neurons within the hypothalamus of the brain (Benite-Ribeiro
et al., 2016; Funahashi et al., 2003). mRNA expression of the key orexigenic (NPY) and
anorexigenic (POMC) genes were detected within each mouse group along with Brain Derived
Neurotrophic Factor (BDNF). BDNF has been shown to be upregulated by exercise (Jodeiri
Farshbaf et al., 2016) and plays a role in anxiety, cognition, mood, and behavior (Archer,
Josefsson, & Lindwall, 2014). With regard to appetite regulation, we saw that there was a trend
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for all exercised groups to have a decreased fold change in NPY mRNA expression (Table 16),
which could cause a decrease in food intake.
On the other hand, there was an increased expression of LepR (would induce satiety)
within every mouse group in comparison to the WT S mice except the [Tg(CAT)±] E and BobCat E groups. POMC was also analyzed. Known for its downstream effects of induced satiety
and increased energy expenditure, we found POMC in both the WT E and [Tg(CAT)±] S group
to have >5 fold increase (p<0.05), and the [Tg(CAT)±] E (p<0.05) and Ob/Ob E (p<0.05) mice to
have the highest mRNA expression. Surprisingly, the Bob-Cat S and E groups showed only a
slight fold increase, but it was not significant compared to every other mouse group vs. the WT S
mice.
BDNF levels were also measured since we saw significant changes in the brain weight
(Table 11) and its level has been shown to be increased by exercise potentially through a PGC1alpha, FNDC5, BDNF (Jodeiri Farshbaf et al., 2016; Siamilis et al., 2009). In comparison to the
WT S group, the highest levels were seen in the Bob-Cat S mouse group. However, there was
also a slight increase in the Bob-Cat E group (not significant) and almost a 3-fold increase in the
[Tg(CAT)±] E group.
4.3.9 Impact of Exercise on Microbial Composition and Predicted Function
4.3.9.1 Alpha Diversity
Numerous studies have shown shifts in the taxa and function of the gut microbiome as a
result of physical activity in both humans and mice (J. Chen et al., 2018; Denou et al., 2016;
Monda et al., 2017). Exercise has been shown to increase species richness, the number of
beneficial microbes, the microflora diversity, and the development of commensal bacteria
(Monda et al., 2017). Nonetheless, we are not aware of any studies who have investigated the
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Figure 40. Boxplot of microbiome alpha diversity. A boxplot of the alpha diversity
measured by Faith’s phylogenetic diversity (PD) as implemented in QIIME of the (A)
exercise and sedentary groups of all samples (n≥27) and (B) each intervention group per
genotype (n≥7). A two-sample t-test and non-parametric Monte Carlo permutations (n = 999)
were used for statistical analysis (p<0.05).
synergistic effect of exercise and antioxidant overexpression on the composition and function of
the gut microbiome. In our novel model, we observed changes in skeletal muscle morphology,
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myokine/adipokine crosstalk, and appetite regulation with exercise which may have been a result
of shifts in the gut microbiome in response to increased catalase or exercise intervention.
Therefore, to further our knowledge in the field, the variable regions 3 and 4 of bacterial 16S
rRNA genes were amplified by PCR and sequenced using the Illumina MiSeq platform. To
determine the microbiota phylogenetic richness in each fecal sample, we analyzed the alpha
diversity. No significant differences were shown between sedentary and exercised mouse groups
(Figure 40A).
Because genotype could have played a role in the alpha diversity assessment, we chose
to also analyze alpha diversity between the genotypes on sedentary or exercise regimen. When
only considering the sedentary cohorts, despite differences in species richness, no statistically
significant differences were observed between any pairwise cohort-to-cohort groups. This same
effect was seen when only considering the exercise cohorts. Further analysis of each individual
mouse group (genotype and exercise) showed slight differences in species richness, but none
were statistically significant (Figure 40B).
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4.3.9.2 β Diversity
Exercise is also known to shift the microbial species composition (Denou et al., 2016).
To determine whether there were phylogenetic differences in microbial community composition
(β Diversity) between the sequenced fecal samples, principal coordinate analysis (PCoA) of
weighted UniFrac distances between the fecal boli samples of the various mouse groups were
generated based on a CSS normalized OTU table (Paulson et al., 2013). Pairwise comparison
between exercise and sedentary groups yielded significantly different clustering (anosim

Figure 41. β-Diversity plots of sedentary and exercised mice. PCoA plots of
phylogenetic differences in microbial community composition between sequenced
sedentary and exercised samples. (A) C57/WT (blue), [Tg(CAT)±] (red), Bob-Cat (green),
and Ob/Ob (purple) sedentary mouse groups and (B) of each respective exercised cohort
is displayed in the images showing a defined microbial community composition within
each genotype (anosim p< 0.05). (n≥6)
p<0.05), indicating a profound shift in microbial community composition dependent on exercise.
Further analysis comparing the genotypes of sedentary samples (Figure 41A) showed significant
clustering between cohorts at an anosim p= 0.001, indicating a defined microbial community
composition within each respective mouse group. Comparing each genotype of exercised mice
(Figure 41B) showed the same result thus indicating a defined microbial community
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composition within each respective exercised cohort. Finally, we determined if there were
significantly different microbial community compositions between each genotype (Figure 42AD).

Figure 42. β-Diversity plots per genotype. PCoA plots of phylogenetic differences in
microbial community composition between sequenced sedentary and exercised samples per
mouse genotype. (A) C57/WT, (B) [Tg(CAT)±], (C) Bob-Cat, and (D) Ob/Ob mouse groups
(sedentary depicted as blue and exercise depicted as red dots) as displayed in the images
show a defined microbial community composition within each E and S group of each
genotype (anosim p< 0.05). (n≥6)
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Significant clustering was observed within each genotype: C57/WT: anosim p= 0.031,
[Tg(CAT)±]: anosim p= 0.025, Bob-Cat: anosim p= 0.033, and Ob/Ob: anosim p= 0.021.
Therefore, our data shows evidence of a defined microbial community composition within
exercised and sedentary mice of each respective genotype.
4.3.9.3 Taxa LEfSE Analysis
With significant differences observed in microbial composition between sedentary and
exercised groups within each genotype, we conducted LEfSE analysis to compare the microbial
taxa. This allowed identification of taxonomy shifts in the microbial community composition.
Comparison diagrams were created based on LEfSE results among sedentary mouse groups and
separately among exercised groups of each genotype in comparison to the C57/WT mice.
Between the sedentary groups it was interesting to find that the mice overexpressing catalase
both were enriched with Rikenellaceae and Helicobacteraceae. Additionally, the sedentary BobCat and Ob/Ob shared the taxa Weeksellaceae and Erysipelotrichaceae. Comparisons between
the exercised mouse groups showed that the mouse groups overexpressing catalase were both
enriched with the Helicobacteraceae while both the C57/WT and Ob/Ob mice were both
enriched with Rikenellaceae. Additionally, it was interesting to find that the [Tg(CAT)±] E mice
were enriched with the Bifidobacteriaceae which has been shown to be increased with exercise
intervention and is known to produce the SCFA butyrate (Munukka et al., 2018; Rivière, Selak,
Lantin, Leroy, & De Vuyst, 2016).
We subsequently conducted an analysis to determine the impact of exercise within each
specific mouse group (Figures 43-46). LEfSE analysis plots portrayed significantly enriched
bacterial taxonomy within the sedentary and exercise cohorts of each mouse model (Figure 4346).
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Green- Sedentary
Red- Exercise

Figure 43. C57/WT taxa LEfSe analysis. Linear discriminant analysis (LDA) scores
derived from LEfSe analysis showing the biomarker taxa (LDA score >2.0 and significant at
p<0.05) of C57/WT mouse groups (green- sedentary; red-exercise) determined by Kruskal–
Wallis and pairwise Wilcoxon tests. (n≥7)
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A total of 27 significantly differential taxa between C57/WT S and C57/WT E cohorts
were observed. Of the sedentary C57/WT samples, there was an enrichment of bacteria
belonging to the Firmicutes Phylum while the exercised samples showed an enrichment of the
Bacteriodes S24-7. At the genus level, sedentary groups were significantly enriched in
Oscillospira, while exercised groups were enriched in Corynebacterium, Enterococcus,
Desulfovibrio, and Proteus. In comparing the [Tg(CAT)±] E and S groups, LEfSE analysis only
showed a total of 3 significantly different taxa, the fewest differential taxa of all experimental
groups, comparing the exercise and sedentary mice (Figure 44).

Figure 44. [Tg(CAT)±] taxa LEfSe analysis. Linear discriminant analysis (LDA) scores
derived from LEfSe analysis showing the biomarker taxa (LDA score >2.0 and significant at
p<0.05) of [Tg(CAT)±] sedentary mouse groups (no significantly enriched taxa in the
exercised cohort compared to the sedentary mice) determined by Kruskal–Wallis and
pairwise Wilcoxon tests. (n≥7)
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Green- Sedentary
Red- Exercise

Figure 45. Bob-Cat taxa LEfSe analysis. Linear discriminant analysis (LDA) scores
derived from LEfSe analysis showing the biomarker taxa (LDA score >2.0 and significant at
p<0.05) of Bob-Cat mouse groups (green- sedentary; red-exercise) determined by Kruskal–
Wallis and pairwise Wilcoxon tests. (n≥7)
Also interesting was that all enriched taxa were identified within the sedentary cohort where
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there was an enrichment of Desulfovibrionaceae and Aeromonadaceae at the family level. Within
the Bob-Cat mouse groups, LEfSe analysis determined there was a total of 42 significantly
differential taxa between the sedentary and exercise cohorts (Figure 45).
This was the highest number of significantly differentiating taxonomy compared to every
other genotype analyzed. As with the C57/WT mice, there was also an enrichment of Firmicutes
within the sedentary groups, while within the exercised Bob-Cats, the Bacteroidales was
enriched. At the genus level, sedentary mice were enriched in Methanobrevibacter,
Chryseobacterium, Butyrivibrio, and Bilophila in comparison to their exercised cohorts.
Exercised Bob-Cat mice had significantly higher levels of Parabacteroides, Prevotella,
Ruminococcus, Sutterella, and Akkermansia. Within the obese, Ob/Ob mouse groups there was a
total of 26 significantly differential taxa between the exercised and sedentary cohorts (Figure
46).

206

Green- Sedentary
Red- Exercise

Figure 46. Ob/Ob taxa LEfSe analysis. Linear discriminant analysis (LDA) scores
derived from LEfSe analysis showing the biomarker taxa (LDA score >2.0 and significant
at p<0.05) of Ob/Ob mouse groups (green- sedentary; red-exercise) determined by Kruskal–
Wallis and pairwise Wilcoxon tests. (n≥7)
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Specifically, the Lachnospiraceae were enriched in the exercised cohort compared to the
Ob/Ob S group. Interestingly, with Ob/Ob mice being the parent group of Bob-Cat genotype, this
family was also enriched in the Bob-Cat S mice yet significantly depleted in the Bob-Cat E
group. Additionally, Ob/Ob S mice had significantly higher levels of Adlercreutzia,
Parabacteroides, AF12, Weissella, and Anaeroplasma, while exercised groups had significantly
higher levels of Prevotella and Sutterella.
4.3.9.4 PICRUSt Pairwise LEfSe Analysis
Dependent upon the microbial species present and their interaction with one another,
their overall impact on the host organism changes (Heiss & Olofsson, 2018). To determine the
predicted function of each mouse group’s gut microbiome, PICRUSt functional predictions were
generated from 16S data for each fecal sample and uploaded to the LEfSe analysis tool for
functional biomarker identification between the exercise and sedentary cohort of each mouse
genotype. We observed a total of 7 significantly differential functional predictions between the
sedentary and exercise cohorts of the C57/WT genotype. Of all the remaining cohorts, the
C57/WT genotype had the fewest number of predicted functional pathways. LEfSe analysis
distinguished 29 significantly differential functional predictions between the [Tg(CAT)±] S and E
cohorts. Sedentary mice showed an enrichment of bacteria predicted to carry out butyrate
metabolism, dioxin degradation, and xylene degradation. Within the [Tg(CAT)±] E mouse group,
glycan biosynthesis and metabolism as well as glycan degradation were significantly enriched. A
profound number of 118 significantly differential functional predictions were found between
Bob-Cat S and E cohorts by LEfSe analysis. The high number of functional predictions enriched
in the exercised samples, indicates exercise contributes a strong effect on the functional potential
of the microbial community. Within the Bob-Cat S group, several functional pathways involved
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in cell motility were enriched including flagellar assembly, bacterial motility proteins, and
bacterial chemotaxis. Bob-Cat mice in the exercised cohort showed an enrichment of glycan
biosynthesis, just as was seen in the [Tg(CAT)±] E group. It is also interesting that bacteria
capable of LPS biosynthesis were enriched in the Bob-Cat E group. LEfSe analysis of the
Ob/Ob groups showed a total of 12 significantly differential functional predictions between the
sedentary and exercise cohorts. One pathway particularly enriched was fructose and mannose
metabolism within the Ob/Ob exercised samples.
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4.4 DISCUSSION
Cardiometabolic diseases are characterized by increased levels of ROS that alter glucose
and lipid signaling pathways in key metabolic organs such as adipose tissue, skeletal muscle, and
brain (Barazzoni et al., 2018; Carrier, 2017; Rani et al., 2016). These effects lead to increased
visceral fat mass and risk for adipose tissue inflammation, hyperglycemia, dyslipidemia,
hyperleptinemia, and IR (Carrier, 2017). Both increased endogenous antioxidant expression and
exogenous antioxidant supplementation mitigate the negative effects of high redox stress and
lower risk in acquiring diseases of the metabolic syndrome (Drummond et al., 2011; Haidara et
al., 2011; Park et al., 2016; B. Patel et al., 2018). Additionally, in lean and obese human and
rodent models, increases in moderate physical activity lowers body weight and fat mass,
increases insulin sensitivity, and induces browning of white adipose tissue (Leal et al., 2018; P.
Lee et al., 2014; Nunan et al., 2013; Warburton et al., 2006). Nonetheless, the mechanisms
leading to exercise’s beneficial effects have not been fully elucidated. Recently, we showed
evidence that mice overexpressing catalase in a genetically obese background (Bob-Cat), in
contrast to the C56Bl6/WT mice, significantly lowered redox stress (‘stress-less’ mice),
improved energy metabolism, and modulated the expression of key adipocytokines (D. L. Amos
et al., 2017). In the present study, the effect of an eight-week moderate exercise intervention was
evaluated in the ‘stress-less’ Bob-Cat mice overexpressing catalase compared to WT and
sedentary controls. Results showed increased antioxidant levels within the ‘stress-less’ mice
maintained or decreased body weight and fat mass when put on exercise intervention.
Additionally, these novel mice maintained balanced energy metabolism, normal circadian
rhythm, and showed a trend for increased HDL and decreased plasma TG levels. Most
interestingly, we saw significant differences in skeletal muscle Type 1 / Type 2 fiber ratio and
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mRNA expression of key myokines which may have induced a change in adipose tissue function
via the skeletal muscle-adipose tissue axis (crosstalk). This study also provided evidence for an
exercise and redox-induced shift in the gut microbiome and a change in hypothalamic appetite
regulation as a mechanism of the beneficial impact of exercise on metabolic homeostasis in the
mice overexpressing antioxidant catalase.
Mice overexpressing catalase exercised on a mouse treadmill, in contrast to WT mice and
cohorts that remained sedentary for the 8 week study period, maintained or lowered body weight
and fat mass. This was to be expected due to the effects of exercise causing a deficit in energy
storage from increased energy output vs. input when the mice were sedentary (Fiuza-Luces et al.,
2013; Leal et al., 2018; Sanchis-Gomar et al., 2015) although other studies have not observed
significant decreases in body weight post-exercise. Nonetheless, pathways modulating energy
metabolism were significantly altered (Denou et al., 2016). It is also intriguing that in all groups,
with the exception of the Bob-Cat mice, catalase activity in adipose tissue was increased where
we also observed a loss in body weight or fat mass. Recent studies have indicated that exercise
combined with another anti-obesity intervention should be studied as a therapeutic method for
metabolic disease (Leal et al., 2018). Our data shows in relation to body composition,
endogenous overexpression of antioxidant and exercise may be an effective means of lowering
body weight and fat mass. In addition to decreases in body weight and fat mass within these
groups vs. the WT S group, it was interesting that the Bob-Cat E mice showed a trend for
increased lean mass compared to their sedentary cohorts and the WT S group. Increased lean
mass and lowering of fat mass would be indicative of a metabolically healthier body (Kelly,
Nehrenberg, Hua, Garland, & Pomp, 2011). Opposed to the beneficial effects seen in increased
antioxidant and/or exercise, the Ob/Ob group showed the most significant increases in body
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weight and fat mass. They also showed increases in lean mass, but this was likely only a
response to the increase in body size in general. Nonetheless, it is noteworthy that the Ob/Ob E
group did not have as severe obesogenic markers as their sedentary cohorts.
Because it has been found that there are different metabolic effects dependent on the
levels of SubQ vs. visceral adipose tissue (Bonomini et al., 2015; Harman-Boehm et al., 2007),
we also recorded the weights of each fat depot at the end of the 8 week study period during tissue
collection. Bob-Cat mice had similar levels of fat mass compared to their WT controls although
both sedentary and exercised [Tg(CAT)±] mouse groups showed decreased levels of fat mass in
comparison to the WT control groups. This was reflective of what was observed by analysis
using the ECHO-MRI. As expected, both Ob/Ob mouse groups had the highest measurements of
both adipose depots, but the exercised mice did not accumulate as much fat mass as their
sedentary cohorts. The higher levels of fat mass likely played a role in the higher levels of
oxidized carbonyl groups as was seen in the oxyblot conducted on adipose tissue. Liver weights
were also measured during tissue collection. Although not significant, Bob-Cat mice,
independent of exercise intervention, showed a trend for higher liver weight compared to the WT
control group. This was also seen in Bob-Cat mice when analyzed in our recent Omega 3
enriched dietary intervention study (D. Amos et al., 2019). Ob/Ob mice had a significantly lower
brain weight compared to every other group. In previous studies, neurodegeneration and
increases in chronic stress have been associated with lower brain mass (Lupien, McEwen,
Gunnar, & Heim, 2009; Stern, 2012). Therefore, it was surprising that the exercised [Tg(CAT)±]
mouse group had significantly lower brain weight compared to the WT S group since their
sedentary cohorts had a normal brain mass and exercise has been shown to positively impact
brain development, neurogenesis, and overall function (Delezie & Handschin, 2018; Jodeiri
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Farshbaf et al., 2016). Nonetheless, unlike the Ob/Ob group with a very large body size, the
[Tg(CAT)±] E group had a lower body weight, fat mass, lean mass, and other tissue weights
compared to the other mouse groups. Therefore, it is reasonable to assume that brain weight
would also be lower due to decreased body size in general. Body mass and fat/lean mass is
reflective of both diet and lifestyle. Food consumption over the study period showed that the
only group that consumed less chow than the WT control group was the sedentary [Tg(CAT)±]
mouse group. As shown in previous studies, exercise caused an increase in food intake over time
(M. Martin et al., 2016; Melzer, Kayser, Saris, & Pichard, 2005). Additionally, due to energy
expended during the physical activity, the exercised groups (except Ob/Ob mice) did not gain as
much weight or fat mass, compared to the WT S group.
In addition to body composition, another beneficial effect of exercise is improvement in
the lipid profile (J. Chen et al., 2018). All mouse groups, with the exception of the leptin
deficient, Ob/Ob mice, showed levels of TC lower than the detection limit of the kit (<100
mg/dL) as shown in Table 12. As expected, highest levels of TC were evidenced in the Ob/Ob
sedentary group with exercise showing a trend for lowering these levels in the exercised cohorts.
HDL and TG levels are markers of metabolic health (Coqueiro et al., 2019; Fiuza-Luces et al.,
2013; Sanchis-Gomar et al., 2015), where lower levels of HDL and higher levels of plasma TG
are associated with obesity and other metabolic disorders (Bonomini et al., 2015; Bryan et al.,
2013). As with previous research studies analyzing the effects of exercise, HDL levels were
significantly increased and plasma TG levels were lowered in the mouse groups overexpressing
catalase compared to the sedentary control group. However, specifically in the Bob-Cat S and E
mice, HDL was significantly higher. These groups also had significantly higher liver weights
than the WT control group (Table 11). It was also interesting that exercise increased the HDL
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level in every mouse group with the exception of the Ob/Ob mice (not significant). Although
HDL was highest among the Ob/Ob mouse groups, the TC was also very high. Previous studies
have shown that the ratio of HDL to TC is more indicative of metabolic health than looking
strictly at the level of HDL (Association, 2017; Coqueiro et al., 2019). In this case, it is evident
the Ob/Ob mice do not have a healthy lipid profile with regard to cholesterol levels. With regard
to TG levels, the [Tg(CAT)±] E mice displayed the lowest levels (p<0.05) as shown in Table 12.
This directly correlates with their low levels of adipose tissue compared to all the other mouse
groups. Exercise intervention not only lowered the TG levels (p<0.05), but the effect was
exacerbated in the mice overexpressing catalase. In addition to the lipid profile, we surprisingly
saw a trend for increased levels of plasma glucose within the exercised groups compared to their
sedentary cohorts. Typically, exercise lowers glucose levels (Fryer et al., 2002; Ikeda et al.,
2016). Nonetheless, with the exception of the Ob/Ob mice, all other mouse groups fell under the
normal range remaining well below 250 mg/dL (Collins, Martin, Surwit, & Robidoux, 2004).
Contrary to glucose levels, exercise significantly lowered plasma insulin levels. This did not
come as a surprise knowing that exercise is used as a therapy for T2D as a means of regulating
insulin levels (Golbidi & Laher, 2014; Phillips et al., 2015). Although levels were still high,
Ob/Ob mice subjected to exercise intervention had much lower levels than their sedentary
cohorts. Nonetheless, not having the parent group as an obese mouse model, the [Tg(CAT)±]
mice on exercise intervention had the lowest levels of plasma insulin relative to the sedentary
controls. One of the mechanisms involved in glucose and insulin homeostasis is through the
translocation of GLUT 4 transporters. Skeletal muscle uses this particular GLUT for
maintenance of energy and muscle integrity (Ikeda et al., 2016). With trends for an increase in
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skeletal muscle mRNA of this transporter in exercise groups (Table 14), it is plausible that
GLUT 4 was involved in the insulin lowering effects.
As an additional assessment of metabolic parameters, the CLAMS technology was
utilized to measure FI over a 48 h time period. In comparing the group averages, we saw a trend
for all exercised groups to consume more chow than their sedentary cohorts with the exception
of the Ob/Ob mouse group. Furthermore, mice overexpressing catalase had the highest levels of
intake among the groups when placed on an exercise regimen. This exercise effect is not
uncommon where exercised organisms typically consume more energy to provide for muscle
repair and to fuel the body during exercise (Melzer et al., 2005). However, it is more interesting
that there was a trend seen specifically for the mice overexpressing catalase to have the highest
food intake when their body weight, fat mass, and TG levels were lower than the WT mice on an
exercise or sedentary regimen indicating an increase in energy utilization (Figures 29&30 and
Tables 11&12). Additionally, CLAMS analysis can be indicative of normal eating patterns and
circadian rhythm which can change based on the frequency of food consumption (Sasaki, 2017).
It was surprising that the Ob/Ob mice did not significantly differ in the time period food was
consumed as had been observed in DIO mice in our previous study (D. Amos et al., 2019).
The CLAMS technology also measured the type of fuel primarily oxidized for energy
production. RER measurements showed exercised mice within each genotype had an increase in
the use of carbohydrates vs. fat for energy (p<0.05) compared to both the WT S group and their
sedentary cohorts (Figure 34). This was not expected, as exercise typically increases fat
oxidation in low intensity and moderate exercise (Ramos-Jiménez et al., 2008). However, most
interesting was the differences observed between [Tg(CAT)±] and Bob-Cat mice on exercise
intervention. [Tg(CAT)±] E mice showed the highest RER levels (p<0.0001) independent of the
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light or dark cycle and thus the lowest levels of fat oxidation. Bob-Cat E mice, on the other hand,
had increased levels of RER and CHO oxidation compared to their sedentary cohorts yet retained
similar RER levels to the WT S group on average. Another novel finding was the Bob-Cat S
mice had one of the highest levels of fat oxidation compared to all other groups. Ob/Ob mice
showed results consistent with the previous literature compared to leaner phenotypes of mice
where their RER was significantly higher due to their increased sedentary lifestyle and/or
availability of fat to be taken from storage and oxidized for energy (Hirsch et al., 2016). These
combined results provide evidence for an exercise and/or antioxidant effect on fuel utilization
uncommon to previous data derived from exercise studies. Mechanisms behind this result may be
indicative of alternate signaling pathways utilizing increased levels of carbohydrates.
In addition to the type of fuel utilized, systemic energy expenditure also plays a role in
overall energy metabolism. CLAMS technology indirectly measures the EE of mice which is
then used to compare the mouse groups based on the Cal/h/g of lean body mass. Additionally,
the physical activity level (XAMB) was measured which also contributes to the energy output.
We observed that exercised mice, with the exception of the Ob/Ob E group, had decreased levels
of EE compared to the WT S group during both light and dark cycles. It was more interesting to
see that the lowest levels were among the mice overexpressing catalase on exercise regimen.
This is not uncommon for organisms with lower body mass expending energy through physical
exercise. If the body reaches lower levels of fuel, it will begin to decrease energy used by the
body as a means of being more fuel efficient. This concept, now termed “metabolic flexibility,”
may be what was observed in these exercised mouse groups (Goodpaster & Sparks, 2017).
During the CLAMS analysis, all mouse groups overexpressing antioxidant showed trends of
higher physical activity (XAMB) compared to WT controls with the exception of the
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[Tg(CAT)±] E group. This phenomenon is often observed in exercised organisms (de Carvalho,
Benfato, Moretto, Barthichoto, & de Oliveira, 2016). It is expected that it is due to the body
being fatigued after the increased muscle movement/contraction during the exercised regimen
resulting in lower levels of movement as a result. Nonetheless, this was not the case for the BobCat exercised group. Ob/Ob mice had the lowest levels of physical activity (p<0.05) independent
of exercise intervention as well as the time of day compared to every other mouse group. This
was expected as it would take much more effort for these groups to move across the cage with
their high body weight. The combined data derived from the CLAMS technology, body
composition, and lipid profile provides compelling evidence of an antioxidant and exercise effect
on metabolic pathways in this novel mouse model.
With exercise-induced alterations in metabolic signaling pathways and energy
metabolism, we investigated muscle fiber type and measured the expression levels of key
myokines and adipokines involved in energy metabolism within each mouse group and found
intriguing results. Exercise improves muscle function and strength (Vina et al., 2012). Although
we did not observe differences in grip strength or muscle weight at tissue collection as a result of
exercise intervention or antioxidant overexpression, we did observe significant differences in
Type 1 / Type 2 fiber ratio and myokine levels in the gastrocnemius muscle. It is possible that
the differences of the expression levels of the key myokines analyzed may be due to the higher
levels of Type 1 fibers in comparison to Type 2 fibers (Figure 37) within the gastrocnemius
muscle. Specifically, we observed increased levels of FGF-21, PGC1-alpha, and FNDC5 within
the exercised mice overexpressing antioxidant catalase compared to the sedentary WT control
group. It was also within these antioxidant-overexpressing mouse groups where we observed the
highest levels of Type 1 / Type 2 fiber ratios (Table 14 and Figure 37). It is also interesting to
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note that within these mouse groups there was a trend for increased catalase activity in the
skeletal muscle tissue compared to the sedentary control group (Figure 38). We also observed an
induction in GLUT 4 in the exercised mouse groups which may have played a role in the
lowered insulin levels observed within the mice on exercise intervention compared to their
sedentary littermates. Another myokine we investigated was IL-6. Although not significant, we
observed a trend for increased expression in both mouse groups overexpressing catalase, with an
exacerbated effect observed in the [Tg(CAT)±] E group (>2.5 fold induction). Further
exploration should be conducted to determine if this played an anti-inflammatory role in the
skeletal muscle tissue.
With exercise intervention and redox playing a role in lowering fat mass, enhancing the
lipid profile, and altering energy metabolism (measured by CLAMS) within the novel
antioxidant mouse model, we expected one factor that might be involved in these observed
changes was the induction of the redox sensitive and exercised-induced myokine, FGF-21
(Gomez-Samano et al., 2017; Raschke & Eckel, 2013). We showed FGF-21 mRNA levels in the
skeletal muscle of [Tg(CAT)±] E and Bob-Cat E models had a > 8 fold (p<0.01) and 3 fold
increase (not significant) respectively. FGF-21 not only modulates skeletal muscle function, but
it also crosstalks with adipose tissue (Keipert et al., 2014). Research has shown FGF-21 is able to
induce browning by upregulation of UCP-1 (Fisher et al., 2012; P. Lee et al., 2014). Within
adipose tissue, we observed a 5 fold increase in UCP-1 mRNA expression in the Bob-Cat E mice
(not significant) yet a significant decrease in the [Tg(CAT)±] E mouse group. This may have
been reflective of the loss of fat mass observed in the [Tg(CAT)±] E group, while the Bob-Cat E
group did not actually lose any grams of fat over the 8 week intervention. Furthermore, the
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induced expression of UCP-1 could have also been reflective of the increased mRNA expression
of FGF-21 within the adipose and skeletal muscle tissue of the Bob-Cat E mouse group.
FGF-21’s interplay with adiponectin (Manole et al., 2018), an anti-inflammatory
adipokine that has been shown to be reduced in obese individuals, seems to be observed in our
study as well. In exercised groups of mice, where there were increased levels of skeletal muscle
FGF-21, adiponectin was also increased (p<0.05) providing further evidence of crosstalk
between skeletal muscle and adipose tissue.
Two other key myokines, PGC1-alpha and FNDC5, may have influenced the phenotype
observed in the antioxidant mouse models on exercise intervention. PGC1-alpha as well as
FNDC5 (p<0.05), which are known to be induced by exercise showed a trend for increased fold
change in mouse groups subjected to exercise intervention compared to the control WT S group
and their sedentary cohorts. Previous studies have shown increased plasma irisin levels are a
result of the induction of FNDC5 (Huh et al., 2012) and have a profound effect on browning of
adipose tissue (Leal et al., 2018). However, we were surprised to find no significant differences
in circulating plasma irisin levels between the mouse groups (Table 14). This could have been a
result of the time the analysis took place. It is possible there was a significant increase in irisin
immediately after exercise, but the blood in our study was collected after the mice had been
sedentary for multiple hours since their last bout of exercise. Additionally, as described in the
methods, we used an ELISA kit for human irisin. A few recent articles have noted false results in
detection of irisin within these ELISA kits (Albrecht et al., 2015; Perakakis et al., 2017).
Therefore, with the interesting results of UCP-1 in adipose tissue and alterations in body weight
and fat mass, further studies should be done on irisin, such as measurement immediately post
exercise or staining and analysis of morphology of adipose tissue. With these limitations to our
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analysis of irisin, it is still possible that in addition to FGF-21, exercise-induced myokine
signaling through the PGC1-alpha/FNDC5/irisin pathway modified adipose tissue function
resulting in a leaner mice phenotype in the antioxidant overexpressing mice.
It is known that specific adipokines, such as leptin, influence satiety through the
activation of hypothalamic appetite-regulating neurons (J. Friedman, 2016). Nonetheless, we did
not observe significant differences in adipose mRNA or circulating leptin levels. We also
measured expression levels of the leptin receptor (LepR), located within the appetite regulating hypothalamic region of the brain (Abella et al., 2017). LepR was interestingly increased in every
mouse group in comparison to the WT S mice except the [Tg(CAT)±] E and Bob-Cat E groups.
Nonetheless, with significant differences in body weight, fat mass, and metabolic parameters of
exercised mouse groups overexpressing antioxidant we further evaluated expression levels of the
appetite regulating genes NPY and POMC. With all exercised groups having a decreased fold
change in NPY mRNA expression and increased expression of POMC (some groups did not
quite reach significance), the result would be increased satiety and metabolism through
dissipation of heat thus decreasing body weight/fat mass. These results provide evidence that in
the [Tg(CAT)±] E and Bob-Cat E mouse groups, metabolic pathways other than those regulated
by leptin signaling likely contributed to the observed differences in body parameters,
metabolism, and appetite regulation.
We also measured the expression levels of BDNF within the hypothalamic region, which
has been shown to be induced by exercise (Walsh et al., 2018). Interestingly, one signaling
mechanism involved may be through PGC1-alpha and FNDC5 signaling (Jodeiri Farshbaf et al.,
2016), which is also a pathway involved in the skeletal muscle-brain axis. Additionally, in
relation to obese humans and rodents, upon activation, BDNF has been associated with
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cognition, neuroplasticity, glucose regulation, fat oxidation, and appetite regulation in adults
(Budni, Bellettini-Santos, Mina, Garcez, & Zugno, 2015; Walsh et al., 2018). In comparison to
the WT S group, the highest levels were seen in the Bob-Cat S mouse group. However, there was
also a slight increase in the Bob-Cat E group (not significant) and almost a 3-fold increase in the
[Tg(CAT)±] E group. This warrants further study to determine whether the synergistic effects of
antioxidant catalase and exercise may promote increased neuroplasticity in the novel mouse
model. If so, the Bob-Cat model is potentially useful to study neurodegenerative diseases such as
Alzheimer’s Disease (Budni et al., 2015), or mood disorders including schizophrenia and
depression (Peng, Li, Lv, Zhang, & Zhan, 2018).
Due to differing phenotypic and metabolic data in addition to appetite regulation
modifications likely not related to the key satiety hormone leptin, we chose to investigate
alternative pathways that may play a role in satiety in the exercised ‘stress-less’ mouse groups.
The gut microbiome is considered an endocrine organ (G. Clarke et al., 2014) that is altered by
exercise (Barton et al., 2018; Denou et al., 2016; Estaki et al., 2016; Monda et al., 2017) and has
been shown to be significantly different in obese vs. lean individuals (Turnbaugh et al., 2009)
and rodents (Kallus & Brandt, 2012) due to its functional roles on energy metabolism through
crosstalk with other metabolic tissues. Post fecal collection, sequencing, and analysis of the gut
microbes of the various mouse groups, we observed significant shifts in the microbiome.
Although we only saw slight differences in the alpha diversity (species richness) between
respective cohorts, highly significant differences in β diversity (microbial composition) were
seen among exercise and sedentary groups, as well as mice overexpressing catalase on sedentary
or exercise regimen (ANOSIM p<0.05). Furthermore, LEfSe analysis of the various taxa were
plotted displaying significantly enriched bacterial taxa within the respective sedentary and

221

exercised cohorts. Analysis of microbial enrichment within the genotypes, of the sedentary and
exercised groups separately, showed within the sedentary C57/WT and Bob-Cat cohorts, at the
Phyla taxonomic level, there was an enrichment of Firmicutes vs. Bacteroidetes. This is
consistent in the literature for both sedentary humans and animals to have an enrichment of
Firmicutes vs. Bacteroidetes. This enrichment in Firmicutes is also common in DIO or
overweight/obese organisms vs. the lean phenotype (Ley et al., 2005; Ley et al., 2006; Savini et
al., 2013; Turnbaugh, Backhed, Fulton, & Gordon, 2008; Turnbaugh et al., 2009; Turnbaugh et
al., 2006). Both sedentary mouse groups overexpressing catalase ([Tg(CAT)±] and Bob-Cat)
showed an enrichment of both the Rikenellaceae and Helicobacteraceae where the family of
Rikenellaceae is associated with a lower BMI and healthier metabolic state compared to obese
organisms (Clarke et al., 2013; Ottosson et al., 2018). The family Helicobacteraceae is classified
as pathogenic (van der Mee-Marquet et al., 2017). Few studies have associated its prevalence
with respect to parameters associated with obesity or its comorbidities, but Schulz et. al reported
an increased abundance within mice who had been transfected with feces from cohorts fed a
HFD (Schulz et al., 2014). This increase may have been associated with the increased levels of
antioxidant within these mouse groups. Additionally, the sedentary Bob-Cat and Ob/Ob mouse
groups were both enriched with Weeksellaceae and Erysipelotrichaceae. Weeksellaceae is
pathogenic and associated with Irritable Bowel Syndrome (IBS) in humans and primates as well
as rat visceral pain (Fourie et al., 2017), but no studies have specifically looked at its relevance to
obesity. Additionally, there was an enrichment in the family Erysipelotrichaceae. This was of
particular interest because of evidence from the literature showing a bloom of species belonging
to this family in diet-induced obese animals (Turnbaugh et al., 2008). Other studies have also
seen higher levels of this family in obese individuals and individuals producing higher levels of
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the SCFA butyrate (Kaakoush, 2015; H. Zhang et al., 2009). With both sedentary groups having
a leptin deficient background (heterozygous or homozygous for the mutation of the satiety
hormone leptin) showing an enrichment, it is plausible there may be an association between this
family and leptin levels. As with the sedentary groups, we also analyzed taxa enrichment
between genotypes that were exercised. Exercised [Tg(CAT)±] and Bob-Cat mice were both
enriched with the Helicobacteraceae, while both the C57/WT and Ob/Ob mice were enriched
with Rikenellaceae. Additionally, it was interesting to find that the [Tg(CAT)±] E mice were
enriched with the Bifidobacteriaceae which has been shown to be increased with exercise
intervention and enriched in lean male mice (Munukka et al., 2018; Y. Qin et al., 2018). These
results provided evidence of a synergistic effect of antioxidant and exercise on the gut
microbiome as was hypothesized. It is of great interest in future studies to further explore species
of the family Helicobacteraceae in relation to redox stress since there were significant
differences in abundance comparing the exercise and sedentary cohorts in mice overexpressing
catalase.
In addition to genotype comparisons within the sedentary and exercise groups, we also
compared the enrichment of specific taxa between sedentary genotypes and their exercised
cohorts individually. Within the C57/WT groups, exercise shifted the microbial taxa toward an
enrichment of the Corynebacterium, Proteus, Enterococcus, and Desulfovibrio, at the genus
level compared to their sedentary cohorts. At present little data has been published with the
relevance of Corynebacterium or Proteus with parameters related to obesity, but many studies
have shown that Enterococcus is associated with gut dysbiosis and depletion of commensal gut
microbes which can decrease microbial diversity (Dubin & Pamer, 2014; Scotti et al., 2017). The
genus Desulfovibrio of the family Desulfovibrionaceae has been associated with increased
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voluntary exercise and may play a role in mucin function and gut permeability (T. W. Liu et al.,
2015). Additionally, the family in its entirety has been found to be of higher prevalence in lean
as well as healthy individuals (Million et al., 2012) in addition to the genus Desulfovibrio (Zietak
et al., 2016). Within the [Tg(CAT)±] groups, we found exercise shifted the microbiome with
evidences of enriched taxa Desulfovibrionaceae and Aeromonadaceae at the family level. No
taxa were defined to be significantly different between the exercised and sedentary mice of the
[Tg(CAT)±] genotype. As previously described, Desulfovibrionaceae has been associated with
leanness (Million et al., 2012). It is of interest that the sedentary group was enriched and the
exercised group was depleted of the family Aeromonadaceae which is a known human pathogen
(Eid et al., 2017), has been associated with increased risk for the development of atherosclerosis,
and is more abundant in T2D patients (F. Wu et al., 2019). It was of special interest that the
novel Bob-Cat mice showed the largest number (42) of significantly differential taxa between the
sedentary and exercise cohorts in comparison to the other genotypes. This finding indicates
exercise as having a profound effect within the Bob-Cat genotype. Bob-Cat sedentary mice were
enriched in Methanobrevibacter, Chryseobacterium, Butyrivibrio, and Bilophila in comparison
to their exercised cohorts. Exercised Bob-Cat mice had significantly higher levels of
Parabacteroides, Prevotella, Ruminococcus, Sutterella, and Akkermansia. With relevance to
obesogenic characteristics, Methanobrevibacter has been negatively correlated with BMI
(Million et al., 2012) and reduced in obese individuals (Stenman, Burcelin, & Lahtinen, 2016).
Chryseobacterium has not been well studied, but we do know it is catalase-positive and part of
the normal flora (Calderón et al., 2011). Butyrivibrio has been found in individuals with a
healthier physical state and higher microbial diversity (Stenman et al., 2016), but contrary to the
previously mentioned taxa enriched in the Bob-Cat sedentary groups, the Bilophilia which is
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almost depleted in the exercise cohort of Bob-Cat mice is associated with increased body weight,
adiposity, insulin, leptin, and inflammatory markers. Additionally, Bilophila are LPS‐producing
bacteria that theoretically could contribute to inflammation associated with obesity (Mulders et
al., 2018). It was most interesting that the exercised Bob-Cat mice were enriched with taxa that
did not have significant associations with increased fat mass or obesity. Parabacteroides were
one of the five most significantly enriched taxa. Parabateriodes have been associated with a
healthy host and gut environment (Fourie et al., 2017). The genus Prevotella have been
positively correlated with SCFA propionate levels (Riva et al., 2017), which are typically
increased with exercise and generation of enzymes found to be involved in mucin
oligosaccharide degradation which protects endothelial cell wall against pathogens (Riva et al.,
2017). It is also interesting that this genus was recently associated with non-westernized
populations that were hunter-gatherers (healthier and characterized with a more active lifestyle
than Westernized nations) (de la Cuesta-Zuluaga et al., 2018). The genus Ruminococcus has been
negatively correlated with fasting glucose levels in humans, but as of yet, no studies have shown
significant differences in other obesogenic parameters (Mulders et al., 2018). Suterella were
enriched in a study comparing DIO to lean rodents (Clarke et al., 2013). Unlike the other taxa
previously mentioned, the genus Akkermansia have been studied intensely. They are associated
with a healthy gut microbiome in numerous studies. They are typically more abundant in
individuals who are physically active/athletes in addition to being associated with individuals
possessing a healthier metabolic profile (S. F. Clarke et al., 2014; Lai et al., 2018; Mach &
Fuster-Botella, 2017). Additionally, Akkermansia are enriched in subjects with a low BMI and
correlated with improvements in gut barrier function (G. Clarke et al., 2014). Also, a study
conducted by Fourie et al. showed that epithelial inflammation, IBD, obesity, and diabetes are
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decreased when there is a restoration of this genus (Fourie et al., 2017). Overall, a recent review
has surmised the characteristics of Akkermansia to being negatively correlated with adiposity,
fasting glucose, insulin, IR, leptin, inflammation, and intestinal permeability (Mulders et al.,
2018). With these particular taxa being significantly enriched in the exercised Bob-Cat mouse
group, this strengthens our hypothesis that the combination of exercise and overexpression of
antioxidant is beneficial to the metabolic profile by positively shifting the gut microbiome.
We saw that the sedentary, obese Ob/Ob mice were enriched with taxa associated with
obesogenic parameters. For example, Anaeroplasma, have been positively associated with DIO
in mice and correlated with lower production of the SCFA butyrate which can exacerbate gut
dysbiosis (Hwang et al., 2017). Additionally, there was increased abundance of the taxa
Weissella, which have been correlated with decreased cardiovascular function and increased BW
(Sherman et al., 2018). These taxa were depleted within the exercised Ob/Ob mouse group.
Within the exercised cohort, we found an enrichment of the Lachnospiraceae family, which are
butyrate producing organisms shown to be significantly depleted within diabetic mice on high fat
diets (Serino, Chabo, & Burcelin, 2012). Depletion of these organisms have been associated with
gut barrier disruption, metabolic endotoxemia, and low-grade inflammation leading to other
debilitating diseases (Vital, Karch, & Pieper, 2017). Additionally, we found exercise caused an
enrichment in the taxa Prevotella and Sutterella at the genus level. Prevotella, as previously
mentioned, is associated with an increase in SCFA propionate, improvement in gut health, and
increased in the hunter-gatherer human population (de la Cuesta-Zuluaga et al., 2018; Riva et al.,
2017). Also previously mentioned, and not completely characterized, the Sutterella taxa, have
been found to be enriched in lean vs DIO mice (Clarke et al., 2013). This is interesting where we
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also saw “leaner” phenotypic characteristics in our Ob/Ob exercised mice vs. their sedentary
littermates.
With regard to appetite regulation in the context of the gut microbiome, it is also
interesting that previous studies have shown associations between butyrate levels and the brain.
For example, acute butyrate administration decreased food intake and suppressed orexigenic
neurons that express NPY within the hypothalamic region of the brain (Z. Li et al., 2018), and
chronic butyrate administration prevented DIO, hyperinsulinemia, hypertriglyceridemia, as well
as reduced food intake (Z. Li et al., 2018). Exercise has been shown to increase butyrate
production by the gut microbiome (Lai et al., 2018; Matsumoto et al., 2008). Our findings
showed that the antioxidant models overexpressing catalase put on exercise intervention had
higher levels of Bifidobacteriaceae, Suterella, and Akkermansia which either produce butyrate or
are associated with higher levels of the SCFA (Rivière et al., 2016; J. Ye et al., 2018).
Additionally, Bob-Cat sedentary mice were enriched and exercisers were depleted of Bilophila
and Rikenellaceae (also observed in the [Tg(CAT)±] E group) which thrive in environments of
low levels of butyrate (J. Ye et al., 2018). It was also particularly interesting that the lowest
levels of NPY and highest levels (although not all significant) of POMC expression were found
in the exercised cohorts of each genotype (Table 16). Also interesting is the fact that butyrate
has been associated with lowering TG levels. This also correlates with our findings that the
exercised mice overexpressing antioxidant catalase had lower levels of plasma TG compared to
their sedentary control groups as shown in Table 12.
All of the described significant associations of microbes to particular mouse groups are
extremely interesting; nonetheless, it is the gut microbiome as a whole and the interaction
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between the various microbes that determines the impact on the host organism’s metabolism
(Heiss & Olofsson, 2018; Kreznar et al., 2017).
PICRUSt analysis allowed us to predict the function of the microbiome based on the
species found most prevalent within each mouse group. It was interesting that the lowest number
of functional differences as a result of exercise was found in the C57/WT group analysis, and the
Ob/Ob group only had 12. On the contrary, mice overexpressing catalase, the [Tg(CAT)±] and
Bob-Cat, had 29 and 118 significantly differential functional predictions respectively. This is an
indication that exercise in conjunction with catalase overexpression, is contributing a strong
effect on the functional potential of the microbial community in these groups and is likely
contributing to metabolic pathways related to the phenotypic changes we saw in our study. From
our findings, it was most interesting to discover that within the Bob-Cat sedentary group, several
functional pathways relating to cell motility were enriched including flagellar assembly, bacterial
motility proteins, and bacterial chemotaxis. On the other hand, within the exercised samples, we
observed an enrichment of glycan biosynthesis in addition to bacteria capable of LPS
biosynthesis. Glycan biosynthesis was also enriched within the [Tg(CAT)±] exercised samples in
addition to bacteria capable of glycan degradation. These findings align with recent studies
conducted by Hou et. al (Hou et al., 2017) where PICRUSt analysis showed, in obese
individuals, there were elevated counts of bacterial chemotaxis and depletion of glycan
metabolism and biosynthesis. This finding impeccably aligns with our novel Bob-Cat mice
where the exercised samples showed evidence of an elevation in glycan metabolism and
biosynthesis, and sedentary samples showed an enrichment in bacterial motility genes. Although
in many studies lipopolysacharrides (LPS) are associated with negative health biomarkers, it is
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dependent on which LPS are produced and the other microbes present (some microbes that
produce LPS are beneficial to the microbial environment) (Kreznar et al., 2017).
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4.5 CONCLUSION
In this study, we comprehensively compared the synergistic effects of exercise and
antioxidant overexpression in a novel mouse model. We hypothesized that the combined effects
of catalase overexpression and exercise may play a role in body composition and energy
metabolism by altering myokine and adipokine secretion and shift the diversity and composition
of the gut microbiome. As expected, exercise significantly attenuated weight gain and decreased
fat mass in each mouse genotype, with an exacerbated effect in the mice overexpressing
antioxidant catalase. At the tissue level, known exercised-induced myokines were upregulated
and showed evidence for crosstalk between skeletal muscle and adipose tissue. Additionally, we
saw changes in appetite regulating hormones which may have played a role in changes in the
phenotypic and metabolic data determined in the antioxidant mouse models subjected to
moderate treadmill exercise. Nonetheless, our most interesting and novel findings were
discovered in our analysis of the gut microbiome. We saw shifts related to differences in the
mouse groups based on exercise vs. sedentary intervention in addition to redox status. These
findings mandate further studies on the role of redox stress and exercise in energy homeostasis
by further correlating metadata to microbial species and conducting fecal transfer to determine if
the gut microbes from our novel mouse model alter phenotypic and metabolic characteristics in
other mouse models with chronic diseases (Ex. DIO, neurodegenerative models, cancer models,
etc.)
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CHAPTER V: DISCUSSION AND FUTURE DIRECTIONS
DISCUSSION
At the conclusion of my research of the aforementioned studies discussed in Chapters IIIV, I am just as interested now as when I began my research regarding the complexity of energy
metabolism and how it is regulated by so many extrinsic variables such as diet, exercise,
genetics, and other environmental stimuli. I still desire to discover an efficient lifestyle, for
myself and others, to maintain physical health among living in the most obese state (West
Virginia). Obtaining knowledge to prevent or reduce the rising levels of obesity, a key risk factor
for metabolic tissue dysfunction, redox stress, and thus chronic inflammatory and
cardiometabolic diseases, remains important to me.
At the beginning of my research as a PhD student, I studied numerous investigations
conducted in other laboratories, in addition to our own laboratory, showing evidence of redox
stress impacting diseases related to metabolic tissue dysfunction and inflammatory signaling. By
doing this, I saw the critical need to further explore the role of antioxidants as a therapeutic
intervention. Our lab desired to determine the role of one of the key antioxidants, catalase, which
is directly involved in energy metabolism. To accomplish our goal, we engineered a novel mouse
model expressing the human antioxidant catalase in addition to mouse catalase with an obese
parent background (D. L. Amos et al., 2017). From this point, we developed three hypotheses: I.
modulating redox stress by altering endogenous antioxidant content (overexpression of catalase)
alone would enhance adipose tissue function, glucose and lipid signaling, and overall energy
metabolism; II. modulating redox stress by antioxidant overexpression or dietary intervention
with an enriched OM3 diet (45%) vs. a HFD (45% lard) would positively regulate fatty acid
signaling, glucose and lipid homeostasis, energy metabolism, and overall metabolic function; III.

232

antioxidant overexpression in addition to exercise would both enhance skeletal muscle and
adipose tissue function, alter appetite signaling, and shift the composition and function of the gut
microbiome thus improving overall energy metabolism in the ‘stress-less’ mice. To address our
first hypothesis (Chapter II), we investigated both male and female ‘stress-less’ mice and found
that the novel mouse model had significant differences in energy expenditure, activity levels,
metabolic profile, and oxidative stress levels compared to the other genotypes studied
(C57Bl6/WT, [Tg(CAT)±], and Ob/Ob). Additionally, we also showed evidence of sexual
dimorphism, which suggests more studies should be conducted in both male and female genders
separately to better treat the population in a manner that specifically targets an individual’s
abnormalities. Additionally, in generating the Bob-Cat mice, being heterozygous for the Ob
mutation (Ob/+) in combination with the expression of the human catalase gene, we generated a
few mice that were homozygous for the Ob mutated gene and expressed the human catalase
gene. This new genotype was titled “Big Bob,” and its basic characteristics were also discussed
in Chapter II. The intriguing characteristics of the Bob-Cat mice kindled our desire to explore the
potential of coupling antioxidant catalase with other therapeutic interventions to study
mechanisms involved in regulating energy metabolism.
Since redox stress plays a key role in obesity and cardiometabolic diseases, and a
common treatment is dietary intervention, we tested our second hypothesis using male and
female mice overexpressing endogenous antioxidant catalase to study the impact of altered redox
balance and an enriched OM3 diet (D. Amos et al., 2019). As discussed in Chapter III, we
discovered that after eight weeks of OM3 dietary intervention in the novel mice, compared to
their littermates on HFD, the mice fed OM3 diet maintained or lowered body weight and fat
mass, enhanced energy metabolism, maintained normal circadian rhythm, and sustained insulin
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sensitivity. Our data showed these results were all due to the regulation of GPR120-Nrf2 crosstalk, which to our knowledge, had not been previously shown in any other studies. This study
advanced the field of nutrition and in a direction showing the potential therapeutic capacity of
overexpression of antioxidants. Additionally, we also saw sexual dimorphism play a role in the
metabolic parameters assessed. Further investigation should be conducted on this topic to
determine the mechanisms behind these differences.
With exercise being another major remedy to counteract metabolic diseases, we
addressed our third hypothesis and studied the impact of a 30 min. exercise regimen, 5 days a
week, for 8 weeks in the ‘stress-less’ mouse model. Here, we showed increased antioxidant
levels in the catalase over-expressing mice maintained or decreased body weight and fat mass.
Additionally, the novel mice maintained balanced energy metabolism, normal circadian rhythm,
and showed a trend for increased HDL and decreased plasma TG levels. Most interestingly, we
saw significant differences in skeletal muscle Type 1 / Type 2 fiber ratio and mRNA expression
of key myokines which may have caused a change in adipose tissue function by a skeletal
muscle-adipose tissue axis (crosstalk). This study provided additional knowledge to the field
with evidence of an exercise and redox-induced shift in the gut microbiome and a change in
appetite regulation as a mechanism of the beneficial impact of exercise on metabolic homeostasis
in the mice overexpressing antioxidant catalase, as discussed in Chapter IV. With the results
from each of the studies outlined in Chapters II-IV, it is evident our hypotheses were correct.
Antioxidant catalase functions as an adjuvant to OM3 diet or exercise to enhance metabolic
tissue function and improve overall energy metabolism in the novel ‘stress-less’ mouse.
Additionally, antioxidant overexpression shifted the composition and function of the gut
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microbiome, which was further shifted with exercise, showing potential for impacting the
alterations seen in the body composition and metabolic measurements we collected.
In conclusion, with the newly generated Bob-Cat mice, we have successfully identified
key ways this model can be used to study the impact of altered redox in the context of energy
metabolism, cancer, and other chronic illnesses mandating new therapies to counter their
detrimental effects on the human population. Although we have clearly shown the benefits of
overexpressing catalase in mice with an obese-parent background (Bob-Cats) when provided an
OM3 rich diet or put on exercise intervention, many future projects have been devised and some
are already underway. By continuing our investigation, we believe that the Bob-Cat model has
the potential to lead to the development of therapies that will reverse the rising levels of obesity,
cardiometabolic diseases, chronic inflammatory conditions, in addition to altering signaling
pathways involved in the development and progression of cancer and neurological-related
disorders.
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FUTURE DIRECTIONS
The Role of FGF-21 as a Hepatokine
In both our diet study and exercise study, we assessed expression levels of FGF-21, a
myokine, adipokine, and hepatokine (Gomez-Samano et al., 2017) that can be induced as a result
of redox imbalance, exercise intervention, cold stimulus, and starvation (Cuevas-Ramos et al.,
2012; Gomez-Samano et al., 2017; Potthoff et al., 2009). With its pleotropic effects on glucose
and lipid homeostasis, thermoregulation, inflammation, and energy metabolism in general, we
wanted to determine if it played a role in the interventions studied in the Bob-Cat mouse.
Specifically, our results showed evidence of sexual dimorphism as well as inversed levels of
FGF-21 within HFD vs. NC groups overexpressing catalase as described in Chapter III and
shown in Figure 28. Additionally, with exercise intervention, we showed an induction in
skeletal muscle tissue in male mouse groups overexpressing catalase which may have
contributed to an induction of adiponectin in the adipose tissue and differences in expression of
UCP-1 thus stimulating thermogenesis. We have yet to assess female mice, which may show
different results due to an interplay with differing hormone levels such as leptin and various sex
hormones. In the current literature, research has indicated the possibility of “FGF-21-resistance”
in obese individuals where FGF-21 levels are high yet FGF-21’s known effects are absent. With
the strong association between redox stress and obesity, and FGF-21 yet to be assessed in the
context of the liver, where it is primarily secreted, further analysis of this hormone is of great
interest.
Assessment of the Gut Microbiome
In our studies of the ‘stress-less’ mouse subjected to exercise intervention, we analyzed
the gut microbiome and found that exercise significantly shifted the microbial composition and
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function in the mice that overexpressed antioxidant catalase. At the current time, we have only
assessed exercised male mice. However, to further the knowledge in the field of microbiology
and redox homeostasis, we would like to also determine the effects of an enriched OM3 diet in
both genders in addition to an assessment of exercise effects on the microbial species in female
mice. Additionally, we have only began to explore the effects of redox in the novel male mouse
and its relation to the gut microbiome. We plan to do further analysis using the metadata we have
collected, and, if appropriate, begin deep sequencing to determine the signaling pathways
causing the noted shifts in the microbial species and how that affects systemic energy
homeostasis in metabolic tissues. Additionally, we plan to use the method of fecal transfer from
mice overexpressing antioxidant on various mouse models to determine if the core species
residing in their gut can produce the same metabolic effects (Ex. decreased body weight, fat
mass, TG levels, etc.).
Aging Studies
Analysis of the generation of the original [Tg(CAT)±] mice (X. Chen et al., 2003) in
addition to tissue-targeted catalase transgenic mice in other studies showed that these mice
displayed anti-aging effects (H.-Y. Lee et al., 2010; Linford, Schriner, & Rabinovitch, 2006).
Therefore, to determine if our novel mouse which overexpresses antioxidant catalase
ubiquitously (D. L. Amos et al., 2017) would confer the same effects, multiple studies have been
conducted in concert with exercise intervention. Our current status is at the analysis of key
signaling pathways in the context of aging and energy metabolism, since as organisms grow
older there is typically a decline in metabolism, regulation of adipose storage, and dysfunction of
skeletal muscle function (Shimokata & Kuzuya, 1993). We expect that by decreasing the level of
free radicals through an induction of antioxidant catalase, the aging process will be allayed. If
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our hypothesis is true, we would like to determine if the gut microbiome of the mice
overexpressing catalase, which we have shown to be significantly shifted in our studies (Chapter
IV) could potentially play a role in any anti-aging effects observed.

Behavioral Analysis
Obesity increases the risk for the development and progression of cardiometabolic
diseases, diabetes, and cancer (Goossens, 2017; Manna & Jain, 2015) in addition to promoting
behavior modifications (Singh, 2014). This includes excess food consumption in addition to
stress, and depression which is commonly observed in individuals with high levels of adiposity
(Sominsky & Spencer, 2014). Therefore, we desire to determine if lowering oxidative stress by
increasing antioxidant catalase using our ‘stress-less’ mouse model would lower obesityregulated behavioral stress.
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APPENDIX B: LIST OF ABBREVIATIONS
IR

Insulin Resistance

T2D

Type 2 diabetes

NAFLD

Non-alcoholic fatty liver disease

BMI

Body mass index

CVD

Cardiovascular disease

POMC

Proopiomelanocortin

NPY

Neuropeptide Y

WAT

White adipose tissue

BAT

Brown adipose tissue

UCP-1

Uncoupling protein 1

TNF-alpha (α)

Tumor necrosis factor alpha

IL-6

Interleukin 6

MCP-1/JE

Monocyte chemotactic protein 1

LepR

Leptin receptor

ARC

Arcuate nucleus

IL

Interleukin

H2O2

Hydrogen peroxide

NADPH

Nicotinamide adenine dinucleotide phosphate hydrogen

ESR

Electron spin resonance

O.S.

Oxidative Stress

Ox-LDL

Oxidatively modified low density lipoprotein

AAOP

Arachidonic acid oxidation product
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TBARS

Thiobarbituric acid reactive molecules

Nrf2

Nuclear factor erythroid 2-related factor 2

Keap1

Kelch like ECH associated protein 1

SOD

Superoxide dismutase

GPX

Glutathione peroxidase

TAC

Total antioxidant capacity

LDL

Low-density lipoproteins

ROS

Reactive oxygen species

RNS

Reactive nitrogen species

TG

Triglyceride

ATP

Adenosine triphosphate

TCA

Tricarboxylic acid

NADH

Nicotinamide adenine dinucleotide

FADH

Flavin adenine dinucleotide

ER

Endoplasmic Reticulum

MetS

Metabolic syndrome

HDL

High-density lipoproteins

PI3k

Phosphatidylinositol 3-kinase

Akt

Protein kinase B

NO/NOX

Nitric oxide

mTOR

Rapamycin

SFA

Saturated fatty acids

DIO

Diet induced obesity
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FFA

Free fatty acids

HFD

High fat diet

OM6 PUFA

Omega 6 polyunsaturated fatty acids

CLA

Conjugated linoleic acids

MUFA

Monounsaturated fatty acids

OM3 PUFA

Omega 3 polyunsaturated fatty acids

GPR120

G-protein coupled receptor 120

FFAR4

Free fatty acid receptor 4

GLUT-4

Glucose transporter 4

HO-1

Heme oxygenase 1

FGF

Fibroblast growth factor

FGF-21

Fibroblast growth factor 21

PGC1-alpha

Peroxisome proliferator-activated receptor -y coactivator -1 alpha

FNDC5

Fibronectin type III domain-containing protein 5

AMPK

AMP- activated protein kinase

OM3

Omega 3-enriched diet

AMP

Adenosine monophosphate

IBD

Inflammatory bowel disease

HOMA-IR

Homeostasis model assessment for insulin resistance

GPBAR-1

G protein-coupled bile acid receptor 1

FXR

Farnesoid X receptor

PYY

Peptide YY

SCFA

Short chain fatty acid
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5-HT

5-hydroxytryptamine

NF-κB

Nuclear factor kappa-light-chain-enhancer of activated B cells

LPS

Lipopolysaccharides

ClpB

Caseinolytic protease B

CNS

Central nervous system

[Tg(CAT)±]

Catalase transgenic mice

U.S.A.

United States of America

hCAT

Human catalase

EtOH

Ethanol

TE

Tris – EDTA

WT

Wild type

EtBr

Ethidium bromide

ECHO-MRI

ECHO magnetic resonance imaging

CLAMS

Comprehensive lab animal monitoring system

VO2

Volume of O2 consumption

VCO2

Volume of CO2 production

RER

Respiratory Exchange Ratio/Rate

XAMB/X-AMB

X Ambulatory

EE

Energy Expenditure

FI

Food Intake

RBCs

Red blood cells

IM

Intestinal mucosa

TC

Total Cholesterol
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mCAT

Mouse catalase

RIPA buffer

Radioimmunoprecipitation assay buffer

1X TBST

1X Tris buffered saline

SDS

Sodium dodecyl sulfate

DNP

Dinitrophenylhydrazone

DNPH

Dinitrophenylhydrazine

1X PBST

Phosphate buffered saline and Tween 20

BSA

Bovine serum albumin

S.E.M.

Standard Error of the Mean

PUFA

Polyunsaturated fatty acids

C57Bl6

C57/WT

NC

Normal Chow

CHO

Carbohydrate (CHO) Oxidation

ALA

α-linoleic acid

AGRP

Agouti Related Peptide

CART

Cocaine-Amphetamine Related Transcript

Gas

Gastrocnemius

OCT

Optimal Cutting Temperature

OTU

Operational Taxonomic Units

PCoA

Principal coordinates analyses

LDA

Linear Discriminant Analysis

BW

Body Weight

SubQ

Subcutaneous
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E

Exercise

S

Sedentary

PICRUSt

Phylogenetic Investigation of Communities by Reconstruction of
Unobserved States

BDNF

Brain Derived Neurotrophic Factor

IBS

Irritable Bowel Syndrome
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APPENDIX C: CURRICULUM VITAE
Deborah L. Amos
amos23@marshall.edu
2026 Blennerhassett Heights, Parkersburg, WV 26101
(304)-991-5932
EDUCATION
Ph.D. Candidate in Biomedical Sciences, Marshall University, Huntington, WV
Emphasis Cardiovascular Disease, Diabetes, and Obesity
B.S. in Biology, Biology Education, and General Science Education, Spring 2013, University
of Charleston, Charleston, WV
Minor in Chemistry, Spring 2013, University of Charleston, Charleston, WV
RESEARCH EXPERIENCE
Graduate Student, Fall 2013 to present
Marshall University, Dr. Nalini Santanam
Assessing the effects of exercise on appetite regulation and the microbiome using an antioxidant
mouse model with the following techniques and reagents:
• Breeding of Mice and Genotyping (Tail DNA)
• Mouse Grip Strength Tests as a measure of muscle function
• Mouse Treadmill Operation according to developed protocol (Columbus Instruments;
Columbus, OH)
• Mouse MRI (Magnetic Resonance Imaging) use and analysis
• Mouse CLAMS (Comprehensive Animal Monitoring System) use and analysis
• Animal Anesthetization, Blood Draw, and Tissue Collection
• Muscle Sectioning via Cryostat
• Muscle Fiber Typing (myosin ATPase Staining) and H&E staining
• Microscope Analysis of Muscle Fiber Types
• Agarose Gel Electrophoresis
• RNA isolation and reverse transcription
• Real-time Polymerase Chain Reaction (PCR) to determine presence and expression of
adipokines, cytokines, myokines, and oxidative stress markers in collected tissues
• Protein quantification by Lowry method
• SDS-Page and Western blotting
• OxyBlot for detection of oxidized proteins in collected tissues
• Enzymatic Activity of Catalase (use of Kinetics Programing on a Spectrophotometer)
• Simple Protein “Wes” Training
• iLab Training Software
• Basic Cell Culture
• GraphPad Prism 7 Software (Statistical Analysis)
• SPSS Software (Statistical Analysis)
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Capstone Student Mentor, Summer and Fall 2016 and 2017; Spring 2016, 2017, and 2018 at
Marshall University
• Trained undergraduate students to work on an exercise/redox regulation project
Summer Undergraduate Research Student Mentor, Summer 2015, Summer 2016
• Assisted in developing and overseeing projects of students in the NIH-funded WVINBRE program and SRIMS program
Summer Medical Student Research Student Mentor, Summer 2018
• Assisted in developing and advising medical students in conducting biomedical research
funded by the Joan C. Edwards School of Medicine.
PUBLICATIONS
Omega 3 diet modulates energy metabolism via GPR120-Nrf2 crosstalk in a novel
antioxidant mouse model. Amos DL, Cook C, Hoffsted A, Crain C, Santanam N.
Biochim Biophys Acta Mol Cell Biol Lipids. January 2019; doi: 10.1016/j.bbalip.2019.01.002
Catalase overexpression modulates metabolic parameters in a new ‘stress-less’ leptindeficient mouse model. Amos DL, Robinson T, Massie MB, Cook C, Hoffsted A, Crain C,
Santanam N.
Biochim Biophys Acta. June 2017; 1863(9):2293-2306. doi: 10.1016/j.bbadis.2017.06.016.
Mitochondrial redox status as a target for cardiovascular disease.
James Walters, Deborah Amos, Kristeena Ray, Nalini Santanam. Current Opinion in
Pharmacology April 2016; 27:50-55. doi: 10.1016/j.coph.2016.01.006.
SCHOLARSHIPS and GRANTS
2017-2018 WV State NASA Space Grant Consortium: Graduate Student Fellowship
($12,000 Grant); “Exercise Regulates the Gut Microbiome through Skeletal Muscle Myokine
Secretion”
2016-2017 WV State NASA Space Grant Consortium: Graduate Student Fellowship
($12,000 Grant); “Exercise Regulates Brain-adipose Tissue Crosstalk in the Stress less Mouse
Model”
2015-2016 WV State NASA Space Grant Consortium: Graduate Student Fellowship
($12,000 Grant); “Exercise Improves Skeletal Muscle Function in the ‘Stress-less’ Mouse”
Graduate Student Organization Master’s Student Scholarship August 2014
Marshall University Cross Country and Track/Field Scholarship 2013-2014
Kanawha City Lion’s Club Grant: Safety Goggles at Capitol High School Spring 2013
HONORS and AWARDS
• World Congress Targeting Microbiota 2018 Director’s Selection Poster Presentation
Award – “Synergistic effects of exercise and antioxidant-overexpression on myokines
and gut microbiome” October 2018
• Kappa Delta Pi Member of the Month (October 2018)
• Kappa Delta Pi Excellence Award: for outstanding service and contributions in education
April 27, 2018; December 8, 2018
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Marshall University “Spirit of Excellence Award” Recipient: Given to a student with
exceptional contributions to student life. The award formally honors students who excel
in campus involvement and service to the University, their peers, and the broader
community April 19, 2018
2nd Year in a Row Awarded “Who’s Who Among Students in American Universities and
Colleges”- Recognizing outstanding members of the Marshall University student
community for their contributions of leadership and service. April 16, 2018
Recognized as both Kappa Delta Pi Education Honorary Outstanding Member Award
(service and contributions) and Most Active Member December 8, 2017
Marshall University’s Most Outstanding Graduate School Student 2016-2017
(Biomedical Sciences) August 18, 2017
Awarded “Who’s Who Among Students in American Universities and Colleges”Recognizing outstanding members of the Marshall University student community for
their contributions of leadership and service. April 14, 2017
Second Place Poster Presentation Obesity and Diabetes 2016 Appalachian Regional Cell
Conference October 1, 2016.
2016 Young WV Award (recognition for leadership in West Virginia)
Honorarium: Research Seminar at Juniata College: “Exercise, Redox, Microbiome?”
June 2016
First Prize Graduate Poster Presentation Competition NASA S.P.A.C.E. Day April 2016
ASBMB (American Society for Biochemistry and Molecular Biology) Graduate Travel
Award April 2016
Marshall Campus Rec Fitness Award: Fall 2014, Spring 2015, Spring 2016
Kanawha City Lions Club Community Service Award November 2015
Run, Run, Rudolph (5K Road Race) Fall 2014
Track and Field Conference Champion 5K Spring 2013
WVIAC Scholar-Athlete Award (one female chosen per institution) Spring 2013
First Team Capital One Academic All-District selections Spring 2013
Academic All-American (Cross Country) Fall 2011, Fall 2012
University of Charleston Outstanding Student in Science Research April 2012

ABSTRACTS, CONFERENCES, and PRESENTATIONS
• Marshall University Joan C. Edwards School of Medicine Research Day “Redox
regulation of behavior changes in diet-induced ‘stress-less’ obese mouse model,” 2019
Huntington, WV
• World Congress Targeting Microbiota 2018: “Synergistic effects of exercise and
antioxidant-overexpression on myokines and gut microbiome” 2018 Director’s Selection
Poster Presentation Award, October 30, 2018, Porto, Portugal
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Marshall University Joan C. Edwards School of Medicine Research Day “Redox Balance
Regulates FGF21 in the Novel “Stress-less” Mouse Model” March 2018; Huntington,
WV
2017 Appalachian Regional Cell Conference, Oral Presentation “Exercise Improves
Energy Metabolism in a Novel Obese “Stress-Less” Mouse Model” December 2, 2017,
Athens, OH
Biomedical Science Lecture on Research Topic: “Adipose Tissue: What is the Storage
Depot We Call Fat Tissue?” September 1, 2017
Graduate School Lecture on Research Topic: “Obesity: What is the storage molecule we
call fat?” April 26, 2017 Marshall University Huntington, WV
CCTS Spring Conference “Exercise Modulates Energy Metabolism in an Obese ‘StressLess’ Mouse Model” March 30, 2017, Lexington, Kentucky
Marshall University Joan C. Edwards School of Medicine Research Day “Exercise
Modulates Energy Metabolism in an Obese ‘Stress-Less’ Mouse Model” March 24,
2017; Huntington, WV
Lay Talk to Marshall University Undergraduates on Current Research Progress:
“Exercise, Redox Regulation, and Appetite” February 21, 2017; Huntington, WV
2016 Appalachian Regional Cell Conference, November 2016; Huntington, WV * 2nd
Place Poster Presentation
Research Seminar “Exercise, Redox, Microbiome?” Juniata College June 8, 2016;
Huntingdon, PA
CCTS (Center for Clinical and Translational Science) Spring Conference, April 2016;
Lexington, Kentucky
2nd Annual NASA S.P.A.C.E. Day, April 2016; Fairmont, WV *1st Prize Poster
Presentation
Experimental Biology Conference, April 2016; San Diego, CA * ASBMB Travel Award
Recipient
Biomedical Science State of the Art Seminar “Exercise and its myriad of benefits: A
mechanistic update.” at Marshall University March 2016; Huntington, WV
Marshall University School of Medicine Research Day, March 2016; Huntington, WV
2015 Appalachian Regional Cell Conference, November 2015; Huntington, WV
Marshall University School of Medicine Research Day, March 2015; Huntington, WV
Biomedical Science Research Retreat, August 2015; Huntington, WV
2014 Appalachian Regional Cell Conference, November 2014; Huntington, WV
Biomedical Science Research Retreat, August 2014; Huntington, WV

WORK EXPERIENCE
Marshall University School of Medicine Live Patient for Examination- Fall 2013 -Spring
2015
o Served as a “dummy” for medical and pharmacy student examinations.
Mountaineer Family Restaurant- Parkersburg, WV- May 2009 – Summer 2015
o Hostess/Waitress- provided assistance as a server, cashier, and food prep personnel.
Resident Assistant- University of Charleston- Charleston, WV -June 2010 – May 2013
o Directed a minimum of five service projects per year, attended weekly meetings to
organize events and work hours, served as secretary of the Residence Hall Association,
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attended regional meetings to develop further skills in communication and conflict
resolution.
AmeriCorps Energy Express- Martin Elementary School- Parkersburg, WV -June–Aug
2010 - 2013
o Served as a mentor for children K-3rd Grade. Provided instruction in reading, writing, art,
and drama. Taught table manners and directed two community service projects each
summer.
TEACHING EXPERIENCE
Ohio Valley University: Parkersburg, WV (Spring 2019)
- Instructed undergraduates in Microbiology and Human Anatomy and Physiology
Teaching Practicum: Huntington, WV (Spring 2017)
- Taught undergraduates in Cell Metabolism in the Marshall University Biomedical
Science Program
Covenant School 9th Grade Biology Teacher: Huntington, WV (2014-2015)
- Solely instructed the high school biology course for Covenant School
Capitol High School: Charleston, WV (Fall 2012)
- Student Teaching
- Semester long: 9-12th grade Biology, Advanced Biology, AP Biology
DuPont Middle School (Spring 2012)
- Semester long: 6th grade science : focus on the cell and metabolism
AFFILIATIONS
Marshall University Summer Biomedical Science Writing Group Summer 2018
American Heart Association, Student Member 2017-Present
Graduate Women in Science, Student Member 2017-Present
Student Government Association, Senator and Finance Representative 2016-2017, 20172018
Gamma Beta Phi – National Honor Society, Member September 2016-Present
Golden Key International Honor Society, Member September 2016-Present
Kappa Delta Pi (KDP) – Education Honorary, Member September 2016-Present
American Nutrition Society (ASN), Member 2015-Present
American Association for the Advancement of Science (AAAS) Program for Excellence in
Science, Member 2015-Present
Graduate Student Organization, Secretary (2014-2015) Vice President (2015-2016),
Marshall University BMS program
• Scheduled and led monthly meetings and overseeing activities
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Aided in organization of student opportunities such as tutoring for first year students and
various fundraising initiatives (International Food Festival, 50/50 raffle)
Served as BMS graduate program liaison for communication between directors, faculty,
and students within the Biomedical Sciences program
Attended presentations by peers and potential faculty
Volunteered as a Tutor for Graduate Level Entrance Courses
Volunteered for BMS Open House and Ph.D. interview events

Marshall University Lions Club, President, (2015-2016) (2016-2017) (2017-2018) Marshall
University
• Responsible for scheduling and leading bimonthly meetings and overseeing activities
• Communication between Regional Lion’s Clubs and coordinating service events between
the region
• Organized Bake Sales and Other Fundraising Events (all monetary funds go toward
giving back to the community)
• Providing Marshall University Students with opportunities to serve the community
through novel events (Trick or Treat for TP, the “Jared Box,” Cabell Huntington’s
Children’s Hospital Valentine’s Day, Wingate Care Facility Easter Baskets, etc.)
• Served weekly to provide basic necessities to Huntington’s Homeless
Marshall University “Unraveled” (Knitting/Crochet Club) Treasurer, (2015-2016) (20162017) (2017-2018) Marshall University
• Communicated with Marshall University Student Organization Office to acquire funding
and report budget status.
• Kept records of money spent and housing club materials
COMMUNITY INVOLVEMENT and PHILANTHROPY
26th Street church of Christ – Summer 2013 –current
• Attended biweekly services and participated in community dinners, seminars, and sings
• Contributed to organizations providing aid in third world countries and local disaster
relief
• Made cheer baskets for the elderly of the Huntington Community
Herd 4 Christ, 26th Street church of Christ– Summer 2013-current
• Habitat for Humanity- roofing and basic building maintenance
• Mid-Western Children’s Home Retreat- providing assistance in lawn/building
maintenance for orphans
• Biannual Senior Dinners – serving to cook and waitress for the elderly in the
congregation
• Kids for Christ Conference – creating activities for elementary and middle school age
children
Marshall Medical Outreach (MMO) / Saturday Street Ministry- Spring 2014 -current
• Organizing hygiene products and snack packs for those in need
• Clothing Donations (ie. Coat drive, knitting hats/scarves)
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Knitting for the Homeless (various hats, scarves, blankets)
Volunteer Recruitment

Biological Dissections Spring 2018
• Teaching 5th Grade Cabell County “Talented and Gifted” students how to dissect
earthworms, crayfish, grasshoppers, frogs, and fetal pigs
Brain Expo- Fall 2015, Fall 2016, Spring 2017, Spring 2018
• Teaching Elementary Age Students about “Brain Health”
Science “Blitz” Day Spring 2018
• Teaching Elementary – High School students how to properly conduct science projects in
their home
Jared Box Fall 2013, 2014, 2015, 2016, 2017, 2018
• Organized, collected, wrapped, and delivered toys, donated by the community, for
children in Cabell Huntington Hospital
Medical Mission Trips to Managua, Nicarauga (2010, 2011)
• Aided in collection of toiletry products
• Assisted doctors and nurses with blood pressure, pulse, etc.
Director of Covenant School First Annual Science Fair
• Volunteer recruiter/organizer
• Reservation coordinator
• Presenter of Awards
ADDITIONAL SKILLS/CERTIFICATIONS
Laboratory: CITI Certification for Handling of Mice, Handling of Rats, and Surgical
Procedures; Marshall University Biosafety and Chemical Safety; Flinn Scientific
Laboratory/Chemical Safety Certification
Languages: Conversational Spanish
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